
<html lang="en"     class="pb-page"  data-request-id="449370ac-f8e0-48d7-afdf-afe0adda2777"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2007.50.issue-20;article:article:10.1021/jm0704705;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones" /></meta><meta name="dc.Creator" content="Cristina  Gardelli,*,§" /></meta><meta name="dc.Creator" content="Emanuela  Nizi,§" /></meta><meta name="dc.Creator" content="Ester  Muraglia,§" /></meta><meta name="dc.Creator" content="Benedetta  Crescenzi,§" /></meta><meta name="dc.Creator" content="Marco  Ferrara,§" /></meta><meta name="dc.Creator" content="Federica  Orvieto,§" /></meta><meta name="dc.Creator" content="Paola  Pace,§" /></meta><meta name="dc.Creator" content="Giovanna  Pescatore,§" /></meta><meta name="dc.Creator" content="Marco  Poma,§" /></meta><meta name="dc.Creator" content="Maria del Rosario  Rico Ferreira,§" /></meta><meta name="dc.Creator" content="Rita  Scarpelli,§" /></meta><meta name="dc.Creator" content="Carl F.  Homnick,‖" /></meta><meta name="dc.Creator" content="Norihiro  Ikemoto,⊥" /></meta><meta name="dc.Creator" content="Anna  Alfieri,§" /></meta><meta name="dc.Creator" content="Maria  Verdirame,§" /></meta><meta name="dc.Creator" content="Fabio  Bonelli,§" /></meta><meta name="dc.Creator" content="Odalys  Gonzalez Paz,§" /></meta><meta name="dc.Creator" content="Marina  Taliani,§" /></meta><meta name="dc.Creator" content="Edith  Monteagudo,§" /></meta><meta name="dc.Creator" content="Silvia  Pesci,§" /></meta><meta name="dc.Creator" content="Ralph  Laufer,§" /></meta><meta name="dc.Creator" content="Peter  Felock,‡" /></meta><meta name="dc.Creator" content="Kara A.  Stillmock,‡" /></meta><meta name="dc.Creator" content="Daria  Hazuda,‡" /></meta><meta name="dc.Creator" content="Michael  Rowley,§ and" /></meta><meta name="dc.Creator" content="Vincenzo  Summa§" /></meta><meta name="dc.Description" content="The human immunodeficiency virus type-1 (HIV-1) encodes three enzymes essential for viral replication:  a reverse transcriptase, a protease, and an integrase. The latter is responsible for the inte..." /></meta><meta name="Description" content="The human immunodeficiency virus type-1 (HIV-1) encodes three enzymes essential for viral replication:  a reverse transcriptase, a protease, and an integrase. The latter is responsible for the inte..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="September 8, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm0704705" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-50-20-4953" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(07)00470-0" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2007 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm0704705" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm0704705" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm0704705" /></link>
        
    
    

<title>Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm0704705" /></meta><meta property="og:title" content="Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705n00001.jpeg" /></meta><meta property="og:description" content=" The human immunodeficiency virus type-1 (HIV-1) encodes three enzymes essential for viral replication:  a reverse transcriptase, a protease, and an integrase. The latter is responsible for the integration of the viral genome into the human genome and, therefore, represents an attractive target for chemotherapeutic intervention against AIDS. A drug based on this mechanism has not yet been approved. Benzyl-dihydroxypyrimidine-carboxamides were discovered in our laboratories as a novel and metabolically stable class of agents that exhibits potent inhibition of the HIV integrase strand transfer step. Further efforts led to very potent compounds based on the structurally related N−Me pyrimidone scaffold. One of the more interesting compounds in this series is the 2-N-Me-morpholino derivative 27a, which shows a CIC95 of 65 nM in the cell in the presence of serum. The compound has favorable pharmacokinetic properties in three preclinical species and shows no liabilities in several counterscreening assays.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm0704705"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm0704705">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm0704705&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm0704705&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm0704705&amp;href=/doi/10.1021/jm0704705" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2007</span><span class="cit-fg-volume">, 50</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 4953-4975</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/50/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm070435y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm061404q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emanuela++Nizi">Emanuela Nizi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ester++Muraglia">Ester Muraglia</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benedetta++Crescenzi">Benedetta Crescenzi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Ferrara">Marco Ferrara</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Orvieto">Federica Orvieto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Pace">Paola Pace</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Pescatore">Giovanna Pescatore</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Poma">Marco Poma</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+del+Rosario++Rico+Ferreira">Maria del Rosario Rico Ferreira</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Scarpelli">Rita Scarpelli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carl+F.++Homnick">Carl F. Homnick</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norihiro++Ikemoto">Norihiro Ikemoto</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Alfieri">Anna Alfieri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Verdirame">Maria Verdirame</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Bonelli">Fabio Bonelli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Odalys++Gonzalez+Paz">Odalys Gonzalez Paz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marina++Taliani">Marina Taliani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edith++Monteagudo">Edith Monteagudo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Pesci">Silvia Pesci</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph++Laufer">Ralph Laufer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Felock">Peter Felock</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kara+A.++Stillmock">Kara A. Stillmock</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daria++Hazuda">Daria Hazuda</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Summa">Vincenzo Summa</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm0704705&amp;href=/doi/10.1021%2Fjm0704705" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2007</span></span><span class="cit-volume">, 50</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 4953–4975</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 8, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 April 2007</li><li><span class="item_label"><b>Published</b> online</span>8 September 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 October 2007</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm0704705" title="DOI URL">https://doi.org/10.1021/jm0704705</a></div><div class="article_header-article-copyright"><strong>Copyright © 2007 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4953%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCristina%2BGardelli%252C%2BEmanuela%2BNizi%252C%2BEster%2BMuraglia%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D50%26issueNum%3D20%26contentID%3Djm0704705%26title%3DDiscovery%2Band%2BSynthesis%2Bof%2BHIV%2BIntegrase%2BInhibitors%253A%25E2%2580%2589%2BDevelopment%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BN-Methyl%2BPyrimidones%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4975%26publicationDate%3DOctober%2B2007">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm0704705"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3070</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm0704705" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;},{&quot;first_name&quot;:&quot;Emanuela&quot;,&quot;last_name&quot;:&quot;Nizi&quot;},{&quot;first_name&quot;:&quot;Ester&quot;,&quot;last_name&quot;:&quot;Muraglia&quot;},{&quot;first_name&quot;:&quot;Benedetta&quot;,&quot;last_name&quot;:&quot;Crescenzi&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Ferrara&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Orvieto&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Pace&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Pescatore&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Poma&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;del Rosario Rico Ferreira&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Scarpelli&quot;},{&quot;first_name&quot;:&quot;Carl&quot;,&quot;last_name&quot;:&quot;F. Homnick&quot;},{&quot;first_name&quot;:&quot;Norihiro&quot;,&quot;last_name&quot;:&quot;Ikemoto&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Alfieri&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Verdirame&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Bonelli&quot;},{&quot;first_name&quot;:&quot;Odalys&quot;,&quot;last_name&quot;:&quot;Gonzalez Paz&quot;},{&quot;first_name&quot;:&quot;Marina&quot;,&quot;last_name&quot;:&quot;Taliani&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Monteagudo&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Pesci&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Felock&quot;},{&quot;first_name&quot;:&quot;Kara&quot;,&quot;last_name&quot;:&quot;A. Stillmock&quot;},{&quot;first_name&quot;:&quot;Daria&quot;,&quot;last_name&quot;:&quot;Hazuda&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Summa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;50&quot;,&quot;pages&quot;:&quot;4953-4975&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm0704705&quot;},&quot;abstract&quot;:&quot;The human immunodeficiency virus type-1 (HIV-1) encodes three enzymes essential for viral replication:  a reverse transcriptase, a protease, and an integrase. The latter is responsible for the integration of the viral genome into the human genome and, therefore, represents an attractive target for chemotherapeutic intervention against AIDS. A drug based on this mechanism has not yet been approved. Benzyl-dihydroxypyrimidine-carboxamides were discovered in our laboratories as a novel and metabolically stable class of agents that exhibits potent inhibition of the HIV integrase strand transfer step. Further efforts led to very potent compounds based on the structurally related N−Me pyrimidone scaffold. One of the more interesting compounds in this series is the 2-N-Me-morpholino derivative 27a, which shows a CIC95 of 65 nM in the cell in the presence of serum. The compound has favorable pharmacokinetic properties in three preclinical species and shows no liabilities in several counterscreening assays.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0704705&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0704705" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0704705&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0704705" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0704705&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0704705" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm0704705&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0704705&amp;href=/doi/10.1021/jm0704705" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm0704705" /></input><a href="/doi/pdf/10.1021/jm0704705" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (398 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm0704705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm0704705%26sid%3Dliteratum%253Aachs%26pmid%3D17824681%26genre%3Darticle%26aulast%3DGardelli%26date%3D2007%26atitle%3DDiscovery%2Band%2BSynthesis%2Bof%2BHIV%2BIntegrase%2BInhibitors%253A%25E2%2580%2589%2BDevelopment%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BN-Methyl%2BPyrimidones%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D50%26issue%3D20%26spage%3D4953%26epage%3D4975%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292224" title="Serum">Serum</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/50/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The human immunodeficiency virus type-1 (HIV-1) encodes three enzymes essential for viral replication:  a reverse transcriptase, a protease, and an integrase. The latter is responsible for the integration of the viral genome into the human genome and, therefore, represents an attractive target for chemotherapeutic intervention against AIDS. A drug based on this mechanism has not yet been approved. Benzyl-dihydroxypyrimidine-carboxamides were discovered in our laboratories as a novel and metabolically stable class of agents that exhibits potent inhibition of the HIV integrase strand transfer step. Further efforts led to very potent compounds based on the structurally related N−Me pyrimidone scaffold. One of the more interesting compounds in this series is the 2-N-Me-morpholino derivative <b>27a</b>, which shows a CIC<sub>95</sub> of 65 nM in the cell in the presence of serum. The compound has favorable pharmacokinetic properties in three preclinical species and shows no liabilities in several counterscreening assays. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm0704705AF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone:  +39-0691093279. Fax:  +39-0691093654. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4625342f35322f28271921273422232a2a2f062b2334252d6825292b68">[email protected]</a> </p></span></div><div class="fnGroupItem" id="jm0704705AF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A.</p></span></div><div class="fnGroupItem" id="jm0704705AF5"><span><h4><span class="NLM_fn-symbol">‖</span></h4></span><span><p class="last">  Department of Medicinal Chemistry, Merck Research Laboratory.</p></span></div><div class="fnGroupItem" id="jm0704705AF6"><span><h4><span class="NLM_fn-symbol">⊥</span></h4></span><span><p class="last">  Department of Process Research, Merck Research Laboratory.</p></span></div><div class="fnGroupItem" id="jm0704705AF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Department of Antiviral Research, Merck Research Laboratory.</p></span></div><div class="fnGroupItem" id="jm0704705n00001"><span><h4></h4></span><span><p class="first last">Abbreviations:  TFA, trifluoroacetic acid; TMS, tetramethylsilane; DMSO, dimethyl sulfoxide; DCM, dichloromethane; THF, tetrahydrofuran; TEA, triethylamine; <i>m</i>-CPBA, <i>meta</i>-chloroperbenzoic acid; TFAA, trifluoroacetic anhydride; MTBE, <i>tert</i>-butyl methyl ether; DMAP, 4-dimethylaminopyridine; DAST, (diethylamino)sulfur trifluoride; PK, pharmacokinetic.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The HIV genome exists within the virus as a positive sense RNA strand and encodes three constitutive viral enzymes that are required for viral replication:  a protease, a reverse transcriptase, and an integrase. Inhibitors of the viral reverse transcriptase,<sup><a onclick="showRef(event, 'jm0704705b00001 jm0704705b00002 jm0704705b00003 jm0704705b00004'); return false;" href="javascript:void(0);" class="ref jm0704705b00001 jm0704705b00002 jm0704705b00003 jm0704705b00004">1-4</a></sup> along with protease inhibitors,<sup><a onclick="showRef(event, 'jm0704705b00005 jm0704705b00006 jm0704705b00007'); return false;" href="javascript:void(0);" class="ref jm0704705b00005 jm0704705b00006 jm0704705b00007">5-7</a></sup> have been combined to form the basis of the so-called triple combination therapy or “HAART”. Attacking the virus on as many fronts as possible has proven to be the most effective way of suppressing viral replication in patients. While triple therapy has extended the lives of many, there are others for whom drug treatment has failed, either because of the emergence of viral strains resistant to the current drugs or simply because of the intolerable side effects of the drugs themselves. For these reasons, many laboratories have been involved in unraveling the structure and function of HIV integrase, with the ultimate goal of finding small molecule HIV integrase inhibitors with clinical utility.<sup><a onclick="showRef(event, 'jm0704705b00008 jm0704705b00009 jm0704705b00010 jm0704705b00011'); return false;" href="javascript:void(0);" class="ref jm0704705b00008 jm0704705b00009 jm0704705b00010 jm0704705b00011">8-11</a></sup> Integration is believed to be mediated by integrase<sup><a onclick="showRef(event, 'jm0704705b00012'); return false;" href="javascript:void(0);" class="ref jm0704705b00012">12</a></sup> in three steps:  assembly of a stable nucleoprotein complex with viral DNA sequences, cleavage of the two nucleotides from the 3‘ termini of the linear proviral DNA, and covalent joining of the recessed 3‘OH termini of the proviral DNA at a staggered cut made at the host target site. The fourth step in the process, repair synthesis of the resultant gap, may be accomplished by cellular enzymes. The viral integrase is expressed as a 32 kDa, 288 amino acid residue protein containing three distinct regions:  the N-terminus of the enzyme contains a zinc binding domain, including amino acid residues 1−50, with a highly conserved “HH−CC” motif, followed by the catalytic core from residues 51 to 212 and the C-terminal DNA binding domain from residues 213 to 288, whose function is binding and orientation of viral DNA during the integration process. The catalytic core domain contains two aspartate (Asp64, Asp116) and one glutamate (Glu152) residues that are essential for the catalytic activity of the integrase and are believed to bind Mg<sup>2+</sup> or Mn<sup>2+</sup> ions.<sup><a onclick="showRef(event, 'jm0704705b00013'); return false;" href="javascript:void(0);" class="ref jm0704705b00013">13</a></sup> The presence of either of these divalent ions is required for HIV integrase catalytic activity and also the activity of integrase inhibitors such as diketoacids <b>1</b>, which were recently disclosed by us and others,<sup><a onclick="showRef(event, 'jm0704705b00014'); return false;" href="javascript:void(0);" class="ref jm0704705b00014">14</a></sup> was shown to be metal-dependent. The diketoacid structure <b>1</b> was believed to be essential for the activity of many integrase inhibitors. The structures of diketotriazole (S1360),<sup><a onclick="showRef(event, 'jm0704705b00015'); return false;" href="javascript:void(0);" class="ref jm0704705b00015">15</a></sup> diketotetrazoles (5CITEP),<sup><a onclick="showRef(event, 'jm0704705b00016'); return false;" href="javascript:void(0);" class="ref jm0704705b00016">16</a></sup> diketopyridine,<sup><a onclick="showRef(event, 'jm0704705b00017'); return false;" href="javascript:void(0);" class="ref jm0704705b00017">17</a></sup> and 7-carbonyl-8-hydroxy-(1,6)-naphthyridine<sup>17</sup> are examples of bioisosteres of the diketoacid pharmacophore. Naphthyridine <b>2</b> was shown to be efficacious against replication of simian-human immunodeficiency virus (SHIV) 89.6P in infected rhesus macaques, demonstrating that integrase inhibitors can be engineered with all the appropriate properties required for an effective therapy to treat HIV infections.<sup><a onclick="showRef(event, 'jm0704705b00018'); return false;" href="javascript:void(0);" class="ref jm0704705b00018">18</a></sup> In our laboratories, studies on inhibitors of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, such as diketoacids <b>1</b><sup><a onclick="showRef(event, 'jm0704705b00019'); return false;" href="javascript:void(0);" class="ref jm0704705b00019">19</a></sup> and 3-hydroxypyran-4-one carboxylic acid derivative <b>3</b>,<sup><a onclick="showRef(event, 'jm0704705b00020'); return false;" href="javascript:void(0);" class="ref jm0704705b00020">20</a></sup> led to the preparation of a series of 2-aryl-5,6-dihydroxypyrimidine-4-carboxylic acids <b>4</b> (Figure 1<a data-tab="pane-pcw-Figures" href="#jm0704705f00001" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm0704705b00021 jm0704705b00022 jm0704705b00023 jm0704705b00024 jm0704705b00025 jm0704705b00026'); return false;" href="javascript:void(0);" class="ref jm0704705b00021 jm0704705b00022 jm0704705b00023 jm0704705b00024 jm0704705b00025 jm0704705b00026">21-26</a></sup> HIV integrase and HCV RNA polymerase are mechanistically related enzymes in which divalent magnesium cations (Mg<sup>2+</sup>) play a pivotal role in catalysis. Thus, metal-chelating inhibitors such as diketoacids or mimics thereof are effective against both enzymes. Due to their highly charged nature, compounds <b>4</b> showed only moderate inhibition in the subgenomic cell-based assay of HCV replication, despite good in vitro potency.<sup>22</sup> Conversion to carboxamides such as <b>5</b> abolished the activity on the HCV polymerase, but promising inhibition of <a name="jm005002004954" id="jm005002004954"></a> the HIV integrase in the strand transfer assay was observed, where <b>5</b><sup>26</sup> displayed an IC<sub>50</sub> value of 85 nM. <div id="_i4"><figure id="jm0704705f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 From diketoacid inhibitors <b>1</b> to naphthyridine <b>2</b> and dihydroxypyrimidine carboxamide <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A focused library of 200 carboxamides was assembled,<sup><a onclick="showRef(event, 'jm0704705b00027'); return false;" href="javascript:void(0);" class="ref jm0704705b00027">27</a></sup> and the 4-fluorobenzylamide <b>6</b> emerged as the optimal substituent, displaying an 8-fold improvement in potency (<b>6</b>, IC<sub>50</sub> = 10 nM) although with low cellular activity (CIC<sub>95</sub> >10 μM in the presence of 10% FBS). Improvement of potency in the cell-based assay was obtained by the introduction of a basic residue in position 2 of the pyrimidine, leading to <b>7</b> and ultimately to equipotent 2-pyrrolidinyl or 2-piperidinyl-substituted dihydroxypyrimidines <b>8</b> or <b>9</b>, which inhibited the strand transfer process of integration, with an IC<sub>50</sub> of 120 and 220 nM, respectively (Figure 2<a data-tab="pane-pcw-Figures" href="#jm0704705f00002" id="" class=" internalNav"></a> and Table 1<a class="ref showTableEvent internalNav" data-ID="jm0704705t00001" href="#jm0704705t00001"></a>). Both compounds were potent inhibitors of HIV-1 replication in cell culture, with CIC<sub>95</sub> of 150 nM in the presence of 10% fetal bovine serum, which shifted 3−4-fold when the assay was conducted in the presence of 50% normal human serum as a consequence of extensive binding of these molecules to human plasma proteins.<sup><a onclick="showRef(event, 'jm0704705b00028'); return false;" href="javascript:void(0);" class="ref jm0704705b00028">28</a></sup> Compound <b>9</b> was profiled further and showed modest oral bioavailability (<i>F</i> = 27%) and high plasma clearance (Cl = 75 mL/min/kg) in rats. <div id="_i6"><figure id="jm0704705f00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00002.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 From aromatic derivatives to aliphatic heterocyclic compounds.<sup>29</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm0704705t00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Enzymatic and Antiviral Activity, Rat and Human Plasma Protein Binding, Oral Bioavailability, and Plasma Clearance in Rat of Compounds <b>8</b>−<b>11</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">IC<sub>50</sub><i><sup>a</sup></i><sup></sup> (μM)</td><td class="colsep2 rowsep2">CIC<sub>95</sub> (μM) (10% FBS)<i><sup>b</sup></i><sup></sup>/(50% NHS)<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">protein binding rat<i><sup>d</sup></i><sup></sup>/human<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">rat <i>F</i><i><sup>f</sup></i><sup></sup>/Clp<i><sup>g</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">0.12 </td><td class="colsep2 rowsep2">0.15/0.62 </td><td class="colsep2 rowsep2">89/97 </td><td class="colsep2 rowsep2">nd/nd </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2">0.22 </td><td class="colsep2 rowsep2">0.14/0.40 </td><td class="colsep2 rowsep2">95/95 </td><td class="colsep2 rowsep2">27/75 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>10</b></td><td class="colsep2 rowsep2">0.10 </td><td class="colsep2 rowsep2">5.00/5.00 </td><td class="colsep2 rowsep2">67/52 </td><td class="colsep2 rowsep2">nd/nd </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">0.44 </td><td class="colsep2 rowsep2">0.83/1.00 </td><td class="colsep2 rowsep2">48/55 </td><td class="colsep2 rowsep2">100/31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><a onclick="showRef(event, 'jm0704705b00030'); return false;" href="javascript:void(0);" class="ref jm0704705b00030"></a><a onclick="showRef(event, 'jm0704705b00031'); return false;" href="javascript:void(0);" class="ref jm0704705b00031"></a><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup><a onclick="showRef(event, 'jm0704705b00032'); return false;" href="javascript:void(0);" class="ref jm0704705b00032">32</a></sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup>Percentage of compound bound to rat plasma proteins.<sup><a onclick="showRef(event, 'jm0704705b00033'); return false;" href="javascript:void(0);" class="ref jm0704705b00033">33</a></sup><i><sup>e</sup></i><sup></sup> Percentage of compound bound to human plasma proteins.<sup>33</sup><i><sup>f</sup></i><sup></sup> Oral bioavailability (%).<i><sup>g</sup></i><sup></sup> Plasma clearance (mL/min/kg).</p></div></div></div><div class="NLM_p">In parallel with the further development of the dihydroxypirimidines, we studied the effect of methylation on the N-1 pyrimidine nitrogen, with the goal to improve the in vivo potency and the pharmacological properties of the molecules. </div><div class="NLM_p last">In this paper we describe an extensive and consistent structure−activity relationship that led to the identification of compounds that inhibit HIV integrase in vitro at nanomolar concentration, block effectively HIV replication in cell culture in the presence of high serum concentration, and show excellent physicochemical and pharmacokinetic (PK<i><sup>a</sup></i><sup></sup><a class="ref internalNav" href="#jm0704705n00001" aria-label=""></a>) properties. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structure−activity relationship around <b>8</b> and <b>9</b> had previously established that the amine contained in the ring had to occupy the benzylic position with respect to the pyrimidine and that small alkyl groups, such as methyl or ethyl on the nitrogen of the saturated heterocycle, are preferred.<sup><a onclick="showRef(event, 'jm0704705b00029'); return false;" href="javascript:void(0);" class="ref jm0704705b00029">29</a></sup> We hoped that conversion of the dihydroxypyrimidine to the more polar <i>N</i>-methylpyrimidone would be beneficial for cell-based potency by reducing binding to plasma proteins and targeted first the direct analogs of <b>8</b> and <b>9</b> (Figure 3<a data-tab="pane-pcw-Figures" href="#jm0704705f00003" id="" class=" internalNav"></a>). <div id="_i9"><figure id="jm0704705f00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00003.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 From dihydroxypyrimidines <b>8</b> and <b>9</b> to N−Me pyrimidones <b>10</b> and <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Despite the reduction in intrinsic and in cell-based potency, compound <b>11</b> showed only a small shift between 10% and 50% <a name="jm005002004955" id="jm005002004955"></a> serum, because the polar pyrimidone has a lower affinity for plasma proteins. The pyrrolidine derivative <b>10</b> is 5-fold less potent than compound <b>11</b>, but also here no shift in the cell-based assay was observed. The more potent compound <b>11</b> was characterized further and its PK profile in rat was encouraging. The compound showed moderate clearance (Cl = 31 mL/min/kg) and high oral bioavailability (<i>F</i> = 100%). Encouraged by these preliminary data, we continued the SAR studies on five- and six-membered heterocycles, with the aim to further probe both the cell-based activity and the pharmacological properties of these compounds. </div><div class="NLM_p">The structure−activity relationship surrounding the pyrrolidine ring revealed a certain degree of tolerance for diverse chemical functionalities that could be incorporated, and this confirmed the previous observation that the moiety at the 2-position is not involved in a specific interaction with the enzyme (Table 2<a class="ref showTableEvent internalNav" data-ID="jm0704705t00002" href="#jm0704705t00002"></a>). For better comparison of the data, compound <b>10</b> is reported in Table 2 in its enantiomerically pure form, having a 2<i>S</i>-configuration, <b>10a</b>. Initially, a methyl group was scanned on the pyrrolidine ring by preparation of compounds <b>12</b>−<b>15</b>, and the substitution on the position 4 of the ring, as in compounds <b>13</b> and <b>14</b>, gave the best enzymatic activity. The (<i>S</i>)-configuration was preferred, leading to compound <b>13</b>, with an IC<sub>50</sub> = 10 nM. Based on these data, further SAR was conducted. As position 4 was the most appropriate for substitution, to explore the possibility to vary the physicochemical properties of this class of molecules to achieve activity also in cells, the <i>trans</i>-4-hydroxy pyrrolidine was initially selected based on its synthetic accessibility and ease of decoration; this strategy proved to be both informative and productive. <div class="NLM_table-wrap" id="jm0704705t00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Enzymatic and Antiviral Activity of 2-Pyrrolidinyl N-Me-pyrimidones</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00002a.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup> Mixture of diastereoisomers (2:1), undetermined stereochemistry.</p></div></div></div><div class="NLM_p">Starting from this building block, a series of compounds were prepared. The free hydroxyl group present in compound <b>16</b> gave a moderate activity in the cell, whereas the methoxy, ethoxy, and benzyloxy compounds <b>17</b>−<b>19</b> were potent both in vitro and in cell-based assays. Interestingly, no shift was observed for the small alkyloxy groups, while the benzyloxy derivative <b>19</b> showed at least a 4-fold drop in activity in high serum. The sulfonamide <b>20</b> and the acetamide <b>21</b> were potent in vitro, but had low activity in the cell, probably as a result of an increased polar surface area. The replacement of the hydrogen with a fluorine atom gave potent compounds on the enzyme:  a <i>cis</i>- or <i>trans</i>-fluorine atom in the 4-position was well accepted. The stereochemistry of the fluorine proved to be not crucial in vitro, indeed the two diastereoisomers <b>22</b> and <b>23</b> and also the 4,4-difluorinated compound <b>24</b> showed similar potency. In the cell-based assay, compound <b>22</b> had CIC<sub>95</sub> = 0.13 μM, with a 2-fold shift of the low serum value; the diastereoisomeric <i>trans</i> compound <b>23</b> was 2-fold less potent. The difluoroderivative <b>24</b> exhibited good potency in cells in 10% serum, but lost almost 6-fold in high serum. </div><div class="NLM_p">We then analyzed a six-membered-based substitution in position 2 of the pyrimidine, exploiting the possibility in this <a name="jm005002004956" id="jm005002004956"></a> case to introduce heteroatoms both inside and outside of the ring (Table 3<a class="ref showTableEvent internalNav" data-ID="jm0704705t00003" href="#jm0704705t00003"></a>). <div class="NLM_table-wrap" id="jm0704705t00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Six-Membered Heterocycles in the 2-Position of the Pyrimidone</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00003a.gif" alt="" id="_i12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup> A 9:1 mixture, undetermined stereochemistry.</p></div></div></div><div class="NLM_p">Also in the case of six-membered derivatives, the introduction of a heteroatom was beneficial; the 4-OH-N-Me piperidine derivative <b>25</b> was 20-fold more potent in the enzyme assay and it did not show any shift in cells between low and high serum conditions. This shift was more pronounced with the benzyloxy derivative <b>26</b>, as we observed in the pyrrolidine series. The introduction of a heteroatom inside the ring was beneficial:  the morpholine derivative <b>27</b> showed a high affinity for the enzyme and displayed equal activity in the spread assay, with less than a 2-fold shift between low and high serum. Also, the thiomorpholine <b>28</b> was potent, whereas the oxidation of the sulfur to the sulfoxide <b>29</b> and sulfone <b>30</b> caused reduced activity in cells. The piperazine <b>31</b> was potent in cells, while the lactam <b>32</b>, lowering the basicity of the N1 nitrogen, was less active. The interesting data relative to the piperazine compound <b>31</b> led us to further explore this versatile scaffold, and several derivatives were prepared (Table 4<a class="ref showTableEvent internalNav" data-ID="jm0704705t00004" href="#jm0704705t00004"></a>). <div class="NLM_table-wrap" id="jm0704705t00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  2-Piperazinyl N-Me-pyrimidones</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00004a.gif" alt="" id="_i13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup> No data.</p></div></div></div><div class="NLM_p">As for N1, in the case of the nitrogen in the 4 position, the methyl and ethyl residues gave potent compounds such as <b>31</b> and <b>34</b>; a free NH or a bigger substituent gave compounds (<b>33</b> and <b>35)</b> with comparable enzymatic activity but with lower potency in the spread assay. A sterically hindered carbamate <b>36</b> was well tolerated by the enzyme but exhibited an almost 7-fold shift from 10% to 50% serum in cells. The acetyl group was used as a substituent on the N4-nitrogen, as in compound <b>37</b> where it was well-tolerated, and also to reassess the need of an amino group in the position 1 of the piperazine:  compound <b>38</b>, having the acetyl group on the N1 nitrogen was as expected of low activity. Other substitutions on the nitrogen in the 4 position, such as benzoate, amino acetyl, and ethylurea (<b>39</b>−<b>41</b>), were accepted by the enzyme but did not translate into high potency in the cell-based assay. The activity on the enzyme was further increased with sulfonamide and sulfamide moieties, and in the case of a simple mesyl derivative <b>42</b>, the CIC<sub>95</sub> was 125 nM without any shift in high serum. The phenyl sulfonamide <b>43</b> was more potent in the presence of 10% of fetal bovine serum, but the shift was more than 16-fold between the two serum conditions. The sulfamide <b>44</b> had CIC<sub>95</sub> = 125 nM. </div><div class="NLM_p">With all these compounds having good potency on the enzyme and in the cell-based assay available, we decided to further develop some of them to see if the PK profiles might be able to differentiate among these molecules. The PKs of the most potent and structurally different compounds were studied in rats, and the results are summarized in Table 5<a class="ref showTableEvent internalNav" data-ID="jm0704705t00005" href="#jm0704705t00005"></a> together with some measured log D and the plasma protein binding data. <div class="NLM_table-wrap" id="jm0704705t00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Rat Pharmacokinetic Parameters, Log D, Rat, and Human Plasma Protein Binding</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2"><i>F</i><i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Clp<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">AUC<i><sup>d</sup></i><sup></sup> after PO<sub>(mg/kg)</sub></td><td class="colsep2 rowsep2">LogD</td><td class="colsep2 rowsep2">protein binding rat<i><sup>e</sup></i><sup></sup>/human<i><sup>f</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>16</b></td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">0.1<sub>(2.3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2">78/72 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">79 </td><td class="colsep2 rowsep2">19 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">5.2<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2">89/75 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">75 </td><td class="colsep2 rowsep2">28 </td><td class="colsep2 rowsep2">2.3 </td><td class="colsep2 rowsep2">2.3<sub>(2.4)</sub></td><td class="colsep2 rowsep2">2.2 </td><td class="colsep2 rowsep2">93/95 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">94 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">4.5<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2">92/94 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">12 </td><td class="colsep2 rowsep2">2.0 </td><td class="colsep2 rowsep2">12.5<sub>(3)</sub></td><td class="colsep2 rowsep2">0.66 </td><td class="colsep2 rowsep2">97/86 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">93 </td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">0.6 </td><td class="colsep2 rowsep2">11.8<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2">94/88 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">92 </td><td class="colsep2 rowsep2">22 </td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">4.3<sub>(2.3)</sub></td><td class="colsep2 rowsep2">0.59 </td><td class="colsep2 rowsep2">78/69 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">76 </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">9.7<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup>/83 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">62 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">5.1<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup>/72 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">42 </td><td class="colsep2 rowsep2">0.9 </td><td class="colsep2 rowsep2">0.8<sub>(3)</sub></td><td class="colsep2 rowsep2">0.09 </td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup>/70 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">38 </td><td class="colsep2 rowsep2">78 </td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">0.6<sub>(3)</sub></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i><sup>g</sup></i><sup></sup>/69</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Oral bioavailability (%).<i><sup>b</sup></i><sup></sup> Plasma clearance (mL/min/kg).<i><sup>c</sup></i><sup></sup> Plasma half-life following iv administration (h).<i><sup>d</sup></i><sup></sup> Area under the curve following oral administration at the dose indicated in brackets (μM × h).<i><sup>e</sup></i><sup></sup> Percentage of compound bound to rat plasma proteins.<sup>33</sup><i><sup>f</sup></i><sup></sup> Percentage of compound bound to human plasma proteins.<sup>33</sup><i><sup>g</sup></i><sup></sup> No data.</p></div></div></div><div class="NLM_p">Apart from compound <b>16</b>, which displayed a low oral bioavailability (<i>F</i> = 2%), and the piperazine derivatives <b>37</b> and <b>42</b> that in rat showed high clearance (42 and 78 mL/min/kg, respectively) and moderate oral bioavailability (17 and 38, respectively), all the other compounds had moderate-low clearance, from 10 to 28 mL/min/kg and oral bioavailability from 60 to 100%. Two structurally different compounds, such as <b>24</b> and <b>27</b>, were further profiled in dog, where they displayed excellent PKs:  both had 100% oral bioavailability and low plasma clearance (5 and 3 mL/min/kg, respectively, Table 6<a class="ref showTableEvent internalNav" data-ID="jm0704705t00006" href="#jm0704705t00006"></a>). <div class="NLM_table-wrap" id="jm0704705t00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Dog Pharmacokinetic Parameters and Dog Plasma Protein Binding of Compounds <b>24</b> and <b>27</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2"><i>F</i><i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Clp<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub><i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">AUC<i><sup>d</sup></i><sup></sup> after PO (mg/kg)</td><td class="colsep2 rowsep2">dog protein binding<i><sup>e</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">9.9<sub>(1)</sub></td><td class="colsep2 rowsep2">85 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">11<sub>(0.8)</sub></td><td class="colsep2 rowsep2">47</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Oral bioavailability (%).<i><sup>b</sup></i><sup></sup> Plasma clearance (mL/min/kg).<i><sup>c</sup></i><sup></sup> Plasma half-life following iv administration (h).<i><sup>d</sup></i><sup></sup> Area under the curve following oral administration at the dose indicated in brackets (μM × h).<i><sup>e</sup></i><sup></sup> Percentage of compound bound to dog plasma proteins.</p></div></div></div><div class="NLM_p">Due to the better potency in the presence of 50% normal human serum, the lower serum shift, and the lower clearance in dog, compound <b>27</b> was one of the more interesting compounds made so far and it was the focus of further SAR studies. The dihydroxypyrimidine analog <b>45</b> was tested as well, and although it showed better in vitro potency than the analog piperidine compound <b>9</b> and the corresponding N-Me pyrimidone <b>27</b>, it still exhibited an 8-fold shift between low and high serum and its oral bioavailability in rat was relatively low, 16%. The role of the amino group was revisited, and the most indicative analogs, such as compounds <b>46</b>−<b>49</b>, were prepared (Table 7<a class="ref showTableEvent internalNav" data-ID="jm0704705t00007" href="#jm0704705t00007"></a>). The need of an amino group on the nitrogen of the ring linked to the pyrimidine was reassessed, and the tertiary amino group was shown to be optimal for cell activity. Whereas the free NH compound <b>46</b> exhibited low activity in the spread assay, probably as a consequence of a high number of hydrogen bond donors, the ethyl derivative <b>47</b> was equipotent with the methyl <a name="jm005002004957" id="jm005002004957"></a> derivative <b>27</b>. Acetyl compound <b>48</b> and the carbamate <b>49</b>, although potent on the enzyme, showed low activity in the cell-based assay. <div class="NLM_table-wrap" id="jm0704705t00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Morpholino-N-Me-pyrimidones<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00007a.gif" alt="" id="_i14" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">R<sub>1</sub></td><td class="colsep2 rowsep2">IC<sub>50</sub><i><sup>a</sup></i><sup></sup> (nM)</td><td class="colsep2 rowsep2">CIC<sub>95</sub> (nM) (10% FBS)<i><sup>b</sup></i><sup></sup>/(50% NHS)<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">60 </td><td class="colsep2 rowsep2">60/100 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>45</b><i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">30 </td><td class="colsep2 rowsep2">30/230 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">>1000/>1000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">33 </td><td class="colsep2 rowsep2">50/90 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>48</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Ac </td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2">>1000/>1000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Boc </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">>1000/>1000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup> See ref 29.</p></div></div></div><div class="NLM_p">The structure−activity relationship around the benzylamide portion was assessed by the preparation of different amides (Table 8<a class="ref showTableEvent internalNav" data-ID="jm0704705t00008" href="#jm0704705t00008"></a>). <div class="NLM_table-wrap" id="jm0704705t00008"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 8.  2-N-Me-morpholinyl-N-Me-pyrimidone Carboxamides<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00008a.gif" alt="" id="_i15" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">R<sub>1</sub></td><td class="colsep2 rowsep2">R<sub>2</sub></td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2"><i>n</i></td><td class="colsep2 rowsep2">IC<sub>50</sub><i><sup>a</sup></i><sup></sup><sub> </sub>(nM)</td><td class="colsep2 rowsep2">CIC<sub>95 </sub>(nM) (10% FBS)<i><sup>b</sup></i><sup></sup>/(50% NHS)<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">66 </td><td class="colsep2 rowsep2">156/156 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">71 </td><td class="colsep2 rowsep2">>8000/>8000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">>5000 </td><td class="colsep2 rowsep2">>8000/>8000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>53</b></td><td class="colsep2 rowsep2">2-F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">175 </td><td class="colsep2 rowsep2">156/625 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>54</b></td><td class="colsep2 rowsep2">3-F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">62 </td><td class="colsep2 rowsep2">125/250 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>55</b></td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">62 </td><td class="colsep2 rowsep2">16/63 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>56</b></td><td class="colsep2 rowsep2">3-Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">19 </td><td class="colsep2 rowsep2">16/63 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>57</b></td><td class="colsep2 rowsep2">3-OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">140 </td><td class="colsep2 rowsep2">125/125 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>58</b></td><td class="colsep2 rowsep2">4-F </td><td class="colsep2 rowsep2">3-F </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">21 </td><td class="colsep2 rowsep2">31/63 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>59</b></td><td class="colsep2 rowsep2">4-F </td><td class="colsep2 rowsep2">3-Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">86 </td><td class="colsep2 rowsep2">16/42 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>60</b></td><td class="colsep2 rowsep2">4-F </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">28 </td><td class="colsep2 rowsep2"><8/31 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>61</b></td><td class="colsep2 rowsep2">4-F </td><td class="colsep2 rowsep2">3-Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">44 </td><td class="colsep2 rowsep2">31/125</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup></p></div></div></div><div class="NLM_p">The unsubstituted benzylamide <b>50</b> was shown to have the ideal length, while the homologous phenethylamide <b>51</b> and the N-Me benzylamide <b>52</b> had CIC<sub>95</sub> higher than 8 μM. Different halogens were tested in the three different positions of the phenyl ring, and considering the activity in the cells in the presence of 50% normal human serum, the 4-position was the favorite for <a name="jm005002004958" id="jm005002004958"></a> substitution; although, also in the <i>meta</i>-position, substitution was well-accepted. The combination of the two different substitutions was beneficial, and compounds <b>59</b>−<b>61</b> were potent, although with a higher serum shift passing from <b>59</b> to <b>61</b> probably as consequence of an increased log D. </div><div class="NLM_p">Separating the two single enantiomers of compound <b>27</b> was possible by chiral HPLC resolution, and compounds <b>27a</b> and <b>27b</b> were submitted for testing (Table 9<a class="ref showTableEvent internalNav" data-ID="jm0704705t00009" href="#jm0704705t00009"></a>). The intrinsic activity on the enzyme was the same for the two enantiomers:  IC<sub>50</sub> = 20 and 25 nM for <b>27a</b> and <b>27b</b>. Compound <b>27a</b> was 3-fold more potent than its enantiomer <b>27b</b> in the spread assay in the presence of 50% normal human serum, so it was further characterized with respect to its PK properties. The hydrochloride salt of compound <b>27a</b> was a white crystalline solid, with a solubility of 5.8 mg/mL at physiological pH and a measured log D = 0.47. <div class="NLM_table-wrap" id="jm0704705t00009"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 9.  N-Me-morpholine Derivatives <b>27</b>, <b>27a</b>, and <b>27b</b><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705u00009a.gif" alt="" id="_i16" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">IC<sub>50</sub><i><sup>a</sup></i><sup></sup> (nM)</td><td class="colsep2 rowsep2">CIC<sub>95</sub> (μM) (10% FBS)<i><sup>b</sup></i><sup></sup>/(50% NHS)<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">human protein binding<i><sup>d</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b>(±)<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">60 </td><td class="colsep2 rowsep2">65/100 </td><td class="colsep2 rowsep2">70 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27a</b>(+)<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">40/65 </td><td class="colsep2 rowsep2">81 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27b</b>(−)<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">25 </td><td class="colsep2 rowsep2">90/190 </td><td class="colsep2 rowsep2">74</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> HIV strand transfer assay results are the mean of at least three independent experiments; IC<sub>50</sub> is the concentration of inhibitor that reduces the HIV integrase activity by 50%.<sup>13,30,31</sup><i><sup>b</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 10% of fetal bovine serum (FBS).<sup>32</sup><i><sup>c</sup></i><sup></sup> Spread assay results are the mean of at least three independent experiments; CIC<sub>95</sub> is the concentration of compound that inhibits HIV replication in the cell-based assay by 95% in the presence of 50% normal human serum (NHS).<sup>32</sup><i><sup>d</sup></i><sup></sup> Percentage of compound bound to human plasma proteins.<sup>33</sup><i><sup>e</sup></i><sup></sup> Trifluoroacetate salt.<i><sup>f</sup></i><sup></sup> Hydrochloride salt.</p></div></div></div><div class="NLM_p">An important feature was that compound <b>27a</b> maintained low affinity toward human plasma protein (hPPB = 81), which translated into a less than 2-fold shift in potency against HIV-1 replication in the presence of 50% NHS. The metabolic stability of compound <b>27a</b> was assessed in rat, dog and human liver microsomes in the presence of UDPGA and NADPH.<sup>34</sup> In the presence of NADPH, it was stable in microsomes from all species and no turnover was observed. Similarly, the glucuronidation rate was minimal; to rank the rate of glucuronidation among the species, we analyzed the rate of appearance of the glucuronide, and this was higher in rat and lower in dog and human microsomes (Figure 4<a data-tab="pane-pcw-Figures" href="#jm0704705f00004" id="" class=" internalNav"></a>). It did not show significant degradation both in human and in rat hepatocytes up to 4 h of incubation (data not shown). <div id="_i17"><figure id="jm0704705f00004" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00004.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Glucuronide formation rate of compound <b>27a</b> in rat, dog, rhesus, and human liver microsomes in the presence of UDPGA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Compound <b>27a</b> was dosed in rats intravenously and orally at 3 mg/kg:  it exhibited low clearance (9 mL/min/kg) and it was found to be well-absorbed, with an oral bioavailability of 56%, a good exposure (AUC = 8.0 μM × h), and high C<sub>max</sub> (5.6 μM). </div><div class="NLM_p">When dosed in dogs intravenously and orally (4 mg/kg iv and 10 mg/kg p.o.), it exhibited low clearance (2.2 mL/min/kg) and good half-life (<i>t</i><sub>1/2</sub> = 7.2 h) and it was found to be well-absorbed, with an oral bioavailability of 69%, excellent exposure (AUC = 136 μM × h), and high C<sub>max</sub> (35 μM). After 48 h, the plasma concentration was still higher than the CIC<sub>95</sub> of the compound (Figure 5<a data-tab="pane-pcw-Figures" href="#jm0704705f00005" id="" class=" internalNav"></a>). Compound <b>27a</b> was dosed intravenously and orally also in rhesus monkeys (1 mg/kg):  it exhibited moderate plasma clearance (14 mL/min/kg) and it was found to be well-absorbed, with an oral bioavailability of 73% (Table 10<a class="ref showTableEvent internalNav" data-ID="jm0704705t00010" href="#jm0704705t00010"></a>). <div id="_i19"><figure id="jm0704705f00005" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00005.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Pharmacokinetic profile for compound <b>27a</b> in dogs dosed intravenously (4 mg/kg) and orally (10 mg/kg) as a solution in 35%DMSO/65% (0.9% NaCl) and in 1% methylcellulose, respectively. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm0704705t00010"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 10.  Rat, Dog and Rhesus Monkey Pharmacokinetic Parameters for the Racemic Compound <b>27</b> and Its Single Enantiomers <b>27a</b> and <b>27b</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">F<i><sup>a</sup></i><sup></sup> rat/dog/ rhesus</td><td class="colsep2 rowsep2">Clp<i><sup>b</sup></i><sup></sup> rat/dog/ rhesus</td><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub><i><sup>c</sup></i><sup></sup> rat/dog/ rhesus</td><td class="colsep2 rowsep2">AUC<i><sup>d</sup></i><sup></sup> after PO<sub>(mg/kg)</sub> rat/dog/rhesus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b>(±) </td><td class="colsep2 rowsep2">92/100/53 </td><td class="colsep2 rowsep2">22/3/14 </td><td class="colsep2 rowsep2">1.5/10/1.4 </td><td class="colsep2 rowsep2">4.3<sub>(2.3)</sub>/22<sub>(1.5)</sub>/1.7<sub>(1)</sub></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27a</b>(+) </td><td class="colsep2 rowsep2">56/69/73 </td><td class="colsep2 rowsep2">9/2.2/14 </td><td class="colsep2 rowsep2">1.1/7.2/2.0 </td><td class="colsep2 rowsep2">8<sub>(3)</sub>/136<sub>(10)</sub>/2.2<sub>(1)</sub></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27b</b>(−) </td><td class="colsep2 rowsep2">84/87/<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">18/2.6/<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">1.0/1.9/<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">6<sub>(3)</sub>/29<sub>(2)</sub>/<i><sup>e</sup></i><sup></sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Oral bioavailability (%).<i><sup>b</sup></i><sup></sup> Plasma clearance (mL/min/kg).<i><sup>c</sup></i><sup></sup> Plasma half-life following iv administration (h).<i><sup>d</sup></i><sup></sup> Area under the curve following oral administration at the dose indicated in brackets (μM × h).<i><sup>e</sup></i><sup></sup> No data.</p></div></div></div><div class="NLM_p">Compound <b>27a</b> presented low to moderate clearance in three preclinical species and good oral bioavailability, thus, was an ideal candidate for further investigation. In counterscreening, it was a selective HIV integrase inhibitor, displaying IC<sub>50</sub> higher than 50 μM with respect to HCV polymerase, HIV reverse transcriptase, and human DNA polymerases α, β, and γ. It was tested on a panel of 170 assays for potential ancillary activities and no significant responses were noted (MDS Pharma Services-Panlabs). </div><div class="NLM_p last">Compound <b>27a</b> was tested for hERG-channel activity, and it showed IC<sub>50</sub> = 24 μM.<sup>35</sup> It did not inhibit the major CyP450 enzymes (3A4, 2D6, 1A2, and 2C19) up to 100 μM. It did not react with glutathione after incubation at 37 °C for 24 h, and the [<sup>3</sup>H]-<b>27a</b> after administration in rat (30 mpk, po) did not <a name="jm005002004959" id="jm005002004959"></a> show measurable covalent binding to liver, kidney, and plasma proteins. Glucuronidation was the major metabolic pathway of compound <b>27a</b> in rats and dogs. The major metabolite in rat urine accounting for about 30% of the dose on the basis of <sup>19</sup>F analysis, was the glucuronide conjugate in position 5 of the pyrimidine.<sup>36</sup> LC-MS and <sup>19</sup>F-NMR experiments demonstrated that no racemization occurs in vivo. A second minor metabolite was the <i>N</i>-demethylated morpholine. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compounds were routinely assessed for activity against the purified HIV-1 integrase enzyme.<sup>13</sup> Integrase-mediated strand transfer activity was determined as published.<sup>37</sup> Compounds were tested in HIV-1 replication assays:  antiviral activity was assessed by measuring the decrease in HIV-1 p24 core antigen in MT-4 human T-lymphoid cells/HIV-1IIIb cultured in the presence of an increasing concentration of inhibitor, as published.<sup>32</sup> Cells were infected en masse at low multiplicity (0.01) using HIV-1 strain IIIb and were incubated for 24 h. At this time, cells were washed and distributed into 96-well microtiter dishes. Serial 2-fold dilutions of inhibitor were added to the wells, and the cultures were maintained for three additional days. Control cultures in the absence of inhibitor were fully infected at 4 days. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemistry used to prepare analogs reported in Tables 3 and 7 is presented in Scheme 1<a data-tab="pane-pcw-Figures" href="#jm0704705h00001" id="" class=" internalNav"></a> for final compounds <b>11</b>, <b>25</b>−<b>30</b>, and <b>46</b>−<b>49</b>. A procedure reported by Culbertson<sup>38</sup> was followed starting from the appropriate nitrile <b>62</b>. Formation of the aldoxime <b>63</b> followed by Michael reaction with dimethylacetylene dicarboxylate (DMAD) gave the mixture of the <i>cis</i>/<i>trans</i> adducts <b>64</b>. <div id="_i23"><figure id="jm0704705h00001" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00001.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  Synthesis of Final Compounds <b>11</b>,<b> 25</b>−<b>30</b>, and <b>46</b>-<b>49</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions (yields are reported for compound <b>27</b>):  (a) NH<sub>2</sub>OH·HCl, Et<sub>3</sub>N, EtOH, reflux, 5 h, 89%; (b) DMAD, CHCl<sub>3</sub>, reflux, 1 h, 78%; (c) <i>o</i>-xylenes, reflux, 12 h, 54%; (d) Bz<sub>2</sub>O, Py, 3 h, 71%; (e) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub>, 64%; (f) 4F-BnNH<sub>2</sub>, MeOH, reflux in a sealed tube, 2 h, 68%; (g) TFA-DCM, rt, quant.; (h) H<sub>2</sub>, Pd/C, MeOH, rt, 5 h; (i) HCOH or CH<sub>3</sub>COH, NaCNBH<sub>3</sub>, MeOH; (l) Ac<sub>2</sub>O, Py; (m) NaIO<sub>4</sub>, H<sub>2</sub>O, EtOH; (n) <i>m</i>-CPBA, DCM; (o) NEt<sub>3</sub>, MeI, THF. <i><sup>b</sup></i><sup></sup><i>cis</i>-Configuration. <i><sup>c</sup></i><sup></sup>Reference 29.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">This mixture was heated in refluxing <i>o</i>-xylene to effect a thermal rearrangement that afforded the dihydroxypyrimidine <b>65</b>,<sup>39,40</sup> which was selectively benzoylated to compound <b>66</b>. Methylation with LiH and dimethyl sulfate gave the desired <i>N</i>-alkylated heterocycle; in the case of compound <b>66a</b>, a 10:1 ratio between the <i>N</i>- and <i>O</i>-regioisomers <b>67a</b> and <b>68a</b> was obtained.<sup>41</sup> Amidation and debenzoylation were accomplished by refluxing with 4F-benzylamine in MeOH, and the corresponding benzylamide <b>49</b> was obtained. Removal of the Boc group under acidic conditions or of the Cbz group by hydrogenation afforded compounds <b>46</b>, which were submitted to reductive alkylation to give compounds <b>11</b>, <b>26</b>−<b>28</b>, and <b>47</b> or to acetylation to obtain compound <b>48</b>. Compound <b>25</b> was obtained from <b>26</b> by catalytic hydrogenation. The oxidized thiomorpholine compounds <b>29</b> and <b>30</b> were obtained from thiomorpholine <b>28</b> through NaIO<sub>4</sub> and <i>m</i>-CPBA oxidations, respectively. </div><div class="NLM_p">As far as the preparation of the starting material, <b>62a</b>, this was initially prepared through a five-step synthesis, arriving at the methyl-morpholine-3-carboxylate. According to a procedure reported in the literature,<sup>42</sup> the carboxylate was then manipulated to the required morpholine-3-nitrile. To overcome the low yield and the length of this pathway, a novel and efficient synthesis to morpholine-3-nitrile <b>71</b>, reported in Scheme 2<a data-tab="pane-pcw-Figures" href="#jm0704705h00002" id="" class=" internalNav"></a>, was developed based on a literature procedure for piperidine 2-carbonitrile.<sup>43</sup><div id="_i25"><figure id="jm0704705h00002" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00002.jpeg" id="_i26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Novel Synthesis of Boc-Protected Morpholine-3-nitrile <b>62a</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) <i>t</i>-BuOCl, MTBE; (b) NaOMe, MeOH; (c) HCN, H<sub>2</sub>O; (d) Boc<sub>2</sub>O, DMAP, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Morpholine nitrile <b>71</b> was prepared from morpholine via oxidation to <i>N</i>-chloromorpholine, followed by elimination/trimerization to <b>70</b>, which was subsequently cyanated. Treatment of <b>71</b> with BOC anhydride gave the nitrile <b>62a</b>. For the formation of <i>N</i>-chloromorpholine, different solvents were evaluated, among these were ethyl ether, THF, and MeOH, but switching to MTBE, the exotherms were milder and the possible formation of an explosive compound such as MeOCl was eliminated. </div><div class="NLM_p">Nitrile <b>62b</b> was prepared from the ethyl thiomorpholine carboxylate <b>72</b> obtained according literature procedure.<sup>44</sup> Nitrile <b>62c</b> was synthesized from the oxygenated pipecolic acid derivative <b>75</b> that was obtained according to a literature procedure<sup>45</sup> (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm0704705h00003" id="" class=" internalNav"></a>). <div id="_i27"><figure id="jm0704705h00003" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00003.jpeg" id="_i28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Synthesis of Boc-Protected Nitriles <b>62b</b> and <b>62c</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, H<sub>2</sub>O, CHCl<sub>3</sub>; (b) NaOH, MeOH; (c) Boc<sub>2</sub>O, NH<sub>4</sub>HCO<sub>3</sub>, Py, dioxane, rt;<sup>46</sup> (d) TFAA, Et<sub>3</sub>N, DCM, rt; (e) <span class="smallcaps smallerCapital">l</span>-selectride, THF, 0 °C, 2.5 h, 95%; (f) NaH, THF, BnBr.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A different synthetic pathway was followed for the synthesis of compound <b>32</b>, and it is illustrated in Scheme 4<a data-tab="pane-pcw-Figures" href="#jm0704705h00004" id="" class=" internalNav"></a>; in this case, the lactam was formed after having built the N−Me pyrimidone carboxamide scaffold <b>79</b>. <div id="_i29"><figure id="jm0704705h00004" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00004.jpeg" id="_i30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4.  Synthesis of Compound <b>32</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub>; (b) 4F-BnNH<sub>2</sub>, MeOH, reflux, 2 d; (c) H<sub>2</sub>, Pd/C, MeOH, 1 N HCl; (d) Et<sub>3</sub>N, DCM, MsCl, rt, 2 h; (e) BnMeNH, CH<sub>3</sub>CN, reflux, 3 h; (f) TFA-DCM, rt, 3 h; (g) EtOCOCOH, NaCNBH<sub>3</sub>, MeOH, Et<sub>3</sub>N; (h) Et<sub>3</sub>N, MeOH, reflux, 5 h; (i) HCOH, NaCNBH<sub>3</sub>, MeOH, Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The five-membered derivatives were synthesized in an analogous manner to compounds reported in Scheme 1, and the synthesis is summarized in Scheme 5<a data-tab="pane-pcw-Figures" href="#jm0704705h00005" id="" class=" internalNav"></a>. Compound <b>10</b> was also prepared in the enantiomerically pure form <b>10a</b>. This led us to a careful monitoring of the enantiomeric excess at each step of <a name="jm005002004960" id="jm005002004960"></a> the synthesis, starting from optically active <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline. After the cyclization step, followed by benzoylation of the 5-OH group, the enantiomeric excess of compound <b>85a</b> was 84%,<sup>47</sup> and this e.e. was retained after the methylation step for compound <b>86a</b>. Recrystallization from ethyl acetate and hexanes gave <b>86a</b> as a white solid with 99.8% e.e., and this high enantiomeric purity was maintained until the end of the synthesis. <div id="_i31"><figure id="jm0704705h00005" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00005.jpeg" id="_i32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5.  Synthesis of Final Compounds <b>10a</b>, and <b>12</b>−<b>24</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NH<sub>2</sub>OH·HCl, Et<sub>3</sub>N, EtOH, reflux, 5 h; (b) DMAD, CHCl<sub>3</sub>, reflux, 1 h; (c) <i>o</i>-xylenes, reflux, 12 h; (d) Bz<sub>2</sub>O, Py, 3 h; (e) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub> or Cs<sub>2</sub>CO<sub>3</sub>, THF, Me<sub>2</sub>SO<sub>4</sub>; (f) 4F-BnNH<sub>2</sub>, MeOH, reflux in a sealed tube, 2 h; (g) H<sub>2</sub>, Pd/C, MeOH; (h) TFA-DCM, rt; (i) MsCl, Et<sub>3</sub>N, DCM, rt, 1 h; (l) Ac<sub>2</sub>O, Py, rt, 1 h; (m) HCOH, NaCNBH<sub>3</sub>, MeOH. <i><sup>b</sup></i><sup></sup>Mixture of diastereoisomers, undetermined stereochemistry.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The necessary nitriles <b>81b</b>−<b>e</b> were synthesized through manipulation of the appropriate pyrrolidine building blocks according to Scheme 6<a data-tab="pane-pcw-Figures" href="#jm0704705h00006" id="" class=" internalNav"></a>. Nitriles <b>81b</b> and <b>81e</b> were prepared from the corresponding pyrrolidinones <b>91b</b> and <b>91e</b> that were Cbz-protected and then reduced with super hydride to the corresponding lactam alcohols <b>93b</b> and <b>93e</b>. These were then submitted to the reaction with TMSCN in the presence of ZnI<sub>2</sub> to give the desired nitriles <b>81b</b> and <b>81e</b>. <div id="_i33"><figure id="jm0704705h00006" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00006.jpeg" id="_i34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6.  Protected Methylpyrrolidine Nitriles <b>81b</b>−<b>e</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, CbzCl, DMF; (b) LiBEt<sub>3</sub>H, THF; (c) TMSCN, ZnI<sub>2</sub>; (d) H<sub>2</sub>, PtO<sub>2</sub>, MeOH; (e) NH<sub>3</sub> 32%, THF; (f) TFAA, Et<sub>3</sub>N, DCM. <i><sup>b</sup></i><sup></sup>Reference 48.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The nitriles <b>81c</b> and <b>81d</b>, as a mixture, were prepared through the usual steps from the 4-methyl proline carboxylate <b>95</b>. Compound <b>95</b> was obtained by catalytic hydrogenation of <a name="jm005002004961" id="jm005002004961"></a> methylene compound <b>94</b> that was prepared in three steps, starting from the commercially available (2<i>S</i>,4<i>R</i>)-4-hydroxy-2-(methoxycarbonyl)pyrrolidinium chloride, using a procedure reported in the literature.<sup>48</sup></div><div class="NLM_p">The nitriles <b>81f</b>−<b>h</b>, having an alkoxy substituent in the 4(<i>R</i>)-position, were synthesized from the corresponding carboxylic acids <b>98</b>, prepared according to the literature.<sup>49</sup> The nitrile <b>81i</b> was obtained through transformation of the (4<i>R</i>)-hydroxyl group into a (4<i>S</i>)-NHBoc moiety, followed by the usual formation of the primary amide and its dehydration. Fluorinated nitriles <b>81l</b>−<b>n</b> were obtained by DAST reaction from the appropriate 4-OH-proline (from 4<i>R</i>-OH for <b>81l</b> and 4<i>S</i>-OH for <b>81</b><b>m</b>) or 4-oxo-proline (Scheme 7<a data-tab="pane-pcw-Figures" href="#jm0704705h00007" id="" class=" internalNav"></a>). <div id="_i35"><figure id="jm0704705h00007" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00007.jpeg" id="_i36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7.  Synthesis of Cbz 4-Substituted Pyrrolidine Nitriles <b>81f</b>−<b>n</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, THF, R<sub>1</sub>X; (b) Boc<sub>2</sub>O, NH<sub>4</sub>HCO<sub>3</sub>, Py, dioxane, rt, 72%;<sup>46</sup> (c) TFAA, Et<sub>3</sub>N, DCM, rt; (d) TsCl, Py; (e) NaN<sub>3</sub>, DMF; (f) PPh<sub>3</sub>; H<sub>2</sub>O, THF; (g) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM; (h) NaOH, MeOH; (i) DAST, dry DCM, −78 °C; (l) DMSO, (COCl)<sub>2</sub>, Et<sub>3</sub>N, DCM. <i><sup>b</sup></i><sup></sup> Reference 49.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The elaboration steps toward the piperazine compounds of Table 4 are reported in Scheme 8<a data-tab="pane-pcw-Figures" href="#jm0704705h00008" id="" class=" internalNav"></a>. The orthogonal protection of the piperazine ring with the Boc and the Cbz groups allowed the distinct derivatization of the N1 and N4 nitrogens. The Cbz deprotection of the N−Me pyrimidone <b>106</b>, followed by reductive alkylation and formation of the 4F-benzylamide gave the advanced intermediate <b>36</b>. This compound was submitted to Boc-deprotection to obtain <b>33</b>, which was reductively alkylated to the corresponding compounds <b>31</b>, <b>34</b>, and <b>35</b>. <a name="jm005002004962" id="jm005002004962"></a> Compound <b>33</b> was acylated to derivatives <b>37</b>, <b>39</b>, and <b>40</b> or sulfonylated to compounds <b>43</b> and <b>44</b>. The ethylurea <b>41</b> was obtained by treatment of compound <b>33</b> with ethyl isocyanate in pyridine. Compound <b>38</b> was obtained by acetylation of the N1 nitrogen followed by Boc-removal and reductive methylation of the N4. The mesylate compound <b>42</b> was obtained by leaving the formation of the 4F-benzylamide and the concomitant deprotection of the benzoyl group as the last step. <div id="_i37"><figure id="jm0704705h00008" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00008.jpeg" id="_i38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8.  Synthesis of Piperazines <b>31</b> and <b>33</b>−<b>44</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) SOCl<sub>2</sub>, Py, DMF, THF, 4 h, 40 °C; (b) NH<sub>3</sub> 0.5 M in dioxane, DCM, 2 h, 40 °C; (c) CbzCl, Et<sub>3</sub>N, DCM, rt, o/n; (d) TFAA, Et<sub>3</sub>N, DCM, 0 °C; (e) NH<sub>2</sub>OH, Et<sub>3</sub>N, MeOH, rt, o/n; (f) DMAD, CHCl<sub>3</sub>, reflux, 12 h; (g) <i>o</i>-xylenes, 160 °C for 8 h and then 120 °C for 48 h; (h) Bz<sub>2</sub>O, Py, rt, 3 h; (i) Cs<sub>2</sub>CO<sub>3</sub>, THF, Me<sub>2</sub>SO<sub>4</sub>, 40 °C, 1 h; (l) H<sub>2</sub>, Pd/C, MeOH; (m) HCOH or CH<sub>3</sub>COH or acetone, NaCNBH<sub>3</sub>, MeOH; (n) 4F-BnNH<sub>2</sub>, MeOH, reflux in sealed tube, 12 h; (o) TFA−DCM, rt; (p) Ac<sub>2</sub>O or Bz<sub>2</sub>O in pyridine or <i>N</i>,<i>N</i>-dimethylglycine hydrochloride, WSCDI, HOBt, DIPEA, DCM; (q) EtNCO, Py, rt, 0.5 h; (r) PhSO<sub>2</sub>Cl or Me<sub>2</sub>NSO<sub>2</sub>Cl, NaOH (1 M), DCM; (s) MsCl, NEt<sub>3</sub>, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">The SAR on the benzylamide portion of the morpholino series reported in Table 8 was performed following a more convergent approach based on the formation of the carboxamide at the last step (Scheme 9<a data-tab="pane-pcw-Figures" href="#jm0704705h00009" id="" class=" internalNav"></a>). <div id="_i39"><figure id="jm0704705h00009" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00009.jpeg" id="_i40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9.  Synthesis of Carboxamides <b>50</b>−<b>61</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) TFA−DCM, rt; (b) HCOH, NaCNBH<sub>3</sub>, MeOH; (c) R<sub>3</sub>R‘NH, MeOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The development of a potent series of <i>N</i>-methyl pyrimidone derivatives exhibiting nanomolar potency against replication of HIV-1 in cell-based assay was described. The N-Me morpholine analog <b>27a</b> inhibited viral growth with a CIC<sub>95</sub> of 65 nM in the presence of 50% normal human serum. This level of antiviral potency is comparable to that of the clinically effective protease inhibitors indinavir and nelfinavir (CIC<sub>95</sub> values of 50 nM and 400 nM, respectively). Compound <b>27a</b> displayed excellent biological and physical properties that reflect excellent PK profiles in rats, dogs, and monkeys. It did not show any liabilities in a great number of counterscreening assays and no CyP450 inhibition. Based on this data, it represents a promising antiviral agent against HIV-1. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solvents and reagents were obtained from commercial suppliers and were used without further purification. Flash chromatography purifications were performed on Merck silica gel (200−400 mesh) as the stationary phase or were conducted using prepacked cartridges on a Biotage system, eluting with petroleum ether/ethyl acetate mixtures. HPLC-MS analyses were performed on a Waters Alliance 2795 apparatus, equipped with a diode array and a ZQ mass spectrometer, using an X-Terra C<sub>18</sub> column (5 μm, 4.6 × 50 mm). The solvent system was acetonitrile−0.1% HCOOH/water−0.1% HCOOH, gradient 10−90% over 6 min, with a flow rate of 1 mL/min. Preparative reversed-phase high-performance liquid chromatography (RP-HPLC) was performed using a Waters Delta Prep 4000 operating with a flow rate of 20 mL/min and incorporating a dual λ absorbance detector 2487 or a Shimadzu HPLC 10AV-VP operating with a flow rate of 15 mL/min and incorporating a diode array detector SPD10AV-VP. The stationary phases used were for compound <b>27</b>, PrepNovaPack HR C<sub>18</sub>, 6 μm-60A (40 × 100 mm); for the other final compounds, Waters Symmetry C<sub>18</sub> 5 μm, 19 × 100 mm, C<sub>18</sub> 7 μm, 19 × 150 mm, and C<sub>18</sub> 7 μm, 19 × 300 mm. The mobile phase comprised a linear gradient of binary mixtures of acetonitrile (containing 0.1% TFA) and H<sub>2</sub>O (containing 0.1% TFA). The purity of final compounds was more than 99% by area. As criterion of purity, chromatographic systems with NMR and MS data were employed. Nuclear magnetic resonance spectra (<sup>1</sup>H NMR recorded at 600, 500, 400, or 300 MHz, <sup>13</sup>C NMR recorded at 100 or 75 MHz) were obtained on Bruker AMX spectrometers and are referenced in ppm relative to TMS. Unless indicated, spectra were acquired at 300 K. Low-resolution mass spectra (<i>m</i>/<i>z</i>) were recorded on a Perkin-Elmer API 100 (electrospray ionization) mass spectrometer. All the accurate mass measurements were carried out by electrospray ionization (ESI) on TSQ Quantum Ultra AM triple quadrupole, operating in enhanced mass-resolution mode (peak width of 0.2 Th FWMH). Accurate mass determinations by ESI-MS were performed using positive negative ionization mode. HPLC analysis of the final compounds was carried out on two systems:  Agilent 1100 HPLC, with chromatography performed on a Waters Sunfire C<sub>18</sub> column (30 × 2.1 mm, 5 μm) at room temperature, and detection was carried out using a ThermoFinnigan TSQ Quantum Ultra mass-spectrometer equipped with an electrospray (ESI) ion source; Waters Acquity UPLC equipped with a PDA <a name="jm005002004963" id="jm005002004963"></a> Detector Acquity, and chromatography was performed on an Acquity UPLC BEH C<sub>18</sub> column (50 × 2.1 mm, 1.7 μM). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl 3-[Amino(hydroxyimino)methyl]morpholine-4-carboxylate (63a).</b> Compound <b>62a</b> (40.0 g, 188 mmol) was dissolved in ethanol (530 mL), then NH<sub>2</sub>OH·HCl (18.57 g, 266 mmol) and Et<sub>3</sub>N (45.0 mL, 320.4 mmol) were added. The reaction mixture was stirred at reflux for 5 h. Ethanol was concentrated and the residue was taken up in EtOAc and water; the aqueous layer was extracted with EtOAc three times, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum to give the desired compound <b>63a</b>, 40 g (89% yield), as a yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.16 (bs, 1H), 5.32 (bs, 2H), 4.30 (bs, 1H), 4.08 (d, <i>J</i> = 11.6 Hz, 1H), 3.75 (d, <i>J</i> = 6.8 Hz, 1H), 3.50−3.33 (m, 4H), 1.38 (s, 9H). MS <i>m</i>/<i>z</i> 246 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Dimethyl </b><b>2-[({-Amino[4-(</b><b><i>tert</i></b><b>-butoxycarbonyl)morpholin-3-yl]methylene}amino)oxy]but-2-enedioate </b><b>(64a).</b> A solution of dimethylacetylene dicarboxylate (228 mL, 226.2 mmol) and compound <b>63a</b> (45 g, 188.5 mmol) was refluxed in chloroform (230 mL) for 1 h. The CHCl<sub>3</sub> was evaporated under vacuum and the residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = from 7:3 to 1:1), yielding the desired adducts <b>64a</b> as a mixture of configurational isomers <i>E</i> and <i>Z</i>, 57 g (78% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 6.60 and 6.20 (2bs, 2H), 5.58 and 5.41 (2s, 1H), 4.36 (bs, 1H), 4.04 (bs, 1H), 3.8 (bs, 1H), 3.76 and 3.72 (2s, 3H), 3.63 and 3.58 (2s, 3H), 3.53 (td, <i>J</i> = 13.6, 3.7 Hz, 1H), 3.44 (t, <i>J</i> = 10.4 Hz, 1H), 3.31 (m, 2H), 1.35 (s, 9H). MS <i>m</i>/<i>z</i> 388 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl 3-[4,5-Dihydroxy-6-(methoxycarbonyl)pyrimidin-2-yl]morpholine-4-carboxylate </b><b>(65a).</b> The mixture of adducts <b>64a</b> (30 g, 77.4 mmol) was refluxed in <i>o</i>-xylene (110 mL) for 12 h. The reaction mixture was cooled down; petroleum ether was added until formation of a precipitate, which was filtered to give the desired compound <b>65a</b> as a light brown solid, 15.3 g (54% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 4.62 (s, 1H), 4.15 (d, <i>J</i> = 12 Hz, 1H), 3.84 (bs, 1H), 3.82 (s, 3H), 3.70 (dd, <i>J</i> = 12.3, 4.0 Hz, 1H), 3.61 (dd, <i>J</i> = 12.2, 3.8 Hz, 1H), 3.56 (t, <i>J</i> = 13 Hz, 1H), 3.43 (td, <i>J</i> = 11.5, 3.4 Hz, 1H), 1.35 (s, 9H). MS <i>m</i>/<i>z</i> 356 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>3-[5-(Benzoyloxy)-4-hydroxy-6-(methoxycarbonyl)pyrimidin-2-yl]morpholine-4-carboxylat</b><b>e (66a).</b> The pyrimidine <a name="jm005002004964" id="jm005002004964"></a><b>65a</b> (23 g, 64.8 mmol) in dry pyridine (260 mL) was treated with benzoic anhydride (29.32 g, 129.6 mmol) and stirred overnight at rt. The mixture was evaporated, taken in ethyl acetate, and washed with HCl (1 N), NaHCO<sub>3</sub> satd soln, and brine. Organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, evaporated, and purified by flash chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = 3:7) to obtain <b>66a</b> as a brown solid (21 g, 71% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 13.3 (bs, 1H), 8.07 (d, <i>J</i> = 7.5 Hz, 2H), 7.76 (t, <i>J</i> = 7.5 Hz, 1H), 7.61 (t, <i>J</i> = 7.5 Hz, 2H), 4.73 (s, 1H), 4.22 (d, <i>J</i> = 12.4 Hz, 1H), 3.86 (d, <i>J</i> = 11.0 Hz, 1H), 3.78 (dd, <i>J</i> = 12.4, 3.9 Hz, 1H), 3.73 (s, 3H), 3.58 (t, <i>J</i> = 13.9 Hz, 2H), 3.47 (td, <i>J</i> = 10.7, 3.6 Hz, 1H), 1.36 (s, 9H). MS <i>m</i>/<i>z</i> 600 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-[4-(</b><b><i>tert</i></b><b>-butoxycarbonyl)morpholin-3-yl]-1-methyl-6-oxo-1,6-dihydropyri</b><b>midine-4-carboxylate (67a).</b> The benzoyl-protected pyrimidine <b>66a</b> (82 g, 87 wt %, 156 mmol) was added to a suspension of LiH (1.36 g, 1.1 equiv) in dioxane (714 mL) at rt. The mixture was aged 45 min at 38 °C and was then cooled to rt. Dimethylsulfate (19 mL, 1.3 equiv) was added, and the mixture was warmed to 38 °C (4 h) and 56 °C (4 h). The reaction mixture was cooled to 16 °C and glacial acetic acid (0.89 mL, 0.1 equiv) was added, followed by water (714 mL) and EtOAc (714 mL). The aqueous layer was separated and extracted with EtOAc (400 mL). The combined organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to an oil containing the two regioisomeric products N−Me (<b>67a</b>) and O−Me (<b>68a</b>) in the ratio 9.4:1.<sup>41</sup> The two regioisomers were separated by column chromatography (SiO<sub>2</sub>, EtOAc/hexanes = 1:1). The fractions containing the desired compound <b>67a</b> were evaporated to a foamy solid. This solid was dissolved in ethyl ether and re-evaporated to a foamy solid that could be scraped out easily. This solid was dried in a vacuum oven overnight at 40 °C to afford <i>N</i>-methylpyrimidone <b>67a</b> as a pale yellow solid, 48 g (64% yield). Crystalline <i>N</i>-methylpyrimidone <b>67a</b> was obtained from ether. (<b>67a</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz, 330 K) δ 8.09 (d, <i>J</i> = 7.3 Hz, 2H), 7.77 (t, <i>J</i> = 7.5 Hz, 1H), 7.62 (t, <i>J</i> = 7.8 Hz, 2H), 5.08 (d, <i>J</i> = 3.4 Hz, 1H), 4.21 (d, <i>J</i> = 12.3 HZ, 1H), 3.95−3.85 (m, 3H), 3.76 (s, 3H), 3.58 (s, 3H), 3.55−3.50 (m, 2H), 1.34 (s, 9H). MS <i>m</i>/<i>z</i> 474 (M + H)<sup>+</sup>. (<b>68a</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 330 K) δ 8.09 (d, <i>J</i> = 7.3 Hz, 2H), 7.77 (t, <i>J</i> = 7.3 Hz, 1H), 7.61 (t, <i>J</i> = 7.4 Hz, 1H), 4.94 (bs, 1H), 4.50 (d, <i>J</i> = 11.6 Hz, 1H), 4.0 (s, 3H), 3.85−3.81 (m, 2H), 3.76 (s, 3H), 3.66 (d, <i>J</i> = 10.4 Hz, 1H), 3.49−3.45 (m, 2H), 1.35 (bs, 9H). MS <i>m</i>/<i>z</i> 474 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>3-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)morpholine-4-carboxylate (49).</b> The methyl ester <b>67a</b> (9.2 g, 19.43 mmol) in dry MeOH (190 mL) was treated with 4-fluorobenzylamine (5.55 mL, 48.6 mL) at reflux in a sealed tube for 2 h. Solvent was removed in vacuum and the residue was triturated with Et<sub>2</sub>O to obtain the title compound <b>49</b> as a white solid (6.14 g, 68% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 320 K) δ 11.95 (bs, 1H), 8.32 (t, <i>J</i> = 6.0 Hz, 1H), 7.39−7.35 (m, 2H), 7.19−7.13 (m, 2H), 4.96 (dd, <i>J</i> = 4.2, 2.4 Hz, 1H), 4.62 (dd, <i>J</i> = 6.9, 4.2 Hz, 1H), 4.49 (dd, <i>J</i> = 14.9, 5.8 Hz, 1H), 4.16 (dd, <i>J</i> = 12.2, 2.0 Hz, 1H), 3.87−3.79 (m, 2H), 3.70−3.64 (m, 1H), 3.55−3.45 (m, 5H), 1.23 (s, 9H). MS <i>m</i>/<i>z</i> 463 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)morpholin-4-ium Trifluoroacetate (46).</b> Compound <b>49</b> (6.13 g, 13.25 mmol) was treated with a mixture of DCM/TFA (2:1, 420 mL) for 1 h at rt. Volatiles were removed under vacuum to give a residue that upon addition of Et<sub>2</sub>O formed a precipitate that was filtered as a pale pink solid <b>46</b> (quantitative yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.45 (bs, 1H), 7.39−7.36 (m, 2H), 7.19−7.15 (m, 2H), 4.93 (d, <i>J</i> = 9.2 Hz, 1H), 4.64 (dd, <i>J</i> = 15.4, 6.7 Hz, 1H), 4.55 (dd, <i>J</i> = 15.4, 6.2 Hz, 1H), 4.35 (d, <i>J</i> = 12.8 Hz, 1H), 4.08 (d, <i>J</i> = 12.6 Hz, 1H), 3.77 (t, <i>J</i> = 12.4 Hz, 1H), 3.55 (s, 3H), 3.54−3.46 (m, 2H), 3.40−3.34 (m,1H). MS <i>m</i>/<i>z</i> 363 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-4-methylmorpholin-4-ium Trifluoroacetate (27).</b> Compound <b>46</b> (4.3 g, 9 mmol) was dissolved in MeOH (9 mL) and treated with TEA (1.37 mL, 9.9 mmol), sodium acetate (1.18 g, 14.4 mmol), formaldehyde 37% w/w aq soln (2.2 mL, 27 mmol), and sodium cyanoborohydride (0.798 g, 12.87 mmol). The mixture was left stirring at rt for 1 h. Volatiles were removed under vacuum and the crude was purified by preparative HPLC giving compound <b>27</b> as trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 600 MHz) δ 12.33 (bs, 1H), 10.05 (bs, 1H), 9.48 (t, <i>J</i> = 6.4 Hz, 1H), 7.35−7.33 (m, 2H), 7.15−7.12 (m, 2H), 4.98 (d, <i>J</i> = 8.8 Hz, 1H), 4.57 (d, <i>J</i> = 6.4 Hz, 2H), 4.36 (d, <i>J</i> = 12.7 Hz, 1H), 4.13 (d, <i>J</i> = 12.4 Hz, 1H), 3.77 (t, <i>J</i> = 12.5 Hz, 1H), 3.69 (d, <i>J</i> = 12.8 Hz, 1H), 3.54 (s, 3H), 3.48−3.41 (m, 2H), 2.83 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 100 MHz) δ 168.4, 161.7, 157.8, 148.0, 142.7, 134.6, 129.2, 124.8, 115.5, 68.1, 64.2, 62.7, 53.4, 41.7, 41.4, 30.7. MS <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 377.16196; found, 377.16156. Compound <b>27</b> was resolved into its enantiomers by semipreparative chiral HPLC on column Chiralpak AS, 250 × 46 mm at 1.0 mL/min, collected by absorption at 260 nM, mobile phase:  hexane:ethanol=1:1 both containing 0.2% TFA. The first eluted was the enantiomer <b>27a</b> [α]<sub>D</sub> = +55.42 (MeOH, <i>c</i> 0.24, 25 °C). The second eluted was the enantiomer <b>27b</b> [α]<sub>D</sub> = −51.63 (MeOH, <i>c</i> 0.215, 25 °C). Compound <b>27a</b> as trifluoroacetate was converted in the hydrochloride salt by dissolving it in dry MeOH and adding to that solution HCl (2 N) in Et<sub>2</sub>O in a ratio of 5:1. The methanolic solution was evaporated under vacuum, and the procedure was repeated five times; the dry material was recrystallized by MeOH to give <b>27a</b> hydrochloride salt as a white crystalline solid. Anal. Calcd for C<sub>18</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>4</sub>Cl:  C, 52.32:  H, 5.35; N, 13.56. Found:  C, 52.61; H, 5.64; N, 13.62. </div><div class="NLM_p"><b>4-Ethyl-3-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyri</b><b>midin-2-yl)morpholin-4-ium Trifluoroacetate (47).</b> Following the same procedure used to synthesize compound <b>27</b>, compound <b>47</b> was prepared from compound <b>46</b> using acetaldehyde instead of formaldehyde. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 10.03 (bs, 1H), 9.65 (t, <i>J</i> = 6.2 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 5.8 Hz, 2H), 7.17 (t, <i>J</i> = 8.7 Hz, 2H), 5.05 (d, <i>J</i> = 8.3 Hz, 1H), 4.65 (dd, <i>J</i> = 15.4, 6.9 Hz, 1H), 4.51 (dd, <i>J</i> = 15.4, 5.8 Hz, 1H), 4.40 (d, <i>J</i> = 12.9 Hz, 1H), 4.19 (d, <i>J</i> = 12.2 Hz, 1H), 3.85 (t, <i>J</i> = 13.4 Hz, 2H), 3.55 (s, 3H), 3.55−3.48 (m, 1H), 3.40−3.25 (m, 2H), 3.20−3.07 (m, 1H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H). MS <i>m</i>/<i>z</i> 391 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(4-Acetylmorpholin-3-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyri</b><b>midine-4-carboxamide (48).</b> Compound <b>67a</b> (0.184 g, 0.39 mmol) was treated with a TFA/DCM/H<sub>2</sub>O solution (65:35:10, 10 mL) at rt for 30 min and then evaporated under vacuum to give a compound that was taken up in Et<sub>2</sub>O and evaporated several times before being dissolved in pyridine (2 mL) and treated with acetic anhydride (0.073 mL, 0.78 mmol). The reaction mixture was stirred at rt overnight and then concentrated to dryness. The resulting crude (0.39 mmol) was then dissolved in MeOH (3.0 mL), and 4-fluorobenzylamine (0.133 mL, 1.17 mmol) was added; the mixture was refluxed overnight. The reaction mixture was then evaporated under vacuum to give a residue that was purified by RP-HPLC to provide compound <b>48</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 330 K) δ 12.00 (bs, 1H), 8.45 (bs, 1H), 7.37 (t, <i>J</i> = 7.8 Hz, 2H), 7.16 (t, <i>J</i> = 8.6 Hz, 2H), 5.25 (s, 1H), 4.61−4.48 (m, 2H), 4.22 (d, <i>J</i> = 12.4 Hz, 1H), 3.88−3.76 (m, 3H), 3.58−3.48 (m, 2H), 3.48 (s, 3H), 2.03 (s, 3H). MS <i>m</i>/<i>z</i> 405 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-{1-[(benzoyloxy)carbonyl]piperidin-2-yl}-1-methyl-6-oxo-1,6-dihydropyri</b><b>midine-4-carboxylate (67d).</b> Pyrimidine <b>66d</b> was dissolved in THF and treated with Cs<sub>2</sub>CO<sub>3</sub> (2.0 equiv) and methyl iodide (5.0 equiv). The reaction mixture was stirred at 40 °C for 2 h, cooled to rt, and concentrated. The residue was taken up in ethyl acetate and washed with 1 N HCl and brine. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated, and the residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 6:4) to give compound <b>67d</b> in 52% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.14 (d, <i>J</i> = 7.9 Hz, 2H), 7.66 (t, <i>J</i> = 7.4 Hz, 1H), 7.61 (t, <i>J</i> = 7.5 Hz, 2H), 7.37−7.34 (m, 5H), 5.30 (bs, 1H), 5.22 (d, <i>J</i> = 12.2 Hz, 1H), 5.17 (d, <i>J</i> = 12.2 Hz, 1H), 4.14−4.11 (m, 1H), 3.83 (s, 3H), 2.99 <a name="jm005002004965" id="jm005002004965"></a> (s, 3H), 2.91−2.88 (m, 1H), 2.55−2.52 (m, 1H), 1.78−1.52 (m, 5H). MS <i>m</i>/<i>z</i> 506 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methylpiperidin-2-yl)-6-oxo-1,6-dihydropyri</b><b>midine-4-carboxamide (11).</b> Compound <b>67d</b> was taken up in methanol and hydrogenated at atmospheric pressure in the presence of 10% Pd/C. The mixture was stirred 5 h at rt, filtered through celite, and concentrated. The residue was suspended in THF and treated with TEA (3 equiv) and methyl iodide (3 equiv). The reaction mixture was stirred at 40 °C for 0.5 h, then concentrated and partitioned between EtOAc and 1 N HCl. The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to an oily residue that was dissolved in <i>N</i>-methylpyrrolidinone and treated with 4-fluorobenzylamine (3 equiv) at 90 °C for 15 min. The reaction mixture was cooled to rt, and the title product <b>11</b> was isolated as its trifluoroacetate salt by RP-HPLC. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 12.28 (bs, 1H), 9.50 (bt, 1H), 9.31 (bs, 1H), 7.37 (dd, <i>J</i> = 8.4, 5.6 Hz, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 4.8−4.6 (m, 1H), 4.57 (d, <i>J</i> = 6.4 Hz, 2H), 3.70−3.60 (m, 1H), 3.50 (s, 3H), 3.40−3.30 (m, 1H), 2.78 (bs, 3H), 2.4−2.3 (m, 1H), 1.92−1.46 (m, 5H). MS <i>m</i>/<i>z</i> 375 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Morpholine-3-carbonitrile (71).</b> In a flask fitted with a condenser and a thermocouple, a solution of morpholine (43.6 g, 0.5 mol) in THF (81 mL) was prepared and cooled to −15 °C. To this, <i>t</i>-BuOCl (56.5 mL, 0.5 mol) was added over 15 min, keeping the internal temperature <0 °C to generate <b>69</b>. After 30 min at this temperature, 25% NaOMe/MeOH (114 mL, 0.5 mol) was added over 15 min, keeping the internal temperature <3 °C. The mixture was allowed to warm to 45 °C over 1 h then cooled to rt to generate <b>70</b>. (<b><i>Caution:</i></b> Warm up gradually to prevent a violent reflux.) The resulting slurry was filtered over celite and rotary evaporated. The residue was diluted with water (100 mL) and solid KCN (32.6 g, 0.5 mol) was added, stirred until most of the solid dissolved, and cooled to 0 °C. Concd HCl (60 mL) was added over 20 min, keeping the internal temperature <20 °C then stirring for 2 h at rt. (<b><i>Caution:</i></b> Acidification generates HCN, therefore, use of fumehood is required and use of caustic scrubber advised to catch any vented gas.) This mixture was cooled and basified to pH 10 with 50% NaOH (12 mL). This was extracted five times with DCM (50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), rotary evaporated to a residue that was chromatographed (SiO<sub>2</sub>, EtOAc containing 0.2% TEA), and concentrated to an oil, which crystallized on standing. The solids were stirred in EtOAc/hexanes = 1:1 and filtered to afford <b>71</b> in two crops, 23 g (41% yield). Mp:  81.4 − 87.3 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 3.9−3.7 (m, 4H), 3.60 (m, 1H), 3.22 (m, 1H), 2.79 (td, <i>J</i> = 12.3, 2.9 Hz, 1H), 2.16 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3,</sub> 100 MHz) δ 118.7, 68.1, 67.5, 46.4, 42.8. LRMS <i>m</i>/<i>z</i> 113 (M + H). HRMS <i>m</i>/<i>z</i> 113.0713 (M + H), 113.0715 (expected). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl 3-Cyanomorpholine-4-carboxylate (62a).</b> Morpholine nitrile <b>71</b> (51.6 g) was dissolved in DCM (350 mL), and DMAP (2.2 g, 0.04 equiv) was added. This was cooled over ice and BOC-anhydride (110 g, 1.1 equiv) was added. The mixture was stirred 3 h at rt and then was quenched with the addition of water (200 mL). The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated to a solid, which was crystallized from EtOAc/hexanes in two crops to afford <b>62a</b>, 52.5 g. The mother liquor was purified by flash chromatography (ethyl acetate/hexanes = 3:7) to afford 28 g additional <b>62a</b> (82% yield). Mp 99.7−101.3 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.88 (brs, 1H), 4.04 (d, <i>J</i> = 11.9 Hz, 1H), 3.94 (brd, <i>J</i> = 10.5 Hz, 1H), 3.80 (brs, <i>J</i> = 12.7 Hz, 1H), 3.61 (dd, <i>J</i> = 11.8, 3.1 Hz, 1H), 3.47 (dt, <i>J</i> = 11.9, 2.8 Hz,1H), 3.22 (brs, 1H), 1.48 (9H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 153.7, 116.6, 82.3, 67.6, 66.6, 44.0, 41.3, 28.2. LRMS <i>m</i>/<i>z</i> 157 (M + H − <i>t</i>-Bu). HRMS <i>m</i>/<i>z</i> 235.1055 (M + Na), 235.1059 (expected). </div><div class="NLM_p"><b>4-(</b><b><i>tert</i></b><b>-Butoxycarbonyl)thiomorpholine-3-carboxylic Acid (73).</b> To a solution of ethyl thiomorpholine-3-carboxylate <b>72</b><sup>44</sup> (15.5 g, 0.11 mol) in CHCl<sub>3</sub>, NaHCO<sub>3</sub> (9.2 g, 0.11 mol), and NaCl (22 g) in H<sub>2</sub>O (168 mL), followed by (Boc)<sub>2</sub>O (26.4 g, 0.12 mol), were added. The reaction mixture was stirred at reflux for 4 h. The aqueous phase was washed with CHCl<sub>3</sub>, and the organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure. The yellow oil obtained was dissolved in MeOH (200 mL) and NaOH (2 M) was added (160 mL). The reaction mixture was stirred at rt for 3 h. MeOH was removed under reduced pressure and the aqueous phase was washed with Et<sub>2</sub>O. To the aqueous phase AcOEt was added, and the mixture was cooled on ice bath and acidified with HCl (6 N). The organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to afford compound <b>73</b> as a yellow solid, which was used in the next step as such (67% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 12.52 (bs, 1H), 4.92 (bs, 1H), 4.13 (d, <i>J</i> = 13.7 Hz, 1H), 3.20−2.82 (m, 3H, (1H hidden by water signal), 2.66−2.52 (m, 2H), 1.41 (s, 9H). MS <i>m</i>/<i>z</i> 248 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl 3-Cyanothiomorpholine-4-carboxylate (62b)</b>. To a solution of carboxylic acid <b>73</b> (18 g, 73 mmol) in dioxane (110 mL) and pyridine (3.65 mL), (Boc)<sub>2</sub>O (20.7 g, 95 mmol) and NH<sub>4</sub>HCO<sub>3</sub> (7.3 g, 92 mmol) were added. The reaction mixture was stirred at rt overnight. The solvent was removed under reduced pressure, and the crude was taken into EtOAc, washed with water, 1 N HCl, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to give a crude compound <b>74</b> as a yellow oil (18 g, 73 mmol), which was suspended in DCM (500 mL) and TEA (21.3 mL, 153 mmol) and treated with TFAA (11.2 mL, 80 mmol) added dropwise. After 20 min, NaHCO<sub>3</sub> satd soln was added, DCM was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to give compound <b>62b</b> as a yellow solid (85% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 5.58 (t, <i>J</i> = 3.4 Hz, 1H), 4.23 (d, <i>J</i> = 14.0 Hz, 1H), 3.10−2.81 (m, 3H, 1H hidden by water signal), 2.71−2.46 (m, 2H), 1.45 (s, 9H). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>3-[5-(Benzoyloxy)-4-(methoxycarbonyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]thiomor</b><b>pholine-4-carboxylate (67b).</b> The product was obtained in five steps from <i>tert</i>-butyl 3-cyanothiomorpholine-4-carboxylate <b>62b</b>, following the same steps described for the synthesis of compound <b>67a</b> (4.8% yield over five steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 340 K) δ 8.08 (d, <i>J</i> = 7.6 Hz, 2H), 7.75 (t, <i>J</i> = 6.8 Hz, 1H), 7.64.7.57 (m, 2H), 5.54−5.23 (m, 1H), 3.98−3.82 (m, 2H), 3.74 (s, 3H), 3.58 (s, 3H), 3.36−3.10 (m, 2H), 2.87−2.65 (m, 2H), 1.31 (s, 9H). MS <i>m</i>/<i>z</i> 490 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>3-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)thiomorpholine-4-carboxylate (49b).</b> From compound <b>67b</b>, following the same step described for compound <b>49</b>, compound <b>49b</b> was obtained in 51% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 340 K) δ 8.77 (bs, 1H), 7.40−7.33 (m, 2H), 7.15−7.08 (m, 2H), 5.12 (bs, 1H), 4.56−4.49 (m, 2H), 3.85−3.18 (m, 2H), 3.48 (s, 3H), 3.25 (dd, <i>J</i> = 14.0, 7.5 Hz, 1H), 3.01 (dd, <i>J</i> = 14.0, 4.0 Hz, 1H), 2.70−2.58 (m, 2H), 1.28 (s, 9H). MS <i>m</i>/<i>z</i> 479 (M + H). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(4-methylthiomorpholin-3-yl)-6-oxo-1,6-dihydro</b><b>pyrimidine-4-carboxamide (28).</b> Compound <b>49b</b> (330 mg, 0.67 mmol) was deprotected and submitted to the next reductive alkylation, following the same step described for compound <b>27</b>, to obtain compound <b>28</b> in 47% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.80 (bs, 1H), 10.09 (bs, 1H), 7.41 (t, <i>J</i> = 7.8 Hz, 2H), 7.13 (t, <i>J</i> = 8.7 Hz, 2H), 5.05−4.90 (m, 1H), 4.56−4.40 (m, 2H), 3.88 (d, <i>J</i> = 12.2 Hz 1H), 3.55 (s, 3H), 3.50−3.26 (m, 3H), 3.05−2.95 (m, 2H), 2.76 (s, 3H). MS <i>m</i>/<i>z</i> 393 (M + H). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(4-methyl-1-oxidothiomorpholin-3-yl)-6-oxo-1,6-</b><b>dihydropyrimidine-4-carboxamide (29).</b> To a solution of compound <b>28</b> (20 mg, 0.04 mmol) in EtOH (0.5 mL), a solution of 0.34 M of NaIO<sub>4</sub> (117 μL) was added dropwise at rt. After 18 h, the solvent was removed under reduced pressure. Purification by prep HPLC gave compound <b>29</b> as a 9:1 mixture of diastereoisomers in 45% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.15 (bs, 1H), 7.41 (t, <i>J</i> = 8.0 Hz, 2H), 7.11 (t, <i>J</i> = 8.4 Hz, 2H), 5.41 (d, <i>J</i> = 11.2 Hz, 0.9H), 5.26 (d, <i>J</i> = 11.2 Hz, 0.1H), 4.56−4.34 (m, 2H), 4.08−3.82 (m, 1H), 3.80−3.57 (m, 2H), 3.56−3.37 (m, 4H), 3.35−3.04 (m, 2H), 2.85 (s, 2.7H), 2.73 (s, 0.3H). MS <i>m</i>/<i>z</i> 409 (M + H). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(4-methyl-1,1-dioxidothiomorpholin-3-yl)-6-oxo-</b><b>1,6-dihydropyrimidine-4-carboxamide (30).</b> To a solution of compound <b>28</b> (20 mg, 0.04 mmol) <a name="jm005002004966" id="jm005002004966"></a> in DCM (0.5 mL), <i>m</i>-CPBA (19.7 mg, 0.08 mmol) was added portionwise at 0 °C. After 18 h at rt, solvent was removed under reduced pressure. Purification by prep HPLC gave compound <b>30</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 9.18 (bs, 1H), 7.39−7.33 (m, 2H), 7.15−7.05 (m, 2H), 5.67 (d, <i>J</i> = 10.4 Hz, 1H), 4.85−4.7 (m, 1H), 4.60−4.40 (m, 2H), 4.15−3.95 (m, 2H), 3.70−3.25 (m, 3H), 3.60 (s, 6H). MS <i>m</i>/<i>z</i> 425 (M + H). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl-4-(benzyloxy)-2-cyanopiperidine-1-carboxylate (62c).</b> Compound <b>75</b> (prepared according to a literature procedure;<sup>45</sup> 7.18 g, 30 mmol) was dissolved in dry THF (200 mL), then L-Selectride (1 M in THF, 70 mL, 70 mmol) was added at 0 °C, and the mixture was stirred at 0 °C for 2.5 h. After quenching with water, boranes were removed by extraction, the aqueous phase was acidified with 1 N HCl and extracted with EtOAc, and the organic layer was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. Crude <b>76</b> (6.85 g, 95%) was used as such. Part of crude <b>76</b> (2.96 g, 12.5 mmol) was dissolved in THF (150 mL) and 60% NaH in mineral oil (2.0 g, 50 mmol) was added at 0 °C; after stirring at rt for 40 min, BnBr (6.0 mL, 50 mmol) was added, again at 0 °C, and the mixture was stirred at rt overnight. Quenching with water and evaporation of solvent gave a bis-benzylated product that was taken in MeOH (50 mL) and hydrolyzed with 2 N aq NaOH (25 mL) at 50 °C for 4 h. After acidification with KHSO<sub>4</sub>, the product was extracted with EtOAc, and the organic layer was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The crude was purified by chromatography to provide compound <b>77</b> (2.86 g, 68%). Compound <b>77</b> (2.85 g, 8.5 mmol) was dissolved in pyridine (25 mL), then Boc<sub>2</sub>O (2.14 g, 9.8 mmol) and NH<sub>4</sub>HCO<sub>3</sub> (0.77 g, 9.8 mmol) were sequentially added, and the mixture was stirred at rt overnight. After removing volatiles, the product was taken in EtOAc, the organic layer was washed with 1 N HCl, NaHCO<sub>3</sub> satd soln, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The crude was dissolved in DCM (30 mL), and TEA (3.5 mL, 25.5 mmol) was added. The resulting mixture was cooled at 0 °C, TFAA (1.8 mL, 12.7 mmol) was added, and the mixture was stirred at rt for 2 h. Solvent was evaporated under vacuum, the residue was taken up in EtOAc, the organic layer was washed with 1 N HCl, satd NaHCO<sub>3</sub>, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The crude was purified by chromatography to provide compound <b>62c</b> (1.87 g, 70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.43 (bd, <i>J</i> = 7.2 Hz, 2H), 7.36 (bt, <i>J</i> = 7.4 Hz, 2H), 7.27−7.31 (m, 1H), 5.19 (bs, 1H), 4.73 (d, <i>J</i> = 12.0 Hz, 1H), 4.54 (d, <i>J</i> = 12.0 Hz, 1H), 3.90 (bs, 1H), 3.85 (t, <i>J</i> = 2.7 Hz, 1H), 3.41 (bs, 1H), 2.32 (d, <i>J</i> = 14.5 Hz, 1H), 1.99 (bd, <i>J</i> = 13.5 Hz, 1H), 1.83 (ddd, <i>J</i> = 14.6, 6.3, 2.5 Hz, 1H), 1.55−1.64 (m, 1H), 1.50 (s, 9H). </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-[4-(benzyloxy)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)piperidin-2-yl]-1-methyl-6-oxo-1,6-</b><b>dihydropyrimidine-4-carboxylate (67c).</b> A solution of hydroxylamine hydrochloride (688 mg, 9.9 mmol) in MeOH (20 mL) was added at 0 °C to a solution of KOH (557 mg, 9.9 mmol) in MeOH (20 mL). After stirring for 10 min, KCl was filtered off, and the filtrate was added to a solution of <b>62c</b> (1.87 g, 5.9 mmol) in MeOH (25 mL); the mixture was stirred at 55 °C overnight. Additional hydroxylamine (0.8 equiv, prepared in the same way) was added and stirring was continued for 5 h. Evaporation to dryness gave a crude <b>63c</b> (2.3 g, 100%) that was used as such. A solution of amidoxime <b>63c</b> (5.9 mmol) and dimethyl acetylene dicarboxylate (1.1 g, 7.7 mmol) in CHCl<sub>3</sub> (50 mL) was stirred at rt overnight. The crude product <b>64c</b>, obtained after evaporation of the solvent under vacuum, was used as such for the following cyclization reaction. A solution of <b>64c</b> (theoretical, 5.9 mmol from previous step) in toluene (120 mL) was refluxed (Dean−Stark trap) for 48 h. The mixture was evaporated under vacuum, the resulting crude <b>65c</b> was dissolved in pyridine (30 mL), and benzoic anhydride (3.0 g, 13 mmol) was added. After 5 h of stirring at rt, the mixture was evaporated under vacuum and the residue was dissolved in EtOAc, washed with 1 N HCl, NaHCO<sub>3</sub> satd soln, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under vacuum to provide crude benzoate, which was purified by flash chromatography to provide <b>66c</b> (632 mg, 19% yield from amidoxime <b>63c</b>) and about 10% of the corresponding <i>trans</i>-isomer. A solution of compound <b>66c</b> (547 mg, 1.0 mmol) in dry 1,4-dioxane (5 mL) was added at rt to a suspension of LiH (9.3 mg, 1.2 mmol) in dry dioxane (3 mL). After stirring 45 min at 40 °C, Me<sub>2</sub>SO<sub>4</sub> (0.14 mL, 1.5 mmol) was slowly added at rt, and the mixture was stirred at 55 °C for 4 h (additional Me<sub>2</sub>SO<sub>4</sub> was added). After pouring into brine, the reaction mixture was extracted with AcOEt, washed with brine, and dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under vacuum<sub>.</sub> Crude was purified by column chromatography (SiO<sub>2</sub>, AcOEt/petroleum ether = 1:1) to afford <b>67c</b> (345 mg, yield 62%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.18 (d, <i>J</i> = 7.3 Hz, 2H), 7.63 (t, <i>J</i> = 7.3 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 7.19−7.33 (m, 5H), 4.90 (bs, 1H), 4.50 (d, <i>J</i> = 11.9 Hz, 1H), 4.39 (d, <i>J</i> = 11.9 Hz, 1H), 4.02−4.16 (m, 1H), 3.85−3.90 (m, 1H), 3.77 (s, 3H), 3.60−3.67 (m, 1H), 3.58 (s, 3H), 2.11−2.28 (m, 2H), 1.85−1.95 (m, 2H), 1.38 (s, 9H). MS <i>m</i>/<i>z</i> 578 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-[4-(Benzyloxy)-1-methylpiperidin-2-yl]-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-</b><b>dihydropyrimidine-4-carboxamide (26).</b> Compound <b>67c</b> (340 mg, 0.59 mmol) was dissolved in MeOH (20.0 mL) and 4-fluorobenzylamine (0.30 mL, 2.7 mmol) was added, and the mixture was refluxed for 4 h. Evaporation to dryness gave crude <b>49c</b>, which was used as such. Crude <b>49c</b> was then treated for 2 h at rt with a TFA/DCM (2.5:1) solution, then evaporated under vacuum to give a crude (1.38 g) that was purified by RP-HPLC to provide <b>46c</b> (61% overall yield from <b>67c</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.30−7.44 (m, 7H), 7.10 (t, <i>J</i> = 8.7 Hz, 2H), 4.76 (bd, <i>J</i> = 12.1 Hz, 1H), 4.58−4.67 (m, 4H), 3.91−4.00 (m, 1H), 3.62−3.70 (m, 1H), 3.62 (s, 3H), 3.25 (t, <i>J</i> = 12.2 Hz, 1H), 2.71 (bd, <i>J</i> = 13.7 Hz, 1H), 2.43 (bd, <i>J</i> = 13.1 Hz, 1H), 1.69−1.80 (m, 1H), 1.57−1.66 (m, 1H). MS <i>m</i>/<i>z</i> 467 (M + H)<sup>+</sup>. Crude <b>46c</b> (0.11 mmol) was dissolved in MeOH (2.0 mL), TEA (0.04 mL, 0.3 mmol), sodium acetate (33 mg, 0.4 mmol), acetic acid (0.023 mL, 0.4 mmol), and sodium cyanoborohydride (25 mg, 0.4 mmol) were added to the solution, followed by a 37% formaldehyde solution in water (0.15 mL, 2.0 mmol). The reaction mixture was stirred at rt for 5 h, then evaporated to get the <i>N</i>-methylated product <b>26</b> that was purified by RP-HPLC (35 mg, 56%). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.39−7.43 (m, 2H), 7.27−7.35 (m, 5H), 7.09 (bt, <i>J</i> = 8.8 Hz, 2H), 4.76−4.84 (m, 1H), 4.63 (s, 2H), 4.61 (bs, 2H), 3.85−3.93 (m, 1H), 3.78 (bd, <i>J</i> = 13.1 Hz, 1H), 3.62 (s, 3H), 3.33−3.39 (m, 1H), 2.86 (s, 3H), 2.67 (bd, <i>J</i> = 14.1 Hz, 1H), 2.42 (bd, <i>J</i> = 14.1 Hz, 1H), 1.78−2.00 (m, 1H), 1.67−1.77 (m, 1H). MS <i>m</i>/<i>z</i> 481 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-2-[4-hydroxy-1-methylpiperidin-2-yl]-1-methyl-6-oxo-1,6-di</b><b>hydro-pyrimidine-4-carboxamide (25).</b> Compound <b>26</b> (25 mg of TFA salt, 0.04 mmol) was dissolved in MeOH (5.0 mL), some drops of 1 N HCl and cat. Pd/C 10% was added, and the reaction mixture was stirred under H<sub>2</sub> atmosphere at rt for 3.5 h. Filtration on celite gave a solution from which solvent was evaporated under vacuum. The residue was purified by RP-HPLC to provide <b>25</b> as trifluoroacetate salt (10.2 mg, yield 50%). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.40 (dd, <i>J</i> = 8.2, 5.5 Hz, 2H), 7.40 (t, <i>J</i> = 8.7 Hz, 2H), 4.85 (under H<sub>2</sub>O peak, 1H), 4.57−4.65 (m, 2H), 3.97−4.05 (m, 1H), 3.76 (bd, <i>J</i> = 12.5 Hz, 1H), 3.62 (s, 3H), 3.39 (t, <i>J</i> = 13.3 Hz, 1H), 2.87 (s, 3H), 2.49 (bd, <i>J</i> = 13.7 Hz, 1H), 2.24 (bd, <i>J</i> = 13.7 Hz, 1H), 1.76−1.86 (m, 1H), 1.63−1.72 (1H, m). MS <i>m</i>/<i>z</i> 391 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(4-methyl-5-oxopiperazin-2-yl)-6-oxo-1,6-dihydr</b><b>opyrimidine-4-carboxamide (80).</b> To a solution of compound <b>78</b> (9.8 g, 18.7 mmol) in dry 1,4-dioxane (150 mL) was added LiH (200 mg, 25 mmol). After stirring 90 min at 100 °C, Me<sub>2</sub>SO<sub>4</sub> (2.7 mL, 28 mmol) was slowly added at rt, and the mixture was stirred at 60 °C for 1.5 h. After pouring into brine, the reaction mixture was extracted with AcOEt, washed with brine, and dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to give a crude that was purified by column chromatography (SiO<sub>2</sub>, AcOEt/petroleum ether = 1:1) to afford the corresponding N−Me pyrimidone (7.0 g, yield 69%). The N−Me pyrimidone (4.86 g, 9.0 mmol) was dissolved in MeOH (70.0 mL), 4-fluorobenzylamine (2.38 mL, 20.8 mmol) was added, and the mixture was then refluxed for 2 days. After cooling to rt, cat. Pd/C <a name="jm005002004967" id="jm005002004967"></a> 10% and 1 N HCl (5 mL) were added, and the reaction mixture was stirred under H<sub>2</sub> atmosphere, at rt overnight. Filtration on celite gave a solution from which solvent was evaporated under vacuum to give a crude compound <b>79</b> (3.9 g) that was used as such. The primary alcohol <b>79</b> (8.9 mmol) was dissolved in dry DCM (100 mL), TEA (6.3 mL, 45 mmol) and MsCl (1.7 mL, 22 mmol) were added, and the mixture was stirred at rt for 2 h. Evaporation to dryness gave a residue (mono- and bismesylate) that was (0.84 mmol) taken up in CH<sub>3</sub>CN (12 mL), and excess BnMeNH (1 mL) was added. The mixture was stirred at reflux for 3 h and then overnight at rt; the residue obtained by evaporation was purified by RP-HPLC to provide a tertiary amine compound that (235 mg, 0.38 mmol) was dissolved in DCM (5 mL); TFA (2 mL) was added, and the mixture was stirred at rt for 3 h. Evaporation to dryness gave a residue that was taken in MeOH (2.0 mL), TEA (0. 4 mL, 3 mmol), and acetic acid (0.25 mL, 4.5 mmol) were added to the solution, followed by ethyl oxoacetate (2.0 mmol) and sodium cyanoborohydride (100 mg, 1.6 mmol). The reaction mixture was stirred at rt for 3 h, then Pd/C 10% and 1 N HCl (1.5 mL) were added, and the mixture was stirred under a H<sub>2</sub> atmosphere overnight; filtration on celite, followed by evaporation, gave a residue that was used as such. This crude (0.38 mmol) was taken up in MeOH, excess TEA was added, and the mixture was refluxed for 5 h. The residue obtained after removing volatiles was purified by chromatography to give the desired <b>80</b> (28 mg of TFA salt, 32% yield over four steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.20 (bs, 1H), 9.39 (t, <i>J</i> = 6.5 Hz, 1H), 7.43 (dd, <i>J</i> = 8.6, 5.5 Hz, 2H), 7.24 (t, <i>J</i> = 8.6 Hz, 2H), 5.32 (bd, <i>J</i> = 6.6 Hz, 1H), 4.62 (bd, <i>J</i> = 4.9 Hz, 2H), 3.90−3.99 (m, 3H), 3.61 (s, 3H), 3.55−3.65 (m, 1H), 2.97 (s, 3H). MS <i>m</i>/<i>z</i> 390 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(1,4-Dimethyl-5-oxopiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dih</b><b>ydro-pyrimidine-4-carboxamide (32).</b> Et<sub>3</sub>N (0.025 mL, 0.18 mmol), acetic acid (0.03 mL), and 37% aq HCHO (0.1 mL) were added to a solution of compound <b>80</b> (30 mg of TFA salt, 0.06 mmol) in MeOH (2 mL); excess NaCNBH<sub>3</sub> (10 mg) was added and the mixture was stirred at rt for 2.5 h. The residue obtained by evaporation was purified by RP-HPLC to provide <b>32</b> as trifluoroacetate salt (15 mg, yield 49%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.28 (t, <i>J</i> = 6.3 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 5.8 Hz, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 5.23 (dd, <i>J</i> = 3.9, 10.4 Hz, 1H), 4.55 (d, <i>J</i> = 6.3 Hz, 2H), 4.23 (d, <i>J</i> = 16.5 Hz, 1H), 4.04 (d, <i>J</i> = 16.5 Hz, 1H), 3.92 (dd, <i>J</i> = 3.9, 13.7 Hz, 1H), 3.66−3.75 (m, 1H), 3.59 (s, 3H), 2.91 (s, 3H), 2.82 (s, 3H). MS <i>m</i>/<i>z</i> 404 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl-5-(benzoyloxy)-2-[(2</b><b><i>S</i></b><b>)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-pyrrolidin-2-yl]-1-methyl-6-oxo-1,6-</b><b>dihydro-pyrimidine-4-carboxylate (86a).</b> Methyl 5-(benzoyloxy)-2-[(2<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-2-yl]-6-hydroxy-pyrimidine-4-carboxylate <b>85a</b> (0.5 g, 1.1 mmol) was added at rt to a suspension of LiH (10 mg, 1.2 mmol) in dioxane (5 mL). The mixture was stirred for 45 min at 38 °C and was then cooled to rt. Dimethylsulfate (0.14 mL, 1.4 mmol) was added dropwise, and the mixture was warmed to 58 °C. After 3 h, the crude was cooled to rt, and brine (2 mL) was added, followed by EtOAc (10 mL). The aqueous phase was separated and extracted two times with EtOAc (2 × 10 mL). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) to afford a residue that was purified by column chromatography (SiO<sub>2</sub>, EtOAc/petroleum ether = 1:1), 80% yield; N−Me/O−Me = 13:1; e.e. 85.5%.<sup>47</sup> Recrystallization from EtOAc/hexanes gave compound <b>86a</b> as a white solid; e.e. 99.8%; [α]<sub>D</sub> = −19.13 (CH<sub>3</sub>CN, <i>c</i> 0.05, 20 °C). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz, mixture of rotamers) δ 8.18 (d, <i>J</i> = 7.5 Hz, 2H), 7.63 (t, <i>J</i> = 7.2 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 5.10−5.00 (m, 0.5H), 5.00−4.90 (m, 0.5H), 3.80 (s, 1.5H), 3.78 (s, 1.5H), 3.69 (s, 1.5H), 3.65 (s, 1.5H), 3.65−3.45 (m, 2H), 2.50−2.30 (m, 1H), 2.30−2.10 (m, 1H), 2.10−1.90 (m, 2H), 1.56 (s, 5H), 1.45 (s, 4H). MS <i>m</i>/<i>z</i> 458 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2(</b><b><i>S</i></b><b>)-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidi</b><b>n-2-yl)-1-methylpyrrolidinium Trifluoroacetate (10a).</b> Compound <b>86a</b> (75 mg, 0.16 mmol) was treated with DCM/TFA = 7:3 (7 mL) at 0 °C. The solution was allowed to warm to rt and stirred for 1 h. Volatiles were removed under reduced pressure, the residue was triturated with Et<sub>2</sub>O, and the corresponding free pyrrolidinium trifluoroacetate was collected by filtration in 97% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.18 (d, <i>J</i> = 7.5 Hz, 2H), 7.67 (t, <i>J</i> = 7.6 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 5.46 (t, <i>J</i> = 6.6 Hz, 1H), 3.82 (s, 3H), 3.63 (s, 3H), 3.70−3.50 (m, 2H), 2.80−2.70 (m, 1H), 2.40−2.00 (m, 3H). MS <i>m</i>/<i>z</i> 358 (M + H)<sup>+</sup>. To a stirred solution of the pyrrolidinium trifluoroacetate (0.1 g, 0.21 mmol) in 1,2-dichloroethane (10 mL), Et<sub>3</sub>N (0.04 mL, 0.25 mmol), AcOH glacial (0.02 mL, 0.34 mmol), 37% HCHO (0.03 mL, 0.42 mmol), and NaCNBH<sub>3</sub> (0.02 g, 0.30 mmol) were added. The reaction mixture was stirred at rt overnight, then poured in aqueous NaHCO<sub>3</sub> satd soln, and extracted in EtOAc. The organic layer was collected, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was used in the next step without further purification. A solution of the <i>N</i>-methylpyrrolidine compound (0.073 g, 0.20 mmol) in <i>N</i>-methyl-2-pyrrolidinone (0.5 mL) was treated with 4-fluorobenzylamine (0.067 mL, 0.60 mmol), and the solution was heated at 90 °C for 30 min. After cooling to rt, the reaction mixture was purified by preparative RP-HPLC to give compound <b>10a</b> in 40% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.47 (bs, 1H), 9.63 (t, <i>J</i> = 6.6 Hz, 1H), 9.42 (bs, 1H), 7.35 (dd, <i>J</i> = 8.6, 5.6 Hz, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 4.95−4.80 (m, 1H), 4.59 (d, <i>J</i> = 6.4 Hz, 2H), 3.80−3.70 (m, 1H), 3.42 (s, 3H), 2.94 (bs, 3H), 2.70−2.10 (m, 1H), 2.30−2.10 (m, 1H), 2.10−1.80 (m, 2H). [α]<sub>D</sub> = −62 (CH<sub>3</sub>CN, <i>c</i> 0.01, 20 °C). MS <i>m</i>/<i>z</i> 361 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-{1-[(benzyloxy)carbonyl]-3-methylpyrrolidin-2-yl}-1-methyl-6-oxo-1,6-di</b><b>hydropyrimidine-4-carboxylate (86b).</b> Compound <b>85b</b> (1.1 g, 2.2 mmol) was added at rt to a suspension of LiH (20 mg, 2.4 mmol) in dioxane (10 mL). The mixture was stirred for 45 min at 38 °C and was then cooled to rt. Dimethylsulfate (0.28 mL, 2.9 mmol) was added dropwise, and the mixture was warmed to 58 °C. After 2 h, the crude was cooled to rt and added to NaCl satd soln, followed by the addition of EtOAc (10 mL). The aqueous phase was separated and extracted with EtOAc. The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) to afford a residue that was purified by flash column chromatography (EtOAc/petroleum ether = 1:1) to give compound <b>86b</b> in 66% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.25−8.12 (m, 2H), 7.70−7.60 (m, 1H), 7.55−7.45 (m, 2H), 7.40−7.30 (m, 5H), 5.20−4.80 (m, 3H), 3.80, 3.79 (2s, 1.5H), 3.78, 3.76 (2s, 3H), 3.60−3.30 (m, 1H), 3.37, 3.34 (2s, 1.5H), 2.80−2.60 (m, 1H), 2.40−2.20 (m, 1H), 2.00−1.90 (m, 1H), 1.70−1.60 (m, 1H), 1.30−0.80 (m, 3H). </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-{1-[(benzyloxy)carbonyl]-5-methylpyrrolidin-2-yl}-1-methyl-6-oxo-1,6-di</b><b>hydropyrimidine-4-carboxylate (86e).</b> Following the same reaction described to obtained compound <b>86b</b>, compound <b>86e</b> was obtained from <b>85e</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.25−8.15 (m, 2H), 7.70−7.60 (m, 1H), 7.60−7.40 (m, 2H), 7.40−7.30 (m, 5H), 5.20−4.80 (m, 3H), 4.50−4.30 (m, 1H), 3.78 (s, 2H), 3.75 (s, 1H), 3.69 (s, 1.5H), 3.41 (s, 1.5H), 2.60−2.30 (m, 2H), 1.95−1.80 (m, 1H), 1.60−1.50 (m, 1H), 1.32 (d, <i>J</i> = 6.4 Hz, 1.5H), 1.22 (d, <i>J</i> = 6.4 Hz, 1.5H). </div><div class="NLM_p"><b>2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-1,3-dimethylpyrrolidinium Trifluoroacetate (12).</b> A solution of compound <b>86b</b> (0.6 g, 1.2 mmol) in MeOH (20 mL) was treated with 4-fluorobenzylamine (0.34 mL, 3.0 mmol), and the solution was stirred at reflux overnight. The solvent was removed in vacuo, and the residue was taken up in EtOAc, washed with 1 N HCl and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent gave a residue <b>89b</b>, which was used in the next step without further purification. To a solution of compound <b>89b</b> (0.5 g, 1.0 mmol) in MeOH (20 mL), Pd/C (10 mg, 0.1 mmol) and HCl (1 N, 1 mL, 1.0 mmol) was added and the reaction mixture was stirred under a H<sub>2</sub> atmosphere (1 atm) for 2 h. Then the mixture was filtered through celite, and the solvent was removed under vacuum affording <b>90b</b>, which was used in the next step without further purification. To a stirred solution of compound <b>90b</b> (0.07 g, 0.17 mmol) in CHCl<sub>3</sub> (10 mL), Et<sub>3</sub>N (0.029 mL, 0.20 mmol), AcOH glacial (0.016 mL, 0.27 mmol), 37% HCHO (0.032 mL, 0.23 mmol), and NaCNBH<sub>3</sub> (0.015 g, 0.24 mmol) were added. The reaction mixture was stirred at rt overnight, then poured in aqueous <a name="jm005002004968" id="jm005002004968"></a> NaHCO<sub>3</sub> satd soln, and extracted in EtOAc. The organic layer was collected, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by preparative RP-HPLC to give compound <b>12</b> as a 2:1 mixture in 26% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.50 (bs, 1H), 9.64 (bs, 1H), 7.38 (t, <i>J</i> = 8.8 Hz, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 5.00−4.90 (m, 1H), 4.60−4.50 (m, 2H), 3.90−3.80 (m, 1H), 3.48 (s, 1H), 3.45 (s, 2H), 3.10−3.00 (m, 1H), 2.88 (s, 3H), 2.40−2.20 (m, 1H), 2.00−1.60 (m, 2H), 1.21 (d, <i>J</i> = 6.5 Hz, 1H), 0.70 (d, <i>J</i> = 6.5 Hz, 2H). MS <i>m</i>/<i>z</i> 375 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-[1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-4-methylpyrrolidin-2-yl]-6-hydroxypyrimidine-4</b><b>-carboxylate (85c,d).</b> Following the usual chemistry toward 5-<i>O</i>-benzoylated pyrimidine <b>85</b>, compounds <b>85c</b> and <b>85d</b> were obtained from nitrile <b>81c</b>,<b>d</b> as a mixture. The two diastereoisomeric products <b>85c</b> and <b>85d</b> were separated by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = from 8:2 to 1:1) as yellow solids:  (<b>85c</b>)<b> Methyl </b><b>5-(Benzoyloxy)-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-4-methylpyrrolidin-2-yl]-6-hydroxypyri</b><b>midine-4-carboxylate</b> (34%); <i>R</i><sub>f</sub> = 0.3 (EtOAc/petroleum ether = 1:1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.10 (d, <i>J</i> = 7.5 Hz, 2H), 7.80 (t, <i>J</i> = 7.2 Hz, 1H), 7.60 (t, <i>J</i> = 7.6 Hz, 2H), 4.60−4.50 (m, 1H), 3.75 (s, 3H), 3.70−3.60 (m, 1H), 3.10−3.00 (m, 1H), 2.50−2.40 (m, 1H), 2.40−2.20 (m, 1H), 1.70−1.50 (m, 1H), 1.40−1.20 (2s, 9H), 1.05 (d, <i>J</i> = 6.6 Hz, 3H). MS <i>m</i>/<i>z</i> 458 (M + H)<sup>+</sup>; (<b>85d</b>) <b>Methyl </b><b>5-(Benzoyloxy)-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-4-methylpyrrolidin-2-yl]-6-hydroxypyri</b><b>midine-4-carboxylate</b> (16%); <i>R</i><sub>f</sub> = 0.4 (EtOAc/petroleum ether = 1:1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.10 (d, <i>J</i> = 7.5 Hz, 2H), 7.80 (t, <i>J</i> = 7.2 Hz, 1H), 7.60 (t, <i>J</i> = 7.6 Hz, 2H), 4.70−4.50 (m, 1H), 3.75 (s, 3H), 3.70−3.60 (m, 1H), 3.00−2.80 (m, 1H), 2.50−2.40 (m, 1H), 2.10−1.80 (m, 2H), 1.40,1.20 (2s, 9H), 1.00 (d, <i>J</i> = 6.6 Hz, 3H). MS <i>m</i>/<i>z</i> 458 (M + H)<sup>+</sup>. </div><div class="NLM_p">M<b>ethyl </b><b>5-(Benzoyloxy)-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-4-methylpyrrolidin-2-yl]-1-methyl-6-oxo</b><b>-1,6-dihydropyrimidine-4-carboxylate (86c).</b> Compound <b>85c</b> (0.4 g, 0.9 mmol) was added at rt to a suspension of LiH (10 mg, 1.0 mmol) in dioxane (5 mL). The mixture was stirred for 45 min at 38 °C and was then cooled to rt. Dimethylsulfate (1.3 equiv, 0.11 mL, 1.1 mmol) was added dropwise, and the mixture was warmed to 58 °C. After 3 h, the crude was cooled to rt and brine (2 mL) was added, followed by EtOAc (10 mL). The aqueous phase was separated and extracted two times with EtOAc (2 × 10 mL). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) to afford a residue, which was purified by column chromatography (SiO<sub>2</sub>, EtOAc/petroleum ether = 1:1) to give compound <b>86c</b> in 68% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.17 (d, <i>J</i> = 7.5 Hz, 2H), 7.62 (t, <i>J</i> = 7.6 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 5.00−4.80 (m, 1H), 3.80, 3.78 (2s, 3H), 3.69 (s, 1.5H), 3.90−3.80 (m, 1H), 3.65 (s, 1.5H), 3.20−2.90 (m, 1H), 2.60−2.50 (m, 1H), 2.40−2.20 (m, 1H), 1.80−1.60 (m, 1H), 1.44, 1.28 (2s, 9H), 1.15 (d, <i>J</i> = 6.6 Hz, 1.5H), 1.12 (d, <i>J</i> = 6.6 Hz, 1.5H). MS <i>m</i>/<i>z</i> 472 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyri</b><b>midin-2-yl)-1,4-dimethylpyrrolidinium trifluoroacetate (13).</b> Compound <b>86c</b> (0.35 g, 0.74 mmol) was treated with DCM/TFA = 7:3 (7 mL) at 0 °C. The solution was allowed to warm to rt and stirred for 1 h. Volatiles were removed under vacuum. The residue was triturated with Et<sub>2</sub>O, and the corresponding free pyrrolidinium trifluoroacetate was collected by filtration in 97% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.16 (d, <i>J</i> = 7.5 Hz, 2H), 7.67 (t, <i>J</i> = 7.6 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 5.50−5.40 (m, 1H), 3.90−3.80 (m, 1H), 3.80 (s, 3H), 3.63 (s, 3H), 3.60−3.50 (m, 1H), 3.10−3.00 (m, 1H), 2.90−2.70 (m, 2H), 1.60−1.50 (m, 1H), 1.20 (d, <i>J</i> = 6.5 Hz, 3H). MS <i>m</i>/<i>z</i> 372 (M + H)<sup>+</sup>. The pyrrolidinium trifluoroacetate (0.1 g, 0.21 mmol) was dissolved in 1,2-dichloroethane (10 mL), Et<sub>3</sub>N (0.035 mL, 0.25 mmol), AcOH glacial (0.02 mL, 0.34 mmol), 37% HCHO (0.03 mL, 0.42 mmol), and NaCNBH<sub>3</sub> (0.02 g, 0.30 mmol) were added. The reaction mixture was stirred at rt overnight, then poured in aqueous NaHCO<sub>3</sub> satd soln, and extracted in EtOAc. The organic layer was collected, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was used in the next step without further purification. It was (0.063 g, 0.16 mmol) dissolved in <i>N</i>-methyl-2-pyrrolidinone (0.5 mL) and treated with 4-fluorobenzylamine (0.047 mL, 0.40 mmol), and the solution was heated at 90 °C for 30 min. After cooling to rt, the reaction mixture was purified by preparative RP-HPLC to give the desired compound <b>13</b> as trifluoroacetate salt in 10% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 330 K) δ 12.50 (bs, 1H), 9.62 (bs, 2H), 7.36 (t, <i>J</i> = 8.8 Hz, 2H), 7.16 (t, <i>J</i> = 8.8 Hz, 2H), 5.00−4.90 (m, 1H), 4.60−4.50 (m 2H), 3.90−3.80 (m, 1H), 3.43 (s, 3H), 2.95 (bs, 3H), 2.90−2.80 (m, 1H), 2.80−2.70 (m, 1H), 1.60−1.50 (m, 1H), 1.07 (d, <i>J</i> = 6.5 Hz, 3H). MS <i>m</i>/<i>z</i> 375 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-4-methylpyrrolidin-2-yl]-1-methyl-6-oxo</b><b>-1,6-dihydropyrimidine-4-carboxylate (86d).</b> Compound <b>86d</b> was obtained from compound <b>85d</b> using the same reaction described to obtain compound <b>86c</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz, 330 K) δ 8.17 (d, <i>J</i> = 7.5 Hz, 2H), 7.62 (t, <i>J</i> = 7.6 Hz, 1H), 7.49 (t, <i>J</i> = 7.6 Hz, 2H), 5.00−4.80 (m, 1H), 3.79, 3.77 (two s, 3H), 3.66 (s, 1.5H), 3.90−3.80 (m, 1H), 3.63 (s, 1.5H), 3.20−3.00 (m, 1H), 2.70−2.60 (m, 1H), 2.10−2.00 (m, 1H), 1.80−1.70 (m, 1H), 1.45, 1.29 (2s, 9H), 1.09 (7, <i>J</i> = 6.6 Hz, 3H). MS <i>m</i>/<i>z</i> 472 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyr</b><b>imidin-2-yl)-1,4-dimethylpyrrolidinium Trifluoroacetate (14).</b> Compound <b>14</b> was obtained from the intermediate <b>86d</b> following the same three steps used to prepare compound <b>13</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.47 (bs, 1H), 9.61 (bs, 2H), 7.35 (m, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 5.00−4.90 (m, 1H), 4.60−4.50 (m 2H), 3.90−3.80 (m, 1H), 3.42 (s, 3H), 2.94 (bs, 3H), 2.30−2.20 (m, 3H), 1.12 (d, <i>J</i> = 6.5 Hz, 3H). MS <i>m</i>/<i>z</i> 375 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-1,5-dimethylpyrrolidinium Trifluoroacetate (15).</b> Following the same steps described for the preparation of compound <b>12</b>, compound <b>15</b> from nitrile <b>81e</b> was obtained as a 1:2 mixture. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 9.55, 9.37 (2bs, 1H), 7.38 (t, <i>J</i> = 7.5 Hz, 2H), 7.17 (t, <i>J</i> = 8.7 Hz, 2H), 5.00−4.90 (m, 1H), 4.70−4.60 (m 2H), 4.20−4.00 (m, 0.5H), 3.70−3.60 (m, 0.5H), 3.46 (s, 1.5H), 3.45 (s, 1.5H), 2.96 (s, 1H), 2.82 (s, 2H), 2.80−2.60 (m, 1H), 2.40−2.30 (m, 0.5H), 2.30−2.10 (m, 0.5H), 2.10−1.90 (m, 1.5H), 1.80−1.70 (m, 0.5H), 1.47 (d, <i>J</i> = 6.6 Hz, 1H), 1.39 (d, <i>J</i> = 6.6 Hz, 2H). MS <i>m</i>/<i>z</i> 375 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-(benzyloxy)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)-pyrrolidin-2-yl]-1-methyl-</b><b>6-oxo-1,6-dihydropyrimidine-4-carboxylate (86f).</b> To compound <b>85f</b> (1.91, 3.58 mmol), dissolved in THF (30 mL), Cs<sub>2</sub>CO<sub>3</sub> (1.75 g, 1.5 equiv) and dimethyl sulfate (678 mg, 1.5 equiv) were added, and the reaction mixture was stirred at 50 °C for 1 h. The reaction mixture was cooled down to 0 °C and HCl (1 N) was added. The reaction mixture was extracted with ethyl acetate, and the organic phase was washed with HCl (1 N) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The title product <b>86f</b> was isolated by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 7:3) as a 2:3 mixture of rotamers by NMR (0.816 g, 40% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.18 (d, <i>J</i> = 8.1 Hz, 2H), 7.63 (t, <i>J</i> = 7.5 Hz ,1H), 7.49 (t, <i>J</i> = 7.5 Hz, 2H), 7.41−726 (m, 5H), 5.13 (t, <i>J</i> = 6 Hz, 0.4H), 5.05 (t, <i>J</i> = 6 Hz ,0.6H),), 4.65−4.45 (m, 2H), 4.41 (bs, 0.4H), 4.32 (bs, 0.6H), 3.95−3.63 (m, 8H), 2.57−2.40 (m, 1H), 2.30−2.20 (m, 1H), 1.44 (s, 3.6H), 1.30 (s, 5.4 H). MS <i>m</i>/<i>z</i> 564 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-(Benzyloxy)-2-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,</b><b>6-dihydropyrimidin-2-yl)-1-methylpyrrolidinium Trifluoroacetate (19).</b> To compound <b>86f</b> (0.20 g, 0.36 mmol) dissolved in methanol (16 mL), 4-F-benzylamine (0.155 g, 3.5 equiv) was added. The reaction mixture was stirred at reflux overnight. Methanol was removed in vacuo, and the residue was dissolved in ethyl acetate and washed with HCl (1 N) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was triturated with diethyl ether to give the compound <b>89f</b> that was submitted to the next step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 330 K) 3:7 mixture of rotamers δ <a name="jm005002004969" id="jm005002004969"></a> 11.98 (bs, 1H), 8.68 (bs, 0.7H), 8.52 (bs, 0.3H), 7.49−7.22 (m, 7H), 7.19 (t, <i>J</i> = 8.8 Hz, 2H), 5.2−4.90 (m, 1H), 4.63−4.42 (m, 4H), 4.25 (bs, 1H), 3.85−3.72 (m, 1H), 3.58 (s, 0.9H), 3.51 (s, 2.1H), 2.15−2.29 (m, 1H), 1.26 (bs, 2.7H), 1.11 (bs, 6.3H). MS <i>m</i>/<i>z</i> 553 (M + H)<sup>+</sup>. Compound <b>89f</b> was treated with DCM−TFA (6 mL, 1:1), and the mixture was stirred at rt. After 1 h, volatiles were evaporated and the residue was triturated with diethyl ether obtaining compound <b>90f</b>, which was submitted to the next step without further purification. Formaldehyde (37 wt. % solution in water; 53 μL, 2 equiv) and sodium acetate (26 mg, 1.6 equiv) were added to a mixture of the compound <b>90f</b> and Et<sub>3</sub>N (49 μL, 1 equiv) in methanol (3 mL), followed after stirring for 10 min by NaCNBH<sub>3</sub> (31 mg, 1.4 equiv). After stirring overnight, volatiles were evaporated under reduced pressure, affording a residue, which was redissolved in DMSO and purified by RP-HPLC. Fractions containing the pure compound were combined and freeze-dried yielding compound <b>19</b> (82 mg, 40% yield over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 12.54 (s, 1H), 9.78 (s, 1H), 9.68 (t, <i>J</i> = 6.2 Hz, 1H), 7.43−7.30 (m, 7H), 7.19 (t, <i>J</i> = 8.8 Hz, 2H), 5.11 (bs, 1H), 5.68−4.53 (m, 4H), 4.48−4.30 (m, 1H), 4.22−3.98 (m, 1H), 3.58−3.50 (m, 1H, partially obscured by water), 3.46 (s, 3H), 2.87 (dd, <i>J</i> = 13.5, 7.7 Hz, 1H), 3.00 (d, <i>J</i> = 3.7 Hz, 3H), 2.19−2.06 (m, 1H), 2.24−2.16 (m, 1H). MS <i>m</i>/<i>z</i> 467 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-py</b><b>rimidin-2-yl)-4-hydroxy-1-methyl-pyrrolidinium Trifluoroacetate (16).</b> Compound <b>86f</b> (0.30 g, 0.53 mmol) was dissolved in methanol (15 mL) and Pd/C (10%, 150 mg, 50% w/w) was added. The mixture was stirred under a H<sub>2</sub> atmosphere at rt overnight. The reaction mixture was filtered and methanol was removed in vacuo to give compound <b>87o</b> (86% yield). Compound <b>87o</b> (0.215 g, 0.45 mmol) was dissolved in methanol (15 mL) and 4-F-benzylamine (0.176 g, 3.1 equiv) was added. The reaction mixture was stirred at reflux overnight. Methanol was removed in vacuo, and the residue was dissolved in ethyl acetate and washed with HCl (1 N) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was triturated with diethyl ether to give the desired compound <b>89o</b> that was submitted to the next step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) 3:7 mixture of rotamers δ 12.15 (bs, 0.7H), 12.08 (s, 0.3H), 8.90 (t, <i>J</i> = 6.6 Hz, 0.7H), 8.71 (t, <i>J</i> = 6.6 Hz, 0.3H), 7.34−7.25 (m, 2H), 7.20−7.05 (m, 2H), 5.05 (bs, 1H), 4.95 (t, <i>J</i> = 7.7 Hz, 1H), 4.98−4.40 (m, 2H), 4.34 (bs, 1H), 3.76 (dd, <i>J</i> = 10.9, 4.0 Hz, 1H), 3.53 (s, 0.9H), 3.50 (s, 2.1H), 2.35−2.05 (m, 2H), 1.26 (bs, 2.7H), 1.10 (bs, 6.3H). MS <i>m</i>/<i>z</i> 463 (M + H)<sup>+</sup>. Compound <b>89o</b> was treated with DCM−TFA (6 mL, 1:1), and the mixture was stirred at rt. After 1 h, volatiles were evaporated, and the residue was triturated with diethyl ether obtaining compound <b>90o</b>, which was submitted to the next step without further purification. Formaldehyde (37 wt. % solution in water; 136 μL, 4 equiv) and sodium acetate (119 mg, 3.2 equiv) were added to the amine <b>90o</b>, dissolved in methanol (10 mL), followed after stirring for 10 min by NaCNBH<sub>3</sub> (80 mg, 2.8 equiv). After stirring overnight, volatiles were evaporated under reduced pressure, affording a residue, which was redissolved in DMSO and purified by RP-HPLC. Fractions containing the pure compounds were combined and freeze-dried, yielding compound <b>16</b> (89 mg, 60% yield over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 12.52 (s, 1H), 9.64 (t, <i>J</i> = 5.5 Hz, 1H), 9.54 (s, 1H), 7.35 (dd, <i>J</i> = 8.6 Hz, 5.7 Hz, 2H), 7.18 (t, <i>J</i> = 8.8 Hz, 2H), 5.80 (bs, 1H), 5.09 (q, <i>J</i> = 8,2 Hz, 1H), 4.57 (d, <i>J</i> = 6.3 Hz, 2H), 4.47 (bs, 1H), 4.01−3.90 (m, 1H), 3.44 (s, 3H), 3.26−3.18 (m, 1H), 3.00 (d, <i>J</i> = 3.7 Hz, 3H), 2.65−2.55 (m, 1H, partially obscured by DMSO), 2.22−2.09 (m, 1H). MS <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-2-[(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-methoxypyrrolidin-2-yl]-1-methyl-6-oxo-1,6-di</b><b>hydropyrimidine-4-carboxamide (90g).</b> Compound <b>89g</b> (0.51 g, 1.02 mmol) was dissolved in methanol (50 mL) and Pd/C (10%, 70 mg, 14% w/w) was added. The mixture was stirred under a H<sub>2</sub> atmosphere at rt. After 2 h, the reaction mixture was filtered and methanol was removed in vacuo to give the title product <b>90g</b>, which was used in the following step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 12.58 (bs, 1H), 10.16 (bs, 1H), 9.74 (t, <i>J</i> = 6.3 Hz, 1H), 8.90 (bs, 1H), 7.36 (dd, <i>J</i> = 8.5, 5.7 Hz, 2H), 7,19 (t, <i>J</i> = 8.8 Hz, 2H), 5.01 (bs, 1H), 4.50−4.60 (m, 2H), 4.19 (bs, 1H), 3.55−3.45 (m, 1H), 3.47 (s, 3H), 3.45−3.35 (m, 1H), 3.32 (s, 3H), 2.74 (dd, <i>J</i> = 13.9, 7.5 Hz, 1H), 2.17−2.10 (m, 1H). MS <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyr</b><b>imidin-2-yl)-4-methoxy-1-methylpyrrolidinium Trifluoroacetate (17).</b> Formaldehyde (37 wt. % solution in water; 32 μL, 3 equiv) and sodium acetate (20 mg, 1.6 equiv) were added to the amine <b>90g</b> (50 mg, 0.133 mmol) in methanol (3 mL) followed by NaCNBH<sub>3</sub> (12 mg, 1.4 equiv) after 10 min. After stirring overnight, volatiles were evaporated under reduced pressure, affording a residue, which was redissolved in DMSO and purified by RP-HPLC. Fractions containing the pure compound were combined and freeze-dried, yielding compound <b>17</b> (20 mg, 36% yield over three step). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 10.65 (bs, 1H), 10.42 (bs, 1H), 7.44 (m, 2H), 7.16 (t, <i>J</i> = 8.7, 2H), 5.05 (t, <i>J</i> = 10.2 Hz, 1H), 4.50−4.42 (m, 2H), 4.21−4.07 (m, 2H), 3.47 (s, 3H), 3.33 (s, 3H), 3.39−3.21 (m, 1H), 2.94 (d, <i>J</i> = 4.5, 3H), 2.76 (dd, <i>J</i> = 7.5, 7.2 Hz 1H), 2.19−2.06 (m, 1H). MS <i>m</i>/<i>z</i> 391 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-Ethoxy-2-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-di</b><b>hydropyrimidin-2-yl)-1-methylpyrrolidinium Trifluoroacetate (18).</b> Following the same reactions performed to obtain compound <b>17</b>, compound <b>18</b> was prepared in 34% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.50 (s, 1H), 9.60 (s, 1H), 9.49 (bs, 1H), 7.37 (m, 2H), 7.20 (t, <i>J</i> = 8.8 Hz ,2H), 5.08 (m, 1H), 4.60 (m, 2H), 4.28 (m, 1H), 3.98 (m, 1H), 3.59−3.40 (m, 6H, partialy obscured by water), 3.00 (d, <i>J</i> = 5.6 Hz, 3H), 2.78 (m, 1H), 2.16 (m, 1H), 1.17 (t, <i>J</i> = 7.2 Hz, 3H). MS <i>m</i>/<i>z</i> 405 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-2-{(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-1-[(benzyloxy)carbonyl]-4-[(</b><b><i>tert</i></b><b>-butoxycarbonyl)-amino]-pyrroli</b><b>din-2-yl}-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate (86i)</b>. The pyrimidine <b>85i</b> (1.9 g, 3.1 mmol) in THF (70 mL) was treated with dimethylsulfate (360 μL, 1.2 equiv) and cesium carbonate (1.2 g, 1.2 equiv). The reaction mixture was stirred at 50 °C for 1.5 h. Volatiles were removed under vacuum, the residue was dissolved in EtOAc, washed with HCl (1 N) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered to give after concentration a residue, which was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = from 4:6 to 3:7), yielding compound <b>86i</b> (1.2 g, 64% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 8.09 (d, <i>J</i> = 7.5 Hz, 2H), 7.45 (t, <i>J</i> = 7.5 Hz, 1H), 7.63 (t, <i>J</i> = 7.6 Hz, 2H), 7.00−6.91 (bm, 5H), 6.92 (bd, <i>J</i> = 5.7 Hz, 1H), 5.18 (dd, <i>J</i> = 8.3, 5.9 Hz, 1H), 5.13−4.80 (bm, 2H), 4.22 (m, 1H), 3.96−3.82 (m, 1H), 3.76 (s, 3H), 3.72−3.31 (br m, 4H), 2.75 (m, 1H), 1.99 (m, 1H), 1.39 (s, 9H). MS <i>m</i>/<i>z</i> 607 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(3</b><b><i>S</i></b><b>,5</b><b><i>S</i></b><b>)-5-[5-(Benzoyloxy)-4-(methoxycarbonyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]</b><b>-1-[(benzyloxy)carbonyl]pyrrolidin-3-aminium Trifluoroacetate (87p).</b> The Boc-protected pyrimidine <b>86i</b> (496 mg, 0.82 mmol) was stirred for 40 min in TFA/DCM/H<sub>2</sub>O (65:35:10, 18 mL). Volatiles were removed iv, and the residue was taken up several times with ethyl ether until a pale brown solid appeared upon removal of volatiles iv, yielding compound <b>87p</b> (556 mg, quantitative yield), which was submitted to the next step without purification.<sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 8.37 (bs, 3H), 8.12 (d, <i>J</i> = 7.7 Hz, 2H), 7.81 (t, <i>J</i> = 7.4 Hz, 1H), 7.66 (t, <i>J</i> = 7.6 Hz, 2H), 7.44−7.03 (bm, 5H), 5.32 (bd, <i>J</i> = 7.9 Hz, 1H), 5.18−4.92 (bm, 2H), 4.07 (bm, 1H), 3.93−3.33 (bm partially obscured by H<sub>2</sub>O, 8H), 2.89−2.73 (m, 1H), 2.40−2.26 (m, 1H). MS <i>m</i>/<i>z</i> 507 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-2-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyri</b><b>midin-2-yl)-1-methyl-4-[(methylsulfonyl)amino]pyrrolidinium Trifluoroacetate (20).</b> Methyl sulfonyl chloride (25 μL, 1.1 equiv) was added dropwise to a solution of compound <b>87p</b> (182 mg, 0.29 mmol) and Et<sub>3</sub>N (102 μL, 2.5 equiv) in DCM (2 mL), cooled at 0 °C, and stirring was continued at rt. After 1 h, volatiles were evaporated under vacuum iv, the residue was dissolved in EtOAc, washed with water, HCl (1 N) and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered to give after concentration a residue, which was purified by column <a name="jm005002004970" id="jm005002004970"></a> chromatography (SiO<sub>2</sub>, DCM/MeOH = 80:1), yielding compound <b>88q</b> (122 mg, 71% yield). Compound <b>88q</b> (118 mg, 0.20 mmol) and 4-F-benzylamine (92 μL, 4 equiv) were heated at 90 °C in methanol (2 mL) in a closed vessel. After 4 d, volatiles were evaporated iv to give a residue, which was washed with ethyl ether leaving the desired compound <b>89q</b>, which was submitted to the next step without purification. Pd/C (10%, 12 mg, 10% w/w) and the pyrimidine <b>89q</b> in methanol (30 mL) were stirred under a hydrogen atmosphere. After 3 h, solids were filtered away and volatiles were evaporated iv to give a residue <b>90q</b>, which was submitted to the next step without purification. Formaldehyde (37 wt. % solution in water; 50 μL, 3 equiv) and sodium acetate (29 mg, 1.6 equiv) were added to the amine <b>90q</b> in methanol (4 mL) followed by NaCNBH<sub>3</sub> (20 mg, 1.4 equiv) after 5 min. After stirring for 4 h, volatiles were evaporated under reduced pressure affording a residue, which was redissolved in DMSO and purified by RP-HPLC. Fractions containing the pure compounds were combined and freeze-dried yielding compound <b>20</b> (82 mg, 72% yield over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 12.80−12.23 (bs, 1H), 9.78−9.47 (bm, 2H), 7.44−7.36 (m, 2H), 7.28 (d, <i>J</i> = 4.3 Hz, 1H), 7.22−7.12 (m, 2H), 4.96 (bm, 1H), 4.63 (m, 2H), 4.38 (bm, 1H), 3.88−3.75 (bm, 1H), 3.67−3.43 (bm partially obscured by H<sub>2</sub>O, 4H), 3.14−2.94 (m, 7H), 2.04 (m, 1H). MS <i>m</i>/<i>z</i> 454 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>2-{(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-4-(Acetylamino)-1-[(benzyloxy)carbonyl]pyrrolidin-2-yl}-5-(benzoyloxy)-1-meth</b><b>yl-6-oxo-1,6-dihydropyrimidine-4-carboxylate</b><b>(88r).</b> Acetic anhydride (58 μL, 2 equiv) was added dropwise to a solution of compound <b>87p</b> (190 mg, 0.31 mmol) in pyridine (2.5 mL). After 2 h, volatiles were evaporated under vacuum iv, the residue was dissolved in EtOAc, washed with water, HCl (1 N), and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered to give after concentration compound <b>88r</b>, which was submitted to the next step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 8.11 (d, <i>J</i> = 7.6 Hz, 2H), 7.92 (bd, <i>J</i> = 6.9 Hz, 1H), 7.80 (t, <i>J</i> = 7.4 Hz, 1H), 7.65 (t, <i>J</i> = 7.6 Hz, 2H), 7.43−6.99 (bm, 5H), 5.21 (dd, <i>J</i> = 8.4, 5.6 Hz, 1H), 5.13−4.82 (bm, 2H), 4.47 (m, 1H), 3.96−3.84 (m, 1H), 3.77 (s, 3H), 3.70−3.33 (m partially obscured by H<sub>2</sub>O, 4H), 2.76 (dt, <i>J</i> = 13.2, 7.8 Hz, 1H), 2.05−1.94 (m, 1H), 1.83 (s, 3H). MS <i>m</i>/<i>z</i> 549 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-4-(Acetylamino)-2-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo</b><b>-1,6-dihydropyrimidin-2-yl)-1-methylpyrrolidinium Trifluoroacetate (21).</b> Following the same three steps used for the synthesis of compound <b>20</b>, final compound <b>21</b> was obtained from <b>88r</b> in 48% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 12.97−11.87 (bs, 1H), 10.43−9.09 (bs, 1H), 9.60 (bm, 1H), 7.98 (d, <i>J</i> = 4.4 Hz, 1H), 7.46−7.32 (m, 2H), 7.23−7.09 (m, 2H), 4.95 (bm, 1H), 4.60 (m, 2H), 4.42 (bm, 1H), 3.83 (bd, <i>J</i> = 11.3 Hz, 1H), 3.58−3.22 (m partially obscured by H<sub>2</sub>O, 2H), 3.46 (s, 3H), 3.07−2.92 (m, 1H), 2.96 (s, 3H), 2.01 (m, 1H), 1.76 (s, 3H). MS <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-4-Fluoro-2-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dih</b><b>ydropyrimidin-2-yl)-1-methylpyrrolidinium Trifluoroacetate (22).</b> Compound <b>86l</b> (1.53 g, 3.00 mmol) and 4-F-benzylamine (1.0 mL, 3 equiv) were heated at 90 °C in methanol (23 mL) in a closed vessel. After 24 h, the reaction mixture was diluted with ethyl ether and the precipitated solid was collected by filtration, affording the desired compound <b>89l</b>, which was submitted to the next step without purification. Pd/C (10%, 100 mg, 10% w/w) and the pyrimidine <b>89l</b> in methanol (110 mL) were stirred under a hydrogen atmosphere. After 17 h, TFA (308 μL, 2 equiv) was added to dissolve the desired product. Solids were filtered away and volatiles were evaporated iv to give a residue containing compound <b>90l</b>, which was submitted to the next step without purification. Formaldehyde (37 wt. % solution in water; 34 μL, 3 equiv), sodium acetate (20 mg, 1.6 equiv), and TEA (42 μL, 2 equiv) were added to compound <b>90l</b> (1/15 of the amount obtained from the previous step) in methanol (3 mL), followed by NaCNBH<sub>3</sub> (14 mg, 1.4 equiv) after 10 min. After stirring for 4 h, volatiles were evaporated under reduced pressure affording a residue, which was redissolved in DMSO and purified by RP-HPLC. Fractions containing the pure compounds were combined and freeze-dried, yielding compound <b>22</b> (57 mg, 57% yield over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.59 (bs, 1H), 10.05−9.87 (bs, 1H), 9.77 (bm, 1H), 7.41−7.32 (m, 2H), 7.25−7.16 (m, 2H), 5.61 (bd, <i>J</i> = 49.9 Hz, 1H), 5.04 (bm, 1H), 4.69−4.53 (m, 2H), 4.17−4.02 (bm, 1H), 3.79−3.62 (m partially obscured by H<sub>2</sub>O, 1H), 3.39 (s, 3H), 3.32−3.01 (m, 1H), 2.93 (bs, 3H), 2.47−2.34 (m, 1H). MS <i>m</i>/<i>z</i> 379 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-Fluoro-2-(4-{[(4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dih</b><b>ydropyrimidin-2-yl)-1-methylpyrrolidinium Trifluoroacetate (23).</b> Following the same steps followed to obtain compound <b>22</b>, compound <b>23</b> was obtained from <b>86</b><b>m</b> in 27% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.57 (bs, 1H), 9.76 (bs, 1H), 9.63 (bs, 1H), 7.41−7.32 (m, 2H), 7.25 (t, <i>J</i> = 9 Hz, 2H), 5. (bd, <i>J</i> = 52.5 Hz, 1H), 5.33 (bt, <i>J</i> = 8.2 Hz, 1H), 4.69−4.53 (m, 2H), 4.25 (dd, <i>J</i> = 31.5, 15.0 Hz, 1H), 3.81 (dd, <i>J</i> = 23.3, 15.0 Hz, 1H), 3.52 (s, 3H), 3.12−2.91 (m, 4H), 2.47−2.34 (m, 1H). MS <i>m</i>/<i>z</i> 379 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-[(2</b><b><i>S</i></b><b>)-4,4-Difluoro-1-methylpyrrolidin-2-yl]-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo</b><b>-1,6-dihydropyrimidine-4-carboxamide (24).</b> Following the same steps followed to obtain compound <b>22</b>, compound <b>24</b> was obtained from <b>86n</b> in 47% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz, 340 K) δ 9.43 (t, <i>J</i> = 6.0 Hz, 1H), 7.43 (t, <i>J</i> = 8.2 Hz, 2H), 7.19 (t, <i>J</i> = 8.9 Hz, 2H), 5.32 (t, <i>J</i> = 9.0 Hz, 1H), 4.60 (dd, <i>J</i> = 15.7, 6.6 Hz, 1H), 4.56 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 4.34 (td, <i>J</i> = 12.3, 4.1 Hz, 1H), 3.96 (dt, <i>J</i> = 18.5, 12.2 Hz, 1H), 3.44 (s, 3H), 3.39−3.30 (m, 1H), 3.00 (s, 3H), 2.88−2.74 (m, 1H). MS <i>m</i>/<i>z</i> 397 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Benzyl 3-Methyl-2-oxopyrrolidine-1-carboxylate (92b).</b> To a suspension of NaH (4.8 g, 121.5 mmol, 60% dispersion in mineral oil) in dry DMF (100 mL) was added 3-methylpyrrolidin-2-one <b>91b</b> (10.0 g, 100.8 mmol) at 0 °C, and after 15 min, benzyl chloroformate (17.3 mL, 121.0 mmol) was added and the solution was stirred at rt for 2 h. Then NH<sub>4</sub>Cl satd soln was added, the aqueous phase was extracted with EtOAc, and the organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of solvent gave a residue, which was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = from 8:2 to 1:1) to obtain compound <b>92b</b> (60% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 7.50−7.30 (m, 5H), 5.28 (s, 2H), 3.90−3.80 (m, 1H), 3.70−3.60 (m, 1H), 2.65−2.50 (m, 1H), 2.30−2.20 (m, 1H), 1.75−1.55 (m, 1H), 1.24 (d, <i>J</i> = 7.0 Hz, 3H). </div><div class="NLM_p"><b>Benzyl 2-Cyano-3-methylpyrrolidine-1-carboxylate (81b).</b> To a solution of compound <b>92b</b> (4.0 g, 17.2 mmol) in dry THF (20 mL) was added lithium triethylboron hydride (superhydride, 20.6 mL, 1 M solution in THF, 20.6 mmol) at −78 °C under nitrogen. After the mixture was stirred for 30 min at this temperature, the reaction was quenched with NaHCO<sub>3</sub> satd soln, and the mixture was allowed to reach 0 °C. Then H<sub>2</sub>O<sub>2</sub> (33%) was added, and the mixture was stirred for 40 min. The aqueous layer was extracted with EtOAc, and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of solvent gave a residue of the lactam alcohol <b>93b</b>, which was used in the next step without further purification. To a solution of compound <b>93b</b> in dry DCM (20 mL), TMSCN (6.9 mL, 51.0 mmol) and ZnI<sub>2</sub> (0.54 g, 1.7 mmol) were added, and the reaction mixture was stirred overnight at rt. The solvent was removed in vacuo, and the residue was partitioned between water and EtOAc. The organic layer was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of solvent gave a residue that was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = 8:2) to obtain compound <b>81b</b> (50% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 7.40−7.30 (m, 5H), 5.20−5.10 (m, 2H), 4.70−4.50 (m, 1H), 3.70−3.60 (m, 1H), 3.50−3.30 (m, 1H), 2.50−2.30 (m, 1H), 2.20−2.10 (m, 1H), 1.90−1.80 (m, 1H), 1.34−1.24 (m, 3H). </div><div class="NLM_p"><b>Benzyl 2-Cyano-5-methylpyrrolidine-1-carboxylate (81e).</b> Following the same three steps for the preparation of nitrile <b>81b</b>, compound <b>81e</b> was prepared from <b>92e</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 7.50−7.30 (m, 5H), 5.30−5.10 (m, 2H), 4.60−4.50 (m, 1H), 4.20−4.10 (m, 1H), 2.40−2.20 (m, 3H), 1.80−1.70 (m, 1H), 1.30−1.10 (m, 3H). </div><div class="NLM_p"><b>1-</b><b><i>tert</i></b><b>-Butyl 2-Methyl (2</b><b><i>S</i></b><b>)-4-Methylpyrrolidine-1,2-dicarboxylate (95).</b> To a solution of 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>)-4-methylenepyrrolidine-1,2-dicarboxylate<sup>48</sup><b>94</b> (0.2 g, 0.8 mmol) in MeOH <a name="jm005002004971" id="jm005002004971"></a> (10 mL), PtO<sub>2</sub> (20 mg, 0.08 mmol) was added and the reaction mixture was stirred under a H<sub>2</sub> atmosphere (1 atm) for 12 h. Then the mixture was filtered through celite and solvent was removed under vacuum affording compound <b>95</b> as an inseparable mixture of <i>cis</i>/<i>trans</i>-isomers (5:1, based on NMR data), which was used in the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 4.20−4.00 (m, 1H), 3.64 (s, 3H), 3.60−3.50 (m, 1H), 3.00−2.80 (m, 1H), 2.40−2.20 (m, 1H), 2.20−2.10 (m, 1H), 1.50−1.40 (m, 1H), 1.37 and 1.31 (2s, 9H), 0.98 (d, <i>J</i> = 6.5 Hz, 3H). MS <i>m</i>/<i>z</i> 244 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>1-</b><b><i>tert</i></b><b>-Butyl (2</b><b><i>S</i></b><b>)-2-(Aminocarbonyl)-4-methylpyrrolidine-1-carboxylate (96).</b> Compound <b>95</b> (0.3 g, 1.23 mmol) was heated in a mixture of THF/32% aq NH<sub>3</sub> solution (1:9, 20 mL) at 60 °C overnight in a sealed tube. The solvents were reduced in vacuo affording the primary amide <b>96</b> as a white solid, which was used in the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 6.30−5.90 (m, 2H), 4.30−4.10 (m, 1H), 3.80−3.60 (m, 1H), 3.00−2.80 (m, 1H), 2.40−2.20 (m, 1H), 2.20−2.10 (m, 1H), 1.80−1.50 (m, 1H), 1.43 and 1.39 (2s, 9H), 1.04 (d, <i>J</i> = 6.6 Hz, 3H). MS <i>m</i>/<i>z</i> 229 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>1-</b><b><i>tert</i></b><b>-Butyl (2</b><b><i>S</i></b><b>)-2-Cyano-4-methylpyrrolidine-1-carboxylate (81c + 81d).</b> A solution of compound <b>96</b> (0.25 g, 1.1 mmol) and Et<sub>3</sub>N (0.5 mL, 3.7 mmol) in DCM(10 mL) was cooled to 0 °C and TFAA (0.18 mL, 1.3 mmol) was added dropwise under nitrogen. Stirring was continued at rt for 1 h, and volatiles were removed in vacuo. The residue was taken up in EtOAc, washed with water and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of solvent gave a residue that was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc = 8:2) to obtain a mixture of <i>cis</i>/<i>trans</i>-nitriles <b>81c</b> and <b>81d</b> in 75% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 4.50−4.30 (m, 1H), 3.70−3.50 (m, 1H), 3.00−2.80 (m, 1H), 2.50−2.30 (m, 1H), 2.30−2.10 (m, 1H), 1.90−1.80 (m, 1H), 1.48, 1.45 (2s, 9H), 1.12 (d, <i>J</i> = 6.6 Hz, 3H). MS <i>m</i>/<i>z</i> 211 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Benzyl-(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-cyano-4-methoxypyrrolidine-1-carboxylate (81g).</b> To compound <b>98g</b> (10.94 g, 39.18 mmol) prepared according literature<sup>49</sup> and dissolved in dioxane (60 mL), Boc-anhydride (11.11 g 1.3 equiv), NH<sub>4</sub>HCO<sub>3</sub> (3.46 g, 1.26 equiv), and pyridine (2 mL) were added. The mixture was stirred overnight at rt. Dioxane was removed in vacuo and the residue, dissolved in ethyl acetate, was washed with HCl (1 N), saturated aqueous NaHCO<sub>3</sub>, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to get the primary amide, which was submitted to the next step without further purification, 7.86 g (72% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.50−7.22 (m, 6H), 7.02−7.11 (m, 1H), 5.14−5.01 (m, 1H), 4.28−4.12 (m, 1H), 3.95 (bs, 1H), 3.61−3.41 (m, 2H), 3.21 (s, 3H), 2.48−2.18 (m, 1H), 1.99−1.82 (m, 1H). The primary amide (7.86 g, 28.3 mmol) was dissolved in DCM (250 mL) and treated with TEA (8.28 mL, 2.1 equiv). The mixture was cooled down to 0 °C and TFAA (4.39 mL, 1.1 equiv) was added. After 1 h, the organic solution was diluted, washed with HCl (1 N), NaHCO<sub>3</sub> satd soln, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated in vacuo. The title product was obtained after purification by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 8:2), yielding compound <b>81g</b> as a 4:6 mixture of rotamers by NMR (4.62 g, 63% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.45−7.3 (m, 5H), 5.14 (s, 1.2H), 5.20 (d, <i>J</i> = 12.0 Hz, 0.4H), 5.12 (d, <i>J</i> = 13.0 Hz, 0.4H), 4.75 (t, <i>J</i> = 7.0 Hz, 0.4H), 4.64 (t, <i>J</i> = 7.8 Hz, 0.6H), 4.02 (bs, 1H), 3.6−3.45 (m, 2H), 3.21 (s, 3H), 2.45−2.40 (partially under DMSO, m, 1H), 2.40−2.25 (m, 1H). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl (2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-4-(Benzyloxy)-2-cyanopyrrolidine-1-carboxylate (81f) and </b><b>Benzyl-(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-cyano-4-ethoxypyrrolidine-1-carboxylate (81h)</b> were prepared by using the procedure described above for the synthesis of compound <b>81g</b>. (<b>81f</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 7.34−7.26 (m, 5H), 4.62 (t, <i>J</i> = 7.9 Hz, 1H), 4.53−4.45 (m, 2H), 4.19 (bs, 1H), 3.57−3.41 (m, 2H), 2.45−2.40 (partially under DMSO, m, 1H), 2.40−2.22 (m, 1H), 1.44 (s, 9H). MS <i>m</i>/<i>z</i> 303 (M + H)<sup>+</sup>. (<b>81h</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 330 K) δ 7.53−7.24 (m, 5H), 5.25−5.11 (m, 2H), 4.72 (m, 1H), 4.21−4.10 (m, 1H), 3.63−3.37 (m, 4H), 2.47−2.25 (partially under DMSO, m, 2H), 1.09 (t, <i>J</i> = 7.0 Hz, 3H). </div><div class="NLM_p"><b>Benzyl (2</b><b><i>S</i></b><b>, 4</b><b><i>S</i></b><b>)-4-[(</b><b><i>tert</i></b><b>-Butoxycarbonyl)amino]-2-cyanopyrrolidine-1-carboxylate (81i).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz, 340 K) δ 7.41 (m, 5H), 7.03 (m, 1H), 5.16 (s, 2H), 4.73 (bm, 1H), 4.07−3.99 (m, 1H), 3.63 (dd, <i>J</i> = 107, 6.3 Hz, 1H), 3.35 (dd, <i>J</i> = 10.7, 4.9 Hz, 1H), 2.47 (m, 1H), 2.30−2.24 (m, 1H), 1.41 (s, 9H). MS <i>m</i>/<i>z</i> 346 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Benzyl-(2</b><b><i>S</i></b><b>,4</b><b><i>S</i></b><b>)-2-cyano-4-fluoropyrrolidine-1-carboxylate (81l)</b> and <b>Benzyl-(2</b><b><i>S</i></b><b>)-2-cyano-4,4-difluoropyrrolidine-1-carboxylate (81n)</b> were obtained from the corresponding carboxylic acids prepared according literature.<sup>50</sup><b>Benzyl-(2</b><b><i>S</i></b><b>,4</b><b><i>R</i></b><b>)-2-cyano-4-fluoropyrrolidine-1-carboxylate (81m)</b> was used as such in the next step of the synthesis and it was not isolated. (<b>81l</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 7.42−7.30 (m, 5H), 5.40 (dbt, J<sub>H</sub><sub>-</sub><sub>F</sub> = 52.3 Hz, 1H), 5.20 (d, <i>J</i> = 12.7 Hz, 1H), 5.16 (d, <i>J</i> = 12.7 Hz, 1H), 4.94 (d, <i>J</i> = 8.4 Hz, 1H), 3.68−3.56 (m, 2H), 2.63−2.41 (m, 2H). MS <i>m</i>/<i>z</i> 249 (M + H)<sup>+</sup>. (<b>81n</b>) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.40−7.34 (m, 5H), 5.20−5.03 (m, 3H), 3.99−3.72 (m, 2H), 3.06−2.69 (m, 2H). </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl 3-(Aminocarbonyl)piperazine-1-carboxylate (101).</b> Compound <b>100</b> (25.0 g, 75.7 mmol) was suspended in THF (125 mL), then pyridine (9.19 mL, 113.6 mmol), DMF (1.925 mL, 25.0 mmol), and thionyl chloride (7.25 mL, 100.8 mmol) were sequentially added, and the mixture was stirred at 40 °C for 4 h. After dilution with brine, the product was extracted with EtOAc, and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The crude was dissolved in DCM (100 mL) and added to a 0.5 M solution of ammonia in dioxane (350 mL, 175 mmol), and the resulting mixture was stirred at 40 °C for 2 h, then at rt overnight. Solvent was evaporated under vacuum, the residue was dissolved in 1 N HCl, washed with diethyl ether, basified with sodium hydroxide solution, extracted with DCM, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to provide <b>101</b> (15.4 g, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 6.92 (bs, 2H), 3.84 (dd, <i>J</i> = 13.0, 3.0 Hz, 1H), 3.60 (d, <i>J</i> = 13.0 Hz, 1H), 3.09 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 2.90−2.78 (m, 3H), 2.60−2.50 (m, 2H), 1.41 (s, 9H). </div><div class="NLM_p"><b>1-Benzyl 4-</b><b><i>tert</i></b><b>-Butyl 2-(Aminocarbonyl)piperazine-1,4-dicarboxylate (102).</b> To a stirred mixture of compound <b>101</b> (3.85 g, 16.8 mmol) and Et<sub>3</sub>N (5.6 mL, 40.4 mmol) in DCM (150 mL), CbzCl (5.8 mL, 38.7 mmol) was added, and the mixture was stirred at rt overnight. The mixture was washed with 1 N HCl, NaHCO<sub>3</sub> satd soln, then brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to provide the product as an oil, which solidified upon treatment with petroleum ether to give <b>102</b> (5.38 g, 88%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 7.39−7.27 (m, 5H), 7.10 (bs, 2H), 5.09 (s, 2H), 4.46−4.42 (m, 1H), 4.26 (d, <i>J</i> = 13.5 Hz, 1H), 3.82−3.72 (m, 2H), 3.46−3.35 (m, 1H), 3.20 (dd, <i>J</i> = 13.5, 4.8 Hz, 1H), 2.97−2.87 (m, 1H), 1.40 (s, 9H). </div><div class="NLM_p"><b>1-Benzyl 4-</b><b><i>tert</i></b><b>-Butyl 2-Cyanopiperazine-1,4-dicarboxylate (103)</b>. To a 0 °C solution of compound <b>102</b> (15.0 g, 41.32 mmol) and TEA (12.1 mL, 87.0 mmol) in DCM (400 mL), TFAA (6.4 mL, 45.5 mmol) was added dropwise. After 2 h, the mixture was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to provide the desired product <b>103</b> in quantitative yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 7.45−7.28 (m, 5H), 5.32 (bs, (1H), 5.15 (s, 2H), 4.22−4.08 (m, 1H), 4.00−3.45 (m, 2H), 3.20−3.04 (m, 1H), 3.02−2.80 (m, 2H), 1.42 (s, 9H). </div><div class="NLM_p"><b>1-Benzyl 4-</b><b><i>tert</i></b><b>-Butyl 2-[(Amino(hydroxyimino)methyl]piperazine-1,4-dicarboxylate (104).</b> A solution of the nitrile <b>103</b> (10.0 g, 29.0 mmol) in MeOH (40 mL) was added to a stirred mixture of hydroxylamine hydrochloride (2.60 g, 37.7 mmol) and TEA (6.0 mL, 43.5 mmol) in MeOH (30.0 mL), and the mixture was stirred at rt overnight. After dilution with water and extraction with EtOAc, the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to provide the product <b>104</b> in quantitative yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 9.15 (bs, 1H), 7.40−7.30 (m, 5H), 5.42 (bs, 2H), 5.07 (s, 2H), 4.53 (bs, 1H), 4.25 (d, <i>J</i> = 13.0 Hz, 1H), 3.85 (bs, 1H), 3.71 (d, <i>J</i> = 13.0 Hz, 1H), 3.42 (bs, 1H), 3.08 (bs, 1H), 2.81 (bs, 1H), 1.37 (s, 9H). MS <i>m</i>/<i>z</i> 379 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>1-Benzyl </b><b>4-</b><b><i>tert</i></b><b>-Butyl-2-[5-(benzoyloxy)-4-hydroxy-6-(methoxycarbonyl)pyrimidin-2-yl]-piperazine-1</b><b>,4-dicarboxylate (105).</b><a name="jm005002004972" id="jm005002004972"></a> A solution of amidoxime <b>104</b> (10.96 g, 29.0 mmol) and dimethyl acetylene dicarboxylate (4.95 g, 34.8 mmol) in CHCl<sub>3</sub> (85 mL) was refluxed for 12 h. The crude product, obtained after evaporation of the solvent under vacuum, (theoretical 29.0 mmol from previous step) was used as such for the following cyclization reaction, and it was heated at 160 °C in xylene (85 mL) for 8 h and at 120 °C for 48 h. The mixture was evaporated under vacuum, the resulting crude was dissolved in pyridine (103 mL), and benzoic anhydride (13.12 g, 58.0 mmol) was added. After 3 h stirring at rt, the mixture was evaporated under vacuum, and the residue was dissolved in EtOAc, washed with water, dried over anhydrous sodium sulfate, filtered, and evaporated under vacuum to provide crude benzoate, which was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc) to provide <b>105</b> (4.01 g, 23% yield over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 13.35 (bs, 1H), 8.07 (d, <i>J</i> = 7.2 Hz, 2H), 7.76 (t, <i>J</i> = 7.2 Hz, 1H), 7.62 (t, <i>J</i> = 7.8 Hz, 2H), 7.40−7.25 (m, 5H), 5.20−5.10 (m, 2H), 4.97−4.94 (m, 1H), 4.29 (d, <i>J</i> = 14.2 Hz, 1H), 3.93 (d, <i>J</i> = 13.8 Hz, 1H), 3.85−3.75 (m, 2H), 3.73 (s, 3H), 3.46 (dd, <i>J</i> = 14.3, 4.5 Hz, 1H), a signal hidden under H<sub>2</sub>O, 1.30 (s, 9H). MS <i>m</i>/<i>z</i> 593 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>1-Benzyl 4-</b><b><i>tert</i></b><b>-Butyl </b><b>2-[5-(Benzoyloxy)-4-(methoxycarbonyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]piperazi</b><b>ne-1,4-dicarboxylate (106).</b> Compound <b>105</b> (1.78 g, 3.0 mmol) was dissolved in dry THF (70 mL), then Cs<sub>2</sub>CO<sub>3</sub> (1.07 g, 3.3 mmol) and dimethysulfate (0.404 mL, 3.3 mmol) were added. After 1 h at 60 °C, the reaction mixture was concentrated, diluted with AcOEt, washed with HCl (1 N), water, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to give a crude that was purified by column chromatography (SiO<sub>2</sub>, AcOEt/petroleum ether = 2:3; 0.74 g, yield 41%). The regioisomeric OMe compound was not isolated. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 8.08 (d, <i>J</i> = 7.3 Hz, 2H), 7.77 (t, <i>J</i> = 7.4 Hz, 1H), 7.63 (t, <i>J</i> = 7.7 Hz, 2H), 7.35−7.20 (m, 5H), 5.35−5.30 (m, 1H), 5.15−5.05 (m, 2H), 4.15 (bd, <i>J</i> = 14.7 Hz, 1H), 4.00−3.90 (m, 2H), 3.80−3.70 (m, 1H), 3.73 (s, 3H), 3.65−3.50 (m, 4H), 1.27 (s, 9H). MS <i>m</i>/<i>z</i> 607 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>3-(4-{[(4-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidin-</b><b>2-yl)-4-methyl-piperazine-1-carboxylate (36).</b> Compound <b>106</b> (0.68 g, 1.12 mmol) was dissolved in MeOH (45.0 mL), Pd/C (10%, 0.068 g, 10% w/w) was added, and the suspension was hydrogenated at atm pressure. After 30 min, the catalyst was filtered and the filtrate was evaporated under vacuum to provide the crude compound, which was used as such for the following reaction. It was dissolved (0.60 g, 1.26 mmol) in MeOH (10.0 mL), NaCNBH<sub>3</sub> (0.11 g, 1.76 mmol) and sodium acetate (0.17 g, 2.02 mmol) were added to the solution, followed by a 37% formaldehyde solution in water (0.204 mL, 2.52 mmol). The reaction mixture was stirred at rt for 2 h, then evaporated to give the <i>N</i>-methylated product that, without further purification, was suspended in MeOH (8.0 mL), where 4-F-benzylamine (1.15 mL, 10.09 mmol) was added, and the mixture was stirred at 80 °C for 12 h. From the crude mixture solvent was evaporated under vacuum, and the crude was purified by RP-HPLC to provide pure <b>36</b> as trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz, 340 K) δ 7.40−7.35 (m, 2H), 7.18−7.10 (m, 2H), 4.83 (d, <i>J</i> = 7.3 Hz, 1H), 4.59 (d, <i>J</i> = 6.3 Hz, 2H), 4.41 (d, <i>J</i> = 14.9 Hz, 1H), 4.20−4.10 (m, 1H), 3.75−3.60 (m, 1H), 3.54 (s, 3H), 3.38−3.25 (m, 2H), 3.15−3.05 (m, 1H), 2.85 (s, 3H), 1.45 (s, 9H). MS <i>m</i>/<i>z</i> 476 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methylpiperazin-2-yl)-6-oxo-1,6-dihydropyri</b><b>midine-4-carboxamide (33).</b> Compound <b>36</b> was treated with a TFA/DCM solution, then evaporated under vacuum to give a residue that was purified by RP-HPLC to provide <b>33</b> (0.065 g, 11% over 4 steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 340 K) δ 12.25 (bs, 1H), 9.03 (bs, 1H), 7.42−7.35 (m, 2H), 7.20−7.10 (m, 2H), 4.62−4.45 (m, 2H), 4.14−4.09 (m, 1H), 3.62 (s, 3H), 3.62−3.52 (m, 1H), 3.48−3.32 (m, 1H), 3.25−3.15 (m, 1H), 3.15−3.05 (m, 2H), 2.44−2.32 (m, 1H), 2.34 (s, 3H). MS <i>m</i>/<i>z</i> 376 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(1,4-Dimethylpiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropy</b><b>rimidine-4-carboxamide (31).</b> Compound <b>33</b> (0.05 g, 0.13 mmol) was dissolved in MeOH (2.0 mL). TEA (0.02 mL, 0.13 mmol), NaCNBH<sub>3</sub> (0.02 g, 0.37 mmol), and sodium acetate (0.04 g, 0.43 mmol) were added to the solution, followed by a 37% formaldehyde solution in water (0.04 mL, 0.67 mmol). The reaction mixture was stirred at rt for 1 h. Solvent was evaporated under vacuum, to give a residue that was purified by RP-HPLC to provide <b>31</b> as trifluoroacetate salt (0.02 g, yield 75%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 9.19 (bs, 1H), 7.45−7.35 (m, 2H), 7.20−7.08 (m, 2H), 4.75−4.65 (m, 1H), 4.54 (d, <i>J</i> = 6.3 Hz, 2H), 3.75−3.45 (m, 6H), 3.48−3.25 (m, 2H), 3.22−3.09 (m, 1H), 2.81 (s, 3H), 2.66 (s, 3H). MS <i>m</i>/<i>z</i> 390 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(4-Ethyl-1-methylpiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihyd</b><b>ropyrimidine-4-carboxamide (34).</b> Compound <b>33</b> (0.1 g, 0.2 mmol) was dissolved in MeOH (2 mL), Et<sub>3</sub>N (0.056 mL, 0.4 mmol), NaCNBH<sub>3</sub> (17.4 mg, 0.28 mmol), AcONa (26.2 mg, 0.32 mmol), and CH<sub>3</sub>CHO (1 mL) were added, and the reaction mixture was stirred at rt for 1 h, and solvent was removed under reduced pressure. The crude was purified by preparative HPLC purification to give compound <b>34</b> (yield 8%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 9.38 (t, <i>J</i> = 5.9 Hz, 1H), 7.40−7.30 (m, 2H), 7.20−7.10 (m, 2H), 5.10−4.98 (m, 1H), 4.60−4.50 (m, 2H), 4.04−3.75 (m, 3H), 3.60−3.32 (m, 4H), 3.33−3.12 (m, 4H), 2.87 (s, 3H), 1.21 (t, <i>J</i> = 7.14 Hz, 3H). MS <i>m</i>/<i>z</i> 404 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-2-(4-isopropyl-1-methylpiperazin-2-yl)-1-methyl-6-oxo-1,6-d</b><b>ihydropyrimidine-4-carboxamide (35).</b> Compound <b>33</b> (0.10 g, 0.2 mmol) was dissolved in MeOH (2 mL), and Et<sub>3</sub>N (0.166 mL, 1.2 mmol), NaCNBH<sub>3</sub> (17.4 mg, 0.28 mmol), AcONa (26.2 mg, 0.32 mmol), and acetone (1 mL) were added. The reaction mixture was stirred at rt for 3 h, solvent was removed under reduced pressure, and the crude was purified by preparative HPLC purification. The product obtained was dissolved in CH<sub>3</sub>CN (0.5 mL), HCl (1 N, 1.5 mL), and water (5 mL) and lyophilized to give <b>35</b> as hydrochloride salt (14% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.08 (bs, 1H), 7.48−7.38 (m, 2H), 7.18−7.08 (m, 2H), 5.21−5.12 (m, 1H), 4.57−4.43 (m, 2H), 4.08−3.80 (m, 3H), 3.70−3.50 (m, 6H), 3.32−3.20 (m, 1H), 2.87 (s, 3H), 1.28 (d, <i>J</i> = 6.6 Hz, 6H). MS <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(4-Acetyl-1-methylpiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihy</b><b>dropyrimidine-4-carboxamide (37).</b> Compound <b>33</b> (0.10 g, 0.2 mmol) was dissolved in pyridine (1 mL) and acetic anhydride (1 equiv) was added. The reaction mixture was stirred at rt for 30 min. Solvent was evaporated under vacuum, to give a residue that was purified by RP-HPLC to provide <b>37</b> as trifluoroacetate salt (0.015 g, 14% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz; two conformers are present with a 1:1 ratio) δ 10.11 (bs, 1 H), 9.45 (bs, 1 H), 7.42−7.31 (m, 2 H), 7.21−7.12 (m, 2 H), 5.03−5.59 (m, 0.5 H), 4.87−4.75 (m, 1 H), 4.64−4.52 (m, 2.5 H), 4.48−4.39 (m, 0.5 H), 4.22−4.12 (m, 0.5 H), 3.66−3.77 (m, 1 H), 3.59−3.46 (m, 3.5 H), 3.42−3.16 (m, 1.5 H), 3.15−2.95 (m, 0.5 H), 2.85−2.71 (m, 3.5 H), 2.14−2.05 (m, 3 H). MS <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(4-Benzoyl-1-methylpiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dih</b><b>ydropyrimidine-4-carboxamide (39).</b> To a solution of compound <b>33</b> (30 mg, 0.06 mmol) in pyridine (1 mL), benzoic anhydride (16 mg, 0.07 mmol) was added. The reaction mixture was stirred at rt for 20 min, solvent was removed under reduced pressure, and the crude was purified by preparative HPLC purification to obtain a compound that was dissolved in CH<sub>3</sub>CN (0.5 mL), HCl (1 N, 0.5 mL), and water (1 mL) and characterized as hydrochloride salt <b>39</b> (53% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz, 340 K) δ 9.75 (bs, 1H), 7.60−7.38 (m, 7H), 7.20−7.10 (m, 2H), 5.02−4.92 (m, 1H), 4.68−4.20 (m, 4H), 3.75−3.20 (m, 7H), 2.83 (s, 3H). MS <i>m</i>/<i>z</i> 480 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-[4-(</b><b><i>N</i></b><b>,</b><b><i>N</i></b><b>-Dimethylglycyl)-1-methylpiperazin-2-yl]-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-</b><b>6-oxo-1,6-dihydropyrimidine-4-carboxamide (40).</b> To a solution of compound <b>33</b> (30 mg, 0.06 mmol) in DCM (2 mL), HOBt (10.5 mg, 0.08 mmol), WSCDI (15 mg, 0.08 mmol), DIPEA (0.06 mL, 0.32 mmol), and <i>N</i>,<i>N</i>-dimethylglycine hydrochloride (17.3 mg, 0.12 mmol) were added. The reaction mixture was stirred at rt for 1 h, solvent was removed under vacuo, and the crude was purified by preparative HPLC to <a name="jm005002004973" id="jm005002004973"></a> give compound <b>40</b> as trifluoroacetate salt (40% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 9.80 (bs, 1H), 9.50 (bs, 1H) 7.43−7.32 (m, 2H), 7.23−7.13 (m, 2H), 5.08−4.80 (m, 1.5H), 4.68−3.70 (m, 6.5H), 3.65−3.20 (m, 5H), 318−2.70 (m, 10H). MS <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-{4-[(Ethylamino)carbonyl]-1-methylpiperazin-2-yl}-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-meth</b><b>yl-6-oxo-1,6-dihydropyrimidine carboxamide (41).</b> To a solution of compound <b>33</b> (0.12 g, 0.2 mmol) in Py (2.0 mL), ethyl isocyanate (0.016 mL, 0.2 mmol) was added. The reaction mixture was stirred at rt for 30 min. Solvent was evaporated under vacuum, to give a residue that was purified by RP-HPLC to provide <b>41</b> as trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz, 340 K) δ 9.30 (bs, partially hidden by water signal, 1 H), 7.44−7.32 (m, 2 H), 7.20−7.08 (m, 2 H), 4.82−4.70 (m, 1 H), 4.65−4.52 (m, 2 H), 4.50−4.38 (m, 1H), 4.28−4.15 (m, 1H), 3.72−3.64 (m, 1H), 3.58 (s, 3H), 3.35−3.21 (m, 2 H), 3.20−3.16 (m, 2 H), 3.04−2.90 (m, 1 H), 2.84 (s, 3 H), 1.12−1.00 (m, 3 H). MS <i>m</i>/<i>z</i> 447 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-4-(phenylsulfonyl)piperazin-2-yl]-6-ox</b><b>o-1,6-dihydropyrimidine-4-carboxamide (43).</b> To a solution of compound <b>33</b> (39 mg, 0.08 mmol) in DCM (0.5 mL), benzenesulphonyl chloride (0.07 mL, 0.56 mmol), and NaOH (1 M, 0.56 mL) were added. The mixture was stirred at rt for 18 h and then warmed to 60 °C. After 2 h, the reaction mixture was cooled and the solvent was removed under reduced pressure. Purification by RP-HPLC gave compound <b>43</b> (35% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz, 340 K) δ 9.20−9.08 (m, 1H), 7.87−7.62 (m, 5H), 7.38−7.25 (m, 2H), 7.20−7.10 (m, 2H), 5.03−4.91 (m, 1H), 4.60−4.48 (m, 2H), 4.30−4.18 (m, 1H), 4.07−3.92 (m, 1H), 3.79−3.69 (m, 1H), 3.56 (s, 3H), 3.50−3.38 (m, 1H), 2.92−2.60 (m, 5H). MS <i>m</i>/<i>z</i> 516 (M + H). </div><div class="NLM_p"><b>2-{4-[(Dimethylamino)sulfonyl]-1-methylpiperazin-2-yl}-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-m</b><b>ethyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide (44).</b> To a solution of compound <b>33</b> (30 mg, 0.06 mmol) in DCM (0.8 mL), TEA (0.03 mL, 0.21 mmol) followed by dimethylsulfamoyl chloride (0.084 mL, 0.08 mmol) was added. After stirring for 18 h at rt, solvent was removed under reduced pressure and the crude was purified by RP-HPLC to give compound <b>44</b> (28% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 600 MHz) δ 9.48−9.40 (m, 1H), 7.39−7.33 (m, 2H), 7.20−7.15 (m, 2H), 5.02−4.94 (m, 1H), 4.59−4.54 (m, 2H), 4.17−4.09 (m, 1H), 3.93−3.84 (m, 1H), 3.78−3.70 (m, 1H), 3.52 (s, 3H), 3.46−3.08 (m, 2H), 3.14−3.04 (m, 1H), 2.86 (s, 3H), 2.78 (s, 6H). MS <i>m</i>/<i>z</i> 483 (M + H). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-4-(methylsulfonyl)piperazin-2-yl]-6-ox</b><b>o-1,6-dihydropyrimidine-4-carboxamide (42).</b> Compound <b>106</b> was deprotected and methylated on the N1 nitrogen, the Boc was removed as previously described, and the resulting compound (0.05 g, 0.1 mmol) was dissolved in DCM (2 mL) and TEA (0.03 mL, 0.21 mmol), and methanesulfonyl chloride (0.01 mL, 0.11 mmol) was added. After 1 h of stirring at rt, the solvent was evaporated and the residue was dissolved in MeOH (1.5 mL), 4-F-benzylamine (0.034 mL, 0.3 mmol) was added, and the mixture was stirred at 80 °C overnight. The residue was purified by RP-HPLC and the product was then treated with a mixture of 3 N HCl/acetonitrile and lyophilized to obtain product <b>42</b> as a hydrochloride salt (0.013 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz, 340 K) δ 9.95−9.88 (m, 1H), 7.45−7.39 (m, 2H), 7.15−7.05 (m, 2H), 5.00−4.93 (m, 1H), 4.52 (d, <i>J</i> = 6.4 Hz, 2H), 4.20−4.14 (m, 1H), 3.95−3.89 (m, 1H), 3.76−3.70 (m, 1H), 3.50−3.37 (m, 2H), 3.21−3.12 (m, 1H), 3.04 (s, 3H), 2.83 (s, 3H). MS <i>m</i>/<i>z</i> 454 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>2-(1-Acetyl-4-methylpiperazin-2-yl)-</b><b><i>N</i></b><b>-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihy</b><b>dropyrimidine-4-carboxamide (38).</b> Compound <b>106</b> was deprotected on the N1 nitrogen of the piperazine, as previously reported, and a solution of the obtained compound (0.10 g, 0.2 mmol) was dissolved in THF (2 mL) and treated with pyridine (0.05 mL, 0.6 mmol), followed by acetyl chloride (0.02 mL, 0.3 mmol). The reaction mixture was stirred at rt for 1 h and then concentrated to dryness. The resulting crude was diluted with AcOEt, washed with HCl (1 N), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The resulting crude was treated with a TFA/DCM solution (2 mL) at rt for 30 min and then evaporated under vacuum to give a compound deprotected on the N4 nitrogen of the piperazine, which was used as such in the next step. To a solution of this crude (theoretical 0.12 mmol) in MeOH (3 mL) and TEA (0.017 mL, 0.12 mmol), NaCNBH<sub>3</sub> (0.01 g, 0.17 mmol), sodium acetate (0.016 g, 0.19 mmol), followed by a 37% formaldehyde solution in water (0.01 mL, 0.12 mmol), was added. The reaction mixture was stirred at rt overnight and then evaporated. The resulting crude was diluted with AcOEt, washed with water, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. The resulting crude was then dissolved in MeOH (2.0 mL) and 4-F-benzylamine (0.036 mL, 0.32 mmol) was added; the mixture was stirred at 60 °C overnight. The reaction mixture was then evaporated under vacuum to give a residue that was purified by RP-HPLC to provide <b>38</b> (0.012 g, 11% yield over five steps).<sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz, 340 K) δ 8.88 (bs, 1H), 7.44−7.35 (m, 2H), 7.14−7.05 (m, 2H), 6.07 (m, 1H), 4.61−4.46 (m, 2H), 4.38−4.25 (m, 1H), 4.06−3.92 (m, 1H), 3.48−3.12 (m, 7H), 2.90 (s, 3H), 2.15 (s, 3H). MS <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>Methyl </b><b>5-(Benzoyloxy)-1-methyl-2-(4-methylmorpholin-3-yl)-6-oxo-1,6-dihydropyrimidine-4-carbo</b><b>xylate (107).</b> A solution of compound <b>67a</b> (1.6 g, 3.4 mmol) in DCM (30 mL) was treated with TFA (25 mL) at 0 °C. The mixture was stirred and allowed to warm to rt over 2 h. Volatiles were removed under reduced pressure to obtain 3-[5-(benzoyloxy)-4-(methoxycarbonyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]morpholin-4-ium trifluoroacetate as a pale yellow solid (1.65 g, quantitative yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.63 (bs, 1H), 9.44 (bs, 1H), 8.09 (d, <i>J</i> = 7.7 Hz, 2H), 7.81 (t, <i>J</i> = 7.1 Hz, 1H), 7.64 (t, <i>J</i> = 7.6 Hz, 2H), 5.05 (d, <i>J</i> = 8.1 Hz, 1H), 4.40 (d, <i>J</i> = 12.1 Hz, 1H), 4.01 (d, <i>J</i> = 11.0 Hz, 1H), 3.87 (t, <i>J</i> = 10.4 Hz, 1H), 3.79 (s, 3H), 3.66−3.57 (m, 4H), 3.41−3.30 (m, 2H). MS <i>m</i>/<i>z</i> 374 (M + H)<sup>+</sup>. This intermediate (1.65 g, 3.4 mmol) was solubilized in 1,2-dichloroethane (20 mL), and Et<sub>3</sub>N (0.57 mL, 4.08 mmol), acetic acid glacial (0.20 mL, 3.57 mmol), and formaldehyde 37% (0.50 mL, 6.8 mmol) were added at rt, followed by NaCNBH<sub>3</sub> (0.256 mg, 4.08 mmol). The mixture was stirred at rt overnight, and then it was diluted with 1,2-dichloroethane (150 mL) and washed with NaHCO<sub>3</sub> satd soln (2 × 50 mL). Organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to obtain compound <b>107</b> as a white solid (1.3 g, 98% yield) that was used as crude in the next step. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ. 8.07 (d, <i>J</i> = 7.5 Hz, 2H), 7.79 (t, <i>J</i> = 7.3 Hz, 1H), 7.63 (t, <i>J</i> = 7.8 Hz, 2H), 3.89 (d, <i>J</i> = 9.4 Hz, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.72−3.57 (m, 2H), 3.32 (s, 3H), 3.10 (q, <i>J</i> = 7.1 Hz, 2H), 2.90 (d, <i>J</i> = 11.8 Hz, 1H), 2.38 (t, <i>J</i> = 9.8 Hz, 1H). MS <i>m</i>/<i>z</i> 388 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>General Procedure for the Preparation of Compounds 50</b><b>−</b><b>61.</b> Compound <b>107</b> (45 mg, 0.18 mmol) in MeOH (2 mL) was treated with the appropriate amine (2 equiv) under microwave irradiation (1500 s, 100 °C). Volatiles were removed under reduced pressure and the final compounds were purified by preparative RP-HPLC. The final compounds were isolated as trifluoracetic salts (yields 20−45%). </div><div class="NLM_p"><b>3-{4-[(Benzylamino)carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl}-4-met</b><b>hylmorpholin-4-ium Trifluoroacetate (50).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 10.12 (bs, 1 H), 9.69 (t, <i>J</i> = 6.5 Hz, 1H), 7.60−7.49 (m, 5H), 5.19 (bs, 1H), 4.83 (d, <i>J</i> = 5.6 Hz, 2 H), 4.60 (d, <i>J</i> = 4.6 Hz, 1H), 4.37 (d, <i>J</i> = 11.3 Hz, 1 H), 3.99 (t, <i>J</i> = 12.5 Hz, 1 H), 3.90 (d, <i>J</i> = 12.4 Hz, 1H), 3.76 (s, 3H), 3.71−3.63 (m, 2H), 3.06 (s, 3H). MS <i>m</i>/<i>z</i> 359 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(5-Hydroxy-1-methyl-6-oxo-4-{[(2-phenylethyl)amino]carbonyl}-1,6-dihydropyrimidin-2-</b><b>yl)-4-methylmorpholin-4-ium Trifluoroacetate (51).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.08 (bs, 1 H), 9.11 (t, <i>J</i> = 5.8 Hz, 1H), 7.32−7.28 (m, 2H), 7.25−7.20 (m, 3H), 4.96 (bs, 1H), 4.39 (dd, <i>J</i> = 13.2, 2.9 Hz, 1 H), 4.17 (dd, <i>J</i> = 13.1, 2.2 Hz, 1 H), 3.78 (t, <i>J</i> = 12.2 Hz, 1H), 3.70 (d, <i>J</i> = 13.2 Hz, 1H), 3.57 (q, <i>J</i> = 7.0 Hz, 2H), 3.53 (s, 3H), 3.43 (dd, <i>J</i> = 12.7, 10.5 Hz, 2H), 2.87 (t, <i>J</i> = 7.0 Hz, 2H), 2.81 (s, 3H). MS <i>m</i>/<i>z</i> 373 (M + H)<sup>+</sup>. </div><div class="NLM_p"><a name="jm005002004974" id="jm005002004974"></a><b>3-(4-{[Benzyl(methyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-</b><b>yl)-4-methylmorpholin-4-ium Trifluoroacetate (52).</b> Two sets of signals, two rotamers (ratio 1:1) were present. <sup>1</sup>H NMR (CD<sub>3</sub>CN + TFA, 400 MHz) δ 7.50−7.34 (m, 5H), 4.86 (bs, 1H), 4.86−4.59 (m, 2H), 4.47−4.12 (m, 2H), 3.98−3.77 (m, 1H), 3.54 (s, 3H), 3.53−3.49 (m, 1H), 3.45−3.34 (m, 2H), 3.10 (s, 3H), 2.92 (s, 1.5 H), 2.86 (s, 1.5 H). MS <i>m</i>/<i>z</i> 373 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(2-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-4-methylmorpholin-4-ium Trifluoroacetate (53).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.08 (bs, 1 H), 9.49 (t, <i>J</i> = 6.1 Hz, 1H), 7.36−7.31 (m, 2H), 7.23−7.16 (m, 2H), 4.98 (bs, 1H), 4.63 (d, <i>J</i> = 6.1 Hz, 2 H), 4.38 (dd, <i>J</i> = 13.0, 2.7 Hz, 1H), 4.16 (dd, <i>J</i> = 13.1, 2.5 Hz, 1 H), 3.80 (t, <i>J</i> = 12.0 Hz, 1 H), 3.70 (d, <i>J</i> = 12.9 Hz, 1H), 3.54 (s, 3H), 3.48−3.35 (m, 2H), 2.84 (s, 3H). MS <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(3-Fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-4-methylmorpholin-4-ium Trifluoroacetate (54).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.04 (bs, 1 H), 9.50 (bt, 1H), 7.43−7.34 (m, 1H), 7.17−7.06 (m, 2H), 5.00 (bs, 1H), 4.63 (d, <i>J</i> = 5.9 Hz, 2 H), 4.39 (d, <i>J</i> = 13.4 Hz, 1 H), 4.15 (d, <i>J</i> = 13.8 Hz, 1 H), 3.79 (t, <i>J</i> = 12.6 Hz, 1H), 3.71 (d, <i>J</i> = 13.2 Hz, 1H), 3.59 (s, 3H), 3.51−3.45 (m 2H), 2.86 (s, 3H). MS <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(3-Chlorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-4-methylmorpholin-4-ium Trifluoroacetate (55).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 10.18 (bs, 1 H), 9.71 (t, <i>J</i> = 6.3 Hz, 1H), 7.64−7.49 (m, 4H), 5.18 (bs, 1H), 4.83 (d, <i>J</i> = 6.4 Hz, 2 H), 4.61 (d, <i>J</i> = 13.3 Hz, 1H), 4.38 (d, <i>J</i> = 12.6 Hz, 1 H), 3.99 (t, <i>J</i> = 13.7 Hz, 1 H), 3.91 (d, <i>J</i> = 13.3 Hz, 1H), 3.76 (s, 3H), 3.72−3.64 (m, 2H), 3.07 (s, 3H). MS <i>m</i>/<i>z</i> 393 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(3-Bromobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2</b><b>-yl)-4-methylmorpholin-4-ium Trifluoroacetate (56).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 10.15 (bs, 1 H), 9.70 (t, <i>J</i> = 6.1 Hz, 1H), 7.73−7.69 (m, 2H), 7.55−7.54 (m, 2H), 5.19 (bs, 1H), 4.83 (d, <i>J</i> = 6.6 Hz, 2 H), 4.61 (d, <i>J</i> = 12.0 Hz, 1H), 4.38 (d, <i>J</i> = 12.2 Hz, 1 H), 4.00 (t, <i>J</i> = 13.3 Hz, 1 H), 3.90 (d, <i>J</i> = 13.1 Hz, 1H), 3.76 (s, 3H), 3.72−3.61 (m, 2H), 3.07 (s, 3H). MS <i>m</i>/<i>z</i> 437/439 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(5-Hydroxy-4-{[(3-methoxybenzyl)amino]carbonyl}-1-methyl-6-oxo-1,6-dihydropyrimidi</b><b>n-2-yl)-4-methylmorpholin-4-ium Trifluoroacetate (57).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 300 MHz) δ 9.97 (bs, 1 H), 9.46 (t, <i>J</i> = 6.5 Hz, 1H), 7.27 (t, <i>J</i> = 7.9 Hz, 1 H), 6.90−6.83 (m, 3H), 4.97 (bs, 1H), 4.59 (d, <i>J</i> = 6.4 Hz, 2 H), 4.39 (dd, <i>J</i> = 13.4, 2.0 Hz, 1H), 4.17 (dd, <i>J</i> = 12.8, 2.0 Hz, 1 H), 3.82−3.67 (m, 5H), 3.55 (s, 3H), 3.49−3.41 (m, 2H), 2.45 (s, 3H). MS <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(3,4-Difluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidi</b><b>n-2-yl)-4-methylmorpholin-4-ium Trifluoroacetate (58).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.08 (bs, 1 H), 9.60 (t, <i>J</i> = 6.3 Hz, 1H), 7.43−7.32 (m, 2H), 7.17−7.14 (m, 1H), 4.97 (bs, 1H), 4.60 (d, <i>J</i> = 6.1 Hz, 2 H), 4.38 (dd, <i>J</i> = 12.9, 2.3 Hz, 1H), 4.15 (dd, <i>J</i> = 12.5, 1.9 Hz, 1 H), 3.80 (t, <i>J</i> = 12.5 Hz, 1 H), 3.68 (d, <i>J</i> = 12.6 Hz, 1H), 3.54 (s, 3H), 3.50−3.36 (m, 2H), 2.84 (s, 3H). MS <i>m</i>/<i>z</i> 395 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(4-Fluoro-3-methylbenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropy</b><b>rimidin-2-yl)-4-methylmorpholin-4-ium Trifluoroacetate (59).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.04 (bs, 1 H), 9.46 (t, <i>J</i> = 6.4 Hz, 1H), 7.23 (d, <i>J</i> = 7.5 Hz, 1H), 7.19−7.08 (m, 2H), 4.98 (bs, 1H), 4.55 (d, <i>J</i> = 6.4 Hz, 2H), 4.39 (dd, <i>J</i> = 12.9, 2.9 Hz, 1H), 4.20 (dd, <i>J</i> = 12.7, 2.9 Hz, 1H), 3.80 (t, <i>J</i> = 11.8 Hz, 1H), 3.70 (d, <i>J</i> = 12.9 Hz, 1H), 3. 56 (s, 3H), 3.49−3.36 (m, 2H), 2.85 (s, 3H), 2.22 (d, <i>J</i> = 1.3 Hz, 3H). MS <i>m</i>/<i>z</i> 391 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>3-(4-{[(3-Chloro-4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropy</b><b>rimidin-2-yl)-4-methylmorpholin-4-ium Trifluoroacetate (60).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 10.06 (bs, 1 H), 9.50 (t, <i>J</i> = 6.3 Hz, 1H), 7.50 (d, <i>J</i> = 7.2 Hz, 1 H), 7.37−7.32 (m, 2H), 5.00 (d, <i>J</i> = 8.8 Hz, 1 H), 4.59 (d, <i>J</i> = 6.1 Hz, 2 H), 4.38 (d, <i>J</i> = 12.7 Hz, 1 H), 4.15 (d, <i>J</i> = 12.5 Hz, 1 H), 3.79 (t, <i>J</i> = 13.0 Hz, 1H), 3.71 (d, <i>J</i> = 13.4 Hz, 1H), 3.56 (s, 3H), 3.51−3.41 (m 2H), 2.86 (s, 3H). MS <i>m</i>/<i>z</i> 411 (M + H)<sup>+</sup>. </div><div class="NLM_p last"><b>3-(4-{[(3-Bromo-4-fluorobenzyl)amino]carbonyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropy</b><b>rimidin-2-yl)-4-methylmorpholin-4-ium Trifluoroacetate (61).</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub> + TFA, 400 MHz) δ 12.21 (bs, 1H), 9.88 (bs, 1H), 9.52 (t, <i>J</i> = 6.0 Hz, 1H), 7.66 (d, <i>J</i> = 6.8 Hz, 1H), 7.38 (d, <i>J</i> = 7.0 Hz, 2H), 5.00−4.90 (m, 1H), 4.70−4.50 (m, 2H), 4.39 (d, <i>J</i> = 12.6 Hz, 1H), 4.16 (d, <i>J</i> = 12.6 Hz, 1H), 3.79 (t, <i>J</i> = 12.4 Hz, 1H), 3.68 (d, <i>J</i> = 12.2 Hz, 1H), 3.55 (s, 3H), 3.50−3.30 (m, 2H), 2.85 (bs, 3H). MS <i>m</i>/<i>z</i> 455/457 (M + H<sup>+</sup>). </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0704705/suppl_file/jm0704705si20070420_035126.pdf">jm0704705si20070420_035126.pdf (237.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm0704705" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuela Nizi</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ester Muraglia</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedetta Crescenzi</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Ferrara</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Orvieto</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Pace</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Pescatore</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Poma</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria del Rosario Rico Ferreira</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Scarpelli</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carl F. Homnick</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norihiro Ikemoto</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Alfieri</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Verdirame</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Bonelli</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Odalys Gonzalez Paz</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marina Taliani</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Monteagudo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Pesci</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph Laufer</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Felock</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kara A. Stillmock</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daria Hazuda</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Summa</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology - Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy, Department of Medicinal Chemistry, Merck Research Laboratory, West Point, Pennsylvania, Department of Process Research, Merck Research Laboratory, Rahway, New Jersey, and Department of Antiviral Research, Merck Research Laboratory, West Point, Pennsylvania </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Francesca Naimo and Massimiliano Fonsi for plasma protein binding determination and microsome stability studies, Annalise Di Marco for CyP450's inhibition data, Vincenzo Pucci for HRMS measurements, Christopher Welch for multigram scale chiral separation, Melissa Egbertson for support in the testing of the first chiral batch of <b>27a</b>, and Stephane Spieser for fruitful discussion. This work was supported in part by a grant from the MIUR. </p></div><div class="NLM_fn" id="jm0704705n00001"><p class="first last">Abbreviations:  TFA, trifluoroacetic acid; TMS, tetramethylsilane; DMSO, dimethyl sulfoxide; DCM, dichloromethane; THF, tetrahydrofuran; TEA, triethylamine; <i>m</i>-CPBA, <i>meta</i>-chloroperbenzoic acid; TFAA, trifluoroacetic anhydride; MTBE, <i>tert</i>-butyl methyl ether; DMAP, 4-dimethylaminopyridine; DAST, (diethylamino)sulfur trifluoride; PK, pharmacokinetic.</p></div><div class="refs-header-label"><a name="jm005002004975" id="jm005002004975"></a></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="jm0704705b00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm0704705b00001_1"><span><span class="NLM_string-ref">Castro, H. C.; Loureiro, N. I. V.; Pujol-Luz, M.; Souza, A. M. T.; Albuquerque, M. G.; Santos, D. O.; Cabral, L. M.; Frugulhetti, I. C.; Rodrigues, C. R. HIV-1 reverse transcriptase:  A therapeutic target in the spotlight. <i>  Curr. Med. Chem.</i><b>2006</b>, <i>13</i>, 313−324.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=324&author=H.+C.+Castro&author=N.+I.+V.+Loureiro&author=M.+Pujol-Luz&author=A.+M.+T.+Souza&author=M.+G.+Albuquerque&author=D.+O.+Santos&author=L.+M.+Cabral&author=I.+C.+Frugulhetti&author=C.+R.+Rodrigues&title=therapeutic+target+in+the+spotlight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DH.%2BC.%26atitle%3Dtherapeutic%2520target%2520in%2520the%2520spotlight%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm0704705b00002_1"><span><span class="NLM_string-ref">Locatelli, G. A.; Cancio, R.; Spadari, S.; Maga, G. HIV-1 reverse transcriptase inhibitors:  Current issues and future perspectives. <i>  Curr. Drug </i><i>Metab.</i><b>2004</b>, <i>5</i>, 283−290.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=290&author=G.+A.+Locatelli&author=R.+Cancio&author=S.+Spadari&author=G.+Maga&title=reverse+transcriptase+inhibitors%3A%E2%80%89+Current+issues+and+future+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DG.%2BA.%26atitle%3Dreverse%2520transcriptase%2520inhibitors%253A%25E2%2580%2589%2520Current%2520issues%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm0704705b00003_1"><span><span class="NLM_string-ref">Silvestri, R.; Maga, G. Current state-of-the-art in preclinical and clinical development of novel non-nucleoside HIV-1 reverse transcriptase inhibitors. <i>  Expert Opin. Ther. Pat.</i><b>2006</b>, <i>16</i>, 939−962.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=962&author=R.+Silvestri&author=G+Maga&title=Current+state-of-the-art+in+preclinical+and+clinical+development+of+novel+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DCurrent%2520state-of-the-art%2520in%2520preclinical%2520and%2520clinical%2520development%2520of%2520novel%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm0704705b00004_1"><span><span class="NLM_string-ref">Vivet-Boudou, V.; Didierjean, J.; Isel, C.; Marquet, R. Nucleoside and nucleotide inhibitors of HIV-1 replication. <i>  Cell. Mol. Life Sci.</i><b>2006</b>, <i>63</i>, 163−186.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=186&author=V.+Vivet-Boudou&author=J.+Didierjean&author=C.+Isel&author=R+Marquet&title=Nucleoside+and+nucleotide+inhibitors+of+HIV-1+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVivet-Boudou%26aufirst%3DV.%26atitle%3DNucleoside%2520and%2520nucleotide%2520inhibitors%2520of%2520HIV-1%2520replication%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26spage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm0704705b00005_1"><span><span class="NLM_string-ref">Lebon, F.; Ledecq, M. Approaches to the design of effective HIV-1 protease inhibitors. <i>  Curr. Med. Chem.</i><b>2000</b>, <i>7</i>, 455−477.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=477&author=F.+Lebon&author=M+Ledecq&title=Approaches+to+the+design+of+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DF.%26atitle%3DApproaches%2520to%2520the%2520design%2520of%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm0704705b00006_1"><span><span class="NLM_string-ref">Mastrolorenzo, A.; Rusconi, S.; Scozzafava, A.; Supuran, C. Inhibitors of HIV-1 protease. 10 years after. <i>  Expert Opin. Ther. Pat.</i><b>2006</b>, <i>16</i>, 1067−1091.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1091&author=A.+Mastrolorenzo&author=S.+Rusconi&author=A.+Scozzafava&author=C+Supuran&title=Inhibitors+of+HIV-1+protease.+10+years+after"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMastrolorenzo%26aufirst%3DA.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease.%252010%2520years%2520after%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm0704705b00007_1"><span><span class="NLM_string-ref">Vacca, J. P.; Condra, J. H. Clinically effective HIV-1 Protease inhibitors. <i>  Drug Discovery Today</i><b>1997</b>, <i>2</i>, 261−272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=272&author=J.+P.+Vacca&author=J.+H+Condra&title=Clinically+effective+HIV-1+Protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DClinically%2520effective%2520HIV-1%2520Protease%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm0704705b00008_1"><span><span class="NLM_string-ref">Anthony, N. J. HIV-1 integrase:  A target for new AIDS chemotherapeutics. <i>  Curr. Top. Med. Chem.</i><b>2004</b>, <i>4</i>, 979−990.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=990&author=N.+J.+Anthony&title=target+for+new+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3Dtarget%2520for%2520new%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm0704705b00009_1"><span><span class="NLM_string-ref">Pommier, Y.; Johnson, A. A.; Marchand, C. Integrase inhibitors to treat HIV/AIDS. <i>  Nat. Rev. Drug Discovery</i><b>2005</b>, <i>4</i>, 236−248.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=248&author=Y.+Pommier&author=A.+A.+Johnson&author=C+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00010"><div class="reference"><div class="NLM_citation" id="jm0704705b00010_1"><span><span class="NLM_string-ref">Young, S. D. Inhibition of HIV-1 integrase by small molecules:  The potential for a new class of AIDS chemotherapeutics. <i>  Curr. Opin. Drug </i><i>Discovery Dev.</i><b>2001</b>, <i>4</i>, 402−410.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=410&author=S.+D+Young&title=Inhibition+of+HIV-1+integrase+by+small+molecules%3A%E2%80%89+The+potential+for+a+new+class+of+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD%26atitle%3DInhibition%2520of%2520HIV-1%2520integrase%2520by%2520small%2520molecules%253A%25E2%2580%2589%2520The%2520potential%2520for%2520a%2520new%2520class%2520of%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm0704705b00011_1"><span><span class="NLM_string-ref">Egbertson, M. S. HIV integrase inhibitors:  From diketoacids to heterocyclic templates:  A history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM). <i>  Curr. Top. Med. Chem.</i><b>2007</b>, <i>7</i>, 1251−1272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1272&author=M.+S+Egbertson&title=HIV+integrase+inhibitors%3A%E2%80%89+From+diketoacids+to+heterocyclic+templates%3A%E2%80%89+A+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS%26atitle%3DHIV%2520integrase%2520inhibitors%253A%25E2%2580%2589%2520From%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%25E2%2580%2589%2520A%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm0704705b00012_1"><span><span class="NLM_string-ref">Chiu, T. K.; Davies, D. R. Structure and function of HIV-1 integrase. <i>  Curr. Top. Med. Chem.</i><b>2004</b>, <i>4</i>, 965−977.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=977&author=T.+K.+Chiu&author=D.+R+Davies&title=Structure+and+function+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DT.%2BK.%26atitle%3DStructure%2520and%2520function%2520of%2520HIV-1%2520integrase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm0704705b00013_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Pramanik, B.; Wolfe, A. L. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. <i>  J. </i><i>Virol.</i><b>1997</b>, <i>71</i>, 7005−7011.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7011&author=D.+J.+Hazuda&author=P.+J.+Felock&author=J.+C.+Hastings&author=B.+Pramanik&author=A.+L+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm0704705b00014_1"><span><span class="NLM_string-ref">Grobler, J. A.; Stillmock, K. A.; Binghua, H.; Witmer, M. V.; Felock, P. J.; Espeseth, A. S.; Wolfe, A. L.; Egbertson, M. S.; Bourgeois, M.; Melamed, J.; Wai, J. S.; Young, S. D.; Vacca, J. P.; Hazuda, D. J. Diketoacid inhibitor mechanism and HIV-1 integrase:  Implications for metal binding in the active site of phosphotransferase enzymes. <i>  Proc. Natl. </i><i>Acad. Sci. </i><i>U.S.A.</i><b>2002</b>, <i>99</i>, 6661−6666.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=6666&author=J.+A.+Grobler&author=K.+A.+Stillmock&author=H.+Binghua&author=M.+V.+Witmer&author=P.+J.+Felock&author=A.+S.+Espeseth&author=A.+L.+Wolfe&author=M.+S.+Egbertson&author=M.+Bourgeois&author=J.+Melamed&author=J.+S.+Wai&author=S.+D.+Young&author=J.+P.+Vacca&author=D.+J+Hazuda&title=Diketoacid+inhibitor+mechanism+and+HIV-1+integrase%3A%E2%80%89+Implications+for+metal+binding+in+the+active+site+of+phosphotransferase+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DDiketoacid%2520inhibitor%2520mechanism%2520and%2520HIV-1%2520integrase%253A%25E2%2580%2589%2520Implications%2520for%2520metal%2520binding%2520in%2520the%2520active%2520site%2520of%2520phosphotransferase%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D6666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm0704705b00015_1"><span><span class="NLM_string-ref">Barreca, M. L.; Ferro, S.; Rao, A.; Luca, L. D.; Zappala, M.; Monforte, A. M.; Debyser, Z.; Witvrouw, M.; Chimirri, A. Pharmacophore-based design of HIV-1 strand transfer inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 7084−7088.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7088&author=M.+L.+Barreca&author=S.+Ferro&author=A.+Rao&author=L.+D.+Luca&author=M.+Zappala&author=A.+M.+Monforte&author=Z.+Debyser&author=M.+Witvrouw&author=A+Chimirri&title=Pharmacophore-based+design+of+HIV-1+strand+transfer+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26atitle%3DPharmacophore-based%2520design%2520of%2520HIV-1%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm0704705b00016_1"><span><span class="NLM_string-ref">Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinage, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor:  A platform for antiviral drug design. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1999</b>, <i>96</i>, 13040−13043.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13043&author=Y.+Goldgur&author=R.+Craigie&author=G.+H.+Cohen&author=T.+Fujiwara&author=T.+Yoshinage&author=T.+Fujishita&author=H.+Sugimoto&author=T.+Endo&author=H.+Murai&author=D.+R+Davies&title=Structure+of+the+HIV-1+integrase+catalytic+domain+complexed+with+an+inhibitor%3A%E2%80%89+A+platform+for+antiviral+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldgur%26aufirst%3DY.%26atitle%3DStructure%2520of%2520the%2520HIV-1%2520integrase%2520catalytic%2520domain%2520complexed%2520with%2520an%2520inhibitor%253A%25E2%2580%2589%2520A%2520platform%2520for%2520antiviral%2520drug%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm0704705b00017_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Anthony, N. J.; Gomez, R. P.; Jolly, S. M.; Wai, J. S.; Zhuang, L.; Fisher, T. E.; Embrey, M.; Guare, J. P.; Egbertson, M. S.; Vacca, J. P.; Huff, J. R.; Felock, P. J.; Witmer, M. V.; Stillmock, K. A.; Danovich, R.; Grobler, J.; Miller, M. D.; Espeseth, A. S.; Jin, L.; Chen, I. W.; Lin, J. H.; Kassahun, K.; Ellis, J. D.; Wong, B. K.; Xu, W.; Pearson, P. G.; Schleif, W. A.; Cortese, R.; Emini, E.; Summa, V.; Holloway, M. K.; Young, S. D. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>2004</b>, <i>101</i>, 11233−11238.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11238&author=D.+J.+Hazuda&author=N.+J.+Anthony&author=R.+P.+Gomez&author=S.+M.+Jolly&author=J.+S.+Wai&author=L.+Zhuang&author=T.+E.+Fisher&author=M.+Embrey&author=J.+P.+Guare&author=M.+S.+Egbertson&author=J.+P.+Vacca&author=J.+R.+Huff&author=P.+J.+Felock&author=M.+V.+Witmer&author=K.+A.+Stillmock&author=R.+Danovich&author=J.+Grobler&author=M.+D.+Miller&author=A.+S.+Espeseth&author=L.+Jin&author=I.+W.+Chen&author=J.+H.+Lin&author=K.+Kassahun&author=J.+D.+Ellis&author=B.+K.+Wong&author=W.+Xu&author=P.+G.+Pearson&author=W.+A.+Schleif&author=R.+Cortese&author=E.+Emini&author=V.+Summa&author=M.+K.+Holloway&author=S.+D+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm0704705b00018_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Young, S. D.; Guare, J. P.; Anthony, N. J.; Gomez, R. P.; Wai, J. S.; Vacca, J. P.; Handt, L.; Motzel, S. L.; Klein, H. J.; Dornadula, G.; Danovich, R. M.; Witmer, M. V.; Wilson, K. A. A.; Tussey, L.; Schleif, W. A.; Gabryelski, L. S.; Jin, L.; Miller, M. D.; Casimiro, D. R.; Emini, E. A.; Shiver, J. W. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. <i>  Science</i><b>2004</b>, <i>305</i>, 528−532.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=532&author=D.+J.+Hazuda&author=S.+D.+Young&author=J.+P.+Guare&author=N.+J.+Anthony&author=R.+P.+Gomez&author=J.+S.+Wai&author=J.+P.+Vacca&author=L.+Handt&author=S.+L.+Motzel&author=H.+J.+Klein&author=G.+Dornadula&author=R.+M.+Danovich&author=M.+V.+Witmer&author=K.+A.+A.+Wilson&author=L.+Tussey&author=W.+A.+Schleif&author=L.+S.+Gabryelski&author=L.+Jin&author=M.+D.+Miller&author=D.+R.+Casimiro&author=E.+A.+Emini&author=J.+W+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm0704705b00019_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Pace, P.; Matassa, V. G.; De Francesco, R.; Altamura, S.; Tomei, L.; Koch, U.; Neuner, P. Discovery of alpha, gamma-diketoacids as potent selective and reversible inhibitors of hepatitis C virus NS5B RNA-dependent RNA Polymerase. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 14−17.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=17&author=V.+Summa&author=A.+Petrocchi&author=P.+Pace&author=V.+G.+Matassa&author=R.+De+Francesco&author=S.+Altamura&author=L.+Tomei&author=U.+Koch&author=P+Neuner&title=Discovery+of+alpha%2C+gamma-diketoacids+as+potent+selective+and+reversible+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520alpha%252C%2520gamma-diketoacids%2520as%2520potent%2520selective%2520and%2520reversible%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520Polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00020"><div class="reference"><div class="NLM_citation" id="jm0704705b00020_1"><span><span class="NLM_string-ref">Pace, P.; Nizi, E.; Pacini, B.; Pesci, S.; Matassa, V.; De Francesco, R.; Altamura, S.; Summa, V. The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase. <i>  Bioorg. </i><i>Med. Chem.</i><i>Letters</i><b>2004</b>, <i>14</i>, 3257−3261.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3261&author=P.+Pace&author=E.+Nizi&author=B.+Pacini&author=S.+Pesci&author=V.+Matassa&author=R.+De+Francesco&author=S.+Altamura&author=V+Summa&title=The+monoethyl+ester+of+meconic+acid+is+an+active+site+inhibitor+of+HCV+NS5B+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26atitle%3DThe%2520monoethyl%2520ester%2520of%2520meconic%2520acid%2520is%2520an%2520active%2520site%2520inhibitor%2520of%2520HCV%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Letters%26date%3D2004%26volume%3D14%26spage%3D3261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm0704705b00021_1"><span><span class="NLM_string-ref">Crescenzi, B.; Poma, M.; Ontoria, J. M.; Marchetti, A.; Nizi, E.; Matassa, V. G.; Gardelli, C. Phenyldihydroxypyrimidines as HCV NS5B RNA dependent RNA polymerase inhibitors. Part I:  Amides and ureas. <i>  Lett. Drug Des. Discovery</i><b>2005</b>, <i>2</i>, 451−455.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=455&author=B.+Crescenzi&author=M.+Poma&author=J.+M.+Ontoria&author=A.+Marchetti&author=E.+Nizi&author=V.+G.+Matassa&author=C+Gardelli&title=Phenyldihydroxypyrimidines+as+HCV+NS5B+RNA+dependent+RNA+polymerase+inhibitors.+Part+I%3A%E2%80%89+Amides+and+ureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrescenzi%26aufirst%3DB.%26atitle%3DPhenyldihydroxypyrimidines%2520as%2520HCV%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%2520inhibitors.%2520Part%2520I%253A%25E2%2580%2589%2520Amides%2520and%2520ureas%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm0704705b00022_1"><span><span class="NLM_string-ref">Koch, U.; Attenni, B.; Malancona, S.; Colarusso, S.; Conte, I.; Di, Filippo, M.; Harper, S.; Pacini, B.; Giomini, C.; Thomas, S.; Incitti, I.; Tomei, L.; De Francesco, R.; Altamura, S.; Matassa, V. G.; Narjes, F. 2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase:  Discovery, SAR, modeling, and mutagenesis. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 1693−1705.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1705&author=U.+Koch&author=B.+Attenni&author=S.+Malancona&author=S.+Colarusso&author=I.+Conte&author=+Di&author=S.+Harper&author=B.+Pacini&author=C.+Giomini&author=S.+Thomas&author=I.+Incitti&author=L.+Tomei&author=R.+De+Francesco&author=S.+Altamura&author=V.+G.+Matassa&author=F.+Narjes&author=+Thienyl&title=as+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A%E2%80%89+Discovery%2C+SAR%2C+modeling%2C+and+mutagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26atitle%3Das%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%25E2%2580%2589%2520Discovery%252C%2520SAR%252C%2520modeling%252C%2520and%2520mutagenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm0704705b00023_1"><span><span class="NLM_string-ref">Ponzi, S.; Giuliano, C.; Donghi, M.; Poma, M.; Matassa, V. G.; Stansfield, I. Phenyldihydroxypyrimidines as HCV NS5B RNA dependent RNA polymerase inhibitors. Part II:  Sulfonamides. <i>  Lett. Drug Des. </i><i>Discovery</i><b>2005</b>, <i>2</i>, 456−461.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=461&author=S.+Ponzi&author=C.+Giuliano&author=M.+Donghi&author=M.+Poma&author=V.+G.+Matassa&author=I+Stansfield&title=Phenyldihydroxypyrimidines+as+HCV+NS5B+RNA+dependent+RNA+polymerase+inhibitors.+Part+II%3A%E2%80%89+Sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzi%26aufirst%3DS.%26atitle%3DPhenyldihydroxypyrimidines%2520as%2520HCV%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%2520inhibitors.%2520Part%2520II%253A%25E2%2580%2589%2520Sulfonamides%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm0704705b00024_1"><span><span class="NLM_string-ref">Stansfield, I.; Avolio, S.; Colarusso, S.; Gennari, N.; Narjes, F.; Pacini, B.; Ponzi, S.; Harper, S. Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid. <i>  Bioorg. Med. Chem.</i><i>Lett.</i><b>2004</b>, <i>14</i>, 5085−5088.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5088&author=I.+Stansfield&author=S.+Avolio&author=S.+Colarusso&author=N.+Gennari&author=F.+Narjes&author=B.+Pacini&author=S.+Ponzi&author=S+Harper&title=Active+site+inhibitors+of+HCV+NS5B+polymerase.+The+development+and+pharmacophore+of+2-thienyl-5%2C6-dihydroxypyrimidine-4-carboxylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfield%26aufirst%3DI.%26atitle%3DActive%2520site%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase.%2520The%2520development%2520and%2520pharmacophore%2520of%25202-thienyl-5%252C6-dihydroxypyrimidine-4-carboxylic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm0704705b00025_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Matassa, V. G.; Taliani, M.; Laufer, R.; De Francesco, R.; Altamura, S.; Pace, P. HCV NS5B RNA-dependent RNA polymerase inhibitors:  From α,γ-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 5336−5339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5339&author=V.+Summa&author=A.+Petrocchi&author=V.+G.+Matassa&author=M.+Taliani&author=R.+Laufer&author=R.+De+Francesco&author=S.+Altamura&author=P.+Pace&title=RNA+polymerase+inhibitors%3A%E2%80%89+From+%CE%B1%2C%CE%B3-diketoacids+to+4%2C5-dihydroxypyrimidine-+or+3-methyl-5-hydroxypyrimidinonecarboxylic+acids.+Design+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DRNA%2520polymerase%2520inhibitors%253A%25E2%2580%2589%2520From%2520%25CE%25B1%252C%25CE%25B3-diketoacids%2520to%25204%252C5-dihydroxypyrimidine-%2520or%25203-methyl-5-hydroxypyrimidinonecarboxylic%2520acids.%2520Design%2520and%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm0704705b00026_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Matassa, V. G.; Gardelli, C.; Muraglia, E.; Rowley, M.; Gonzalez, Paz, O.; Laufer, R.; Monteagudo, E.; Pace, P. 4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profile in preclinical species. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 6646−6649.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6649&author=V.+Summa&author=A.+Petrocchi&author=V.+G.+Matassa&author=C.+Gardelli&author=E.+Muraglia&author=M.+Rowley&author=+Gonzalez&author=R.+Laufer&author=E.+Monteagudo&author=P.+Pace&author=+Dihydroxypyrimidine&title=carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profile+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3Dcarboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profile%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm0704705b00027_1"><span><span class="NLM_string-ref">Petrocchi, A.; Koch, U.; Matassa, V. G.; Pacini, B.; Stillmock, K. A.; Summa, V. From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors; SAR around the amide moiety. <i>  Bioorg. Med. </i><i>Chem.</i><i>Lett.</i><b>2007</b>, <i>17</i>, 350−353.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=353&author=A.+Petrocchi&author=U.+Koch&author=V.+G.+Matassa&author=B.+Pacini&author=K.+A.+Stillmock&author=V+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3B+SAR+around+the+amide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253B%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm0704705b00028_1"><span><span class="NLM_string-ref">Boffito, M.; Back, D. J.; Blaschke, T. F.; Rowland, M.; Bertz, R. J.; Gerber, J. G.; Miller, V. Protein binding in antiretroviral therapies. <i>  AIDS </i><i>Res. Hum. Retroviruses</i><b>2003</b>, <i>19</i>, 825−835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=835&author=M.+Boffito&author=D.+J.+Back&author=T.+F.+Blaschke&author=M.+Rowland&author=R.+J.+Bertz&author=J.+G.+Gerber&author=V+Miller&title=Protein+binding+in+antiretroviral+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoffito%26aufirst%3DM.%26atitle%3DProtein%2520binding%2520in%2520antiretroviral%2520therapies%26jtitle%3DAIDS%2520Res.%2520Hum.%2520Retroviruses%26date%3D2003%26volume%3D19%26spage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm0704705b00029_1"><span><span class="NLM_string-ref">Pace, P.; Di Francesco, M. E.; Gardelli, C.; Muraglia, E.; Nizi, E.; Orvieto, F.; Petrocchi, A.; Rowley, M.; Harper, S.; Scarpelli, R.; Laufer, R.; Gonzalez Paz, O.; Monteagudo, E.; Bonelli, F.; Hazuda, D.; Stillmock, K. A.; Summa, V. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors. <i>  J. Med. Chem.</i><b>2007</b>, <i>50</i>, 2225−2239.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2239&author=P.+Pace&author=M.+E.+Di+Francesco&author=C.+Gardelli&author=E.+Muraglia&author=E.+Nizi&author=F.+Orvieto&author=A.+Petrocchi&author=M.+Rowley&author=S.+Harper&author=R.+Scarpelli&author=R.+Laufer&author=O.+Gonzalez+Paz&author=E.+Monteagudo&author=F.+Bonelli&author=D.+Hazuda&author=K.+A.+Stillmock&author=V.+Summa&author=+Dihydroxypyrimidine&title=as+novel+potent+and+selective+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26atitle%3Das%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00030"><div class="reference"><div class="NLM_citation" id="jm0704705b00030_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Hastings, J. C.; Wolfe, A. L.; Emini, E. A. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. <i>  Nucleic Acids Res.</i><b>1994</b>, <i>22</i>, 1121−1122.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=1122&author=D.+J.+Hazuda&author=J.+C.+Hastings&author=A.+L.+Wolfe&author=E.+A+Emini&title=A+novel+assay+for+the+DNA+strand-transfer+reaction+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%2520assay%2520for%2520the%2520DNA%2520strand-transfer%2520reaction%2520of%2520HIV-1%2520integrase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm0704705b00031_1"><span><span class="NLM_string-ref">Wolfe, A. L.; Felock, P. J.; Hastings, J. C.; Blau, C. U.; Hazuda, D. J. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates. <i>  J. Virol.</i><b>1996</b>, <i>70</i>, 1424−1432.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1996&pages=1432&author=A.+L.+Wolfe&author=P.+J.+Felock&author=J.+C.+Hastings&author=C.+U.+Blau&author=D.+J+Hazuda&title=The+role+of+manganese+in+promoting+multimerization+and+assembly+of+human+immunodeficiency+virus+type+1+integrase+as+a+catalytically+active+complex+on+immobilized+long+terminal+repeat+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DThe%2520role%2520of%2520manganese%2520in%2520promoting%2520multimerization%2520and%2520assembly%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520as%2520a%2520catalytically%2520active%2520complex%2520on%2520immobilized%2520long%2520terminal%2520repeat%2520substrates%26jtitle%3DJ.%2520Virol.%26date%3D1996%26volume%3D70%26spage%3D1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm0704705b00032_1"><span><span class="NLM_string-ref">Vacca, J. P.; Dorsey, B. D.; Schleif, W. A.; Levin, R. B.; McDaniel, S. L.; Darke, P. L.; Zugay, J.; Quintero, J. C.; Blahy, O. M.; Roth, E. L-735,524:  an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1994</b>, <i>91</i>, 4096−4100.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4100&author=J.+P.+Vacca&author=B.+D.+Dorsey&author=W.+A.+Schleif&author=R.+B.+Levin&author=S.+L.+McDaniel&author=P.+L.+Darke&author=J.+Zugay&author=J.+C.+Quintero&author=O.+M.+Blahy&author=E.+Roth&title=an+orally+bioavailable+human+immunodeficiency+virus+type+1+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3Dan%2520orally%2520bioavailable%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm0704705b00033_1"><span><span class="NLM_string-ref">Analytical HPLC/UV detection-based assay that measures the ability of a compound to bind with plasma proteins (primarily albumin) in pH 7.4 at room temperature.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Analytical+HPLC%2FUV+detection-based+assay+that+measures+the+ability+of+a+compound+to+bind+with+plasma+proteins+%28primarily+albumin%29+in+pH+7.4+at+room+temperature.+Analytical+HPLC%2FUV+detection-based+assay+that+measures+the+ability+of+a+compound+to+bind+with+plasma+proteins+%28primarily+albumin%29+in+pH+7.4+at+room+temperature."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm0704705b00034_1"><span><span class="NLM_string-ref">The concentration of compound <b>27a</b> was 1 μM and microsomes 1 mg/mL. The degradation of the substrate was measured by LC/MS/MS during a 1 h incubation.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+concentration+of+compound+27a+was+1+%CE%BCM+and+microsomes+1+mg%2FmL.+The+degradation+of+the+substrate+was+measured+by+LC%2FMS%2FMS+during+a+1+h+incubation.+The+concentration+of+compound+27a+was+1+%CE%BCM+and+microsomes+1+mg%2FmL.+The+degradation+of+the+substrate+was+measured+by+LC%2FMS%2FMS+during+a+1+h+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm0704705b00035_1"><span><span class="NLM_string-ref">Butcher, J. W., Claremon, D. A., Connolly, T. M., Dean, D. C., Karczewski, J., Koblan, K. S., Kostura M.J., Liverton, N. J., Melillo D.G. Radioligand and binding assay. PCT Int. Appl. WO 2002 0205860 A1.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0205860&publication_year=2002&pages=A1&author=J.+W.+Butcher&author=D.+A.+Claremon&author=T.+M.+Connolly&author=D.+C.+Dean&author=J.+Karczewski&author=K.+S.+Koblan&author=M.J.+Kostura&author=N.+J.+Liverton&author=D.G+Melillo&title=Radioligand+and+binding+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26atitle%3DRadioligand%2520and%2520binding%2520assay%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2002%26volume%3D0205860%26spage%3DA1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm0704705b00036_1"><span><span class="NLM_string-ref">Monteagudo, E.; Pesci, S.; Taliani, M.; Fiore, F.; Petrocchi, A.; Nizi, E.; Rowley, M.; Laufer, R.; Summa, V. Studies of metabolism and disposition of potent HIV integrase inhibitors using 19F-NMR spectroscopy. <i>  Xenobiotica</i>, <b>2007</b>, in press.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&conference=Xenobiotica&author=E.+Monteagudo&author=S.+Pesci&author=M.+Taliani&author=F.+Fiore&author=A.+Petrocchi&author=E.+Nizi&author=M.+Rowley&author=R.+Laufer&author=V.+Summa&title=Studies+of+metabolism+and+disposition+of+potent+HIV+integrase+inhibitors+using+19F-NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DMonteagudo%26aufirst%3DE.%26atitle%3DStudies%2520of%2520metabolism%2520and%2520disposition%2520of%2520potent%2520HIV%2520integrase%2520inhibitors%2520using%252019F-NMR%2520spectroscopy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm0704705b00037_1"><span><span class="NLM_string-ref">Zhuang, L.; Wai, J. S.; Embrey, M. W.; Fisher, T. E.; Egbertson, M. S.; Payne, L. S.; Guare, J. P., Jr.; Vacca, J. P.; Hazuda, D. J.; Felock, P. J.; Wolfe, A. L.; Stillmock, K. A.; Witmer, M. V.; Moyer, G.; Schleif, W. A.; Gabryelski, L. J.; Leonard, Y. M.; Lynch, J. J., Jr.; Michelson, S. R.; Young, S. D. Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 453−456.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=456&author=L.+Zhuang&author=J.+S.+Wai&author=M.+W.+Embrey&author=T.+E.+Fisher&author=M.+S.+Egbertson&author=L.+S.+Payne&author=J.+P.+Guare&author=+Jr&author=D.+J.+Hazuda&author=P.+J.+Felock&author=A.+L.+Wolfe&author=K.+A.+Stillmock&author=M.+V.+Witmer&author=G.+Moyer&author=W.+A.+Schleif&author=L.+J.+Gabryelski&author=Y.+M.+Leonard&author=J.+J.+Lynch&author=+Jr&author=S.+D+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm0704705b00038_1"><span><span class="NLM_string-ref">Culbertson, T. P. Synthesis of 5,6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic acid, methyl ester, a correct structure. <i>  J. Heterocycl. Chem.</i><b>1979</b>, <i>16</i>, 1423−1424.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1424&author=T.+P+Culbertson&title=Synthesis+of+5%2C6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic+acid%2C+methyl+ester%2C+a+correct+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCulbertson%26aufirst%3DT.%2BP%26atitle%3DSynthesis%2520of%25205%252C6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic%2520acid%252C%2520methyl%2520ester%252C%2520a%2520correct%2520structure%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm0704705b00039_1"><span><span class="NLM_string-ref">Dreher, S. D.; Ikemoto, N.; Gresham, V.; Liu, J.; Dormer, P. G.; Balsells, J.; Mathre, D.; Novak, T. J.; Armstrong, J. D. I. Highly selective synthesis of 2-substituted-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid derivatives using a novel protected dihydroxyfumarate. <i>  Tetrahedron </i><i>Lett.</i><b>2004</b>, <i>45</i>, 6023−6025.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=6025&author=S.+D.+Dreher&author=N.+Ikemoto&author=V.+Gresham&author=J.+Liu&author=P.+G.+Dormer&author=J.+Balsells&author=D.+Mathre&author=T.+J.+Novak&author=J.+D.+I+Armstrong&title=Highly+selective+synthesis+of+2-substituted-5-hydroxy-6-oxo-1%2C6-dihydropyrimidine-4-carboxylic+acid+derivatives+using+a+novel+protected+dihydroxyfumarate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDreher%26aufirst%3DS.%2BD.%26atitle%3DHighly%2520selective%2520synthesis%2520of%25202-substituted-5-hydroxy-6-oxo-1%252C6-dihydropyrimidine-4-carboxylic%2520acid%2520derivatives%2520using%2520a%2520novel%2520protected%2520dihydroxyfumarate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D6025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00040"><div class="reference"><div class="NLM_citation" id="jm0704705b00040_1"><span><span class="NLM_string-ref">Zhong, Y.-L.; Zhou, H.; Gauthier, D. R.; Askin, D. Efficient synthesis of functionalized pyrimidones via microwave-accelerated reaction. <i>  Tetrahedron Lett.</i><b>2006</b>, <i>47</i>, 1315−1317.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1317&author=Y.-L.+Zhong&author=H.+Zhou&author=D.+R.+Gauthier&author=D+Askin&title=Efficient+synthesis+of+functionalized+pyrimidones+via+microwave-accelerated+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.-L.%26atitle%3DEfficient%2520synthesis%2520of%2520functionalized%2520pyrimidones%2520via%2520microwave-accelerated%2520reaction%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm0704705b00041_1"><span><span class="NLM_string-ref">In some runs, >12:1 selectivity was observed. Presence of pyridine in the Bz-pyrimidine starting material significantly degraded the regioselectivity. A batch with 1 wt% pyridine gave ∼3:1 selectivity. Removal of pyridine after the benzoylation step by extracting with dilute HCl is recommended.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+In+some+runs%2C+%3E12%3A1+selectivity+was+observed.+Presence+of+pyridine+in+the+Bz-pyrimidine+starting+material+significantly+degraded+the+regioselectivity.+A+batch+with+1+wt%25+pyridine+gave+%E2%88%BC3%3A1+selectivity.+Removal+of+pyridine+after+the+benzoylation+step+by+extracting+with+dilute+HCl+is+recommended.+In+some+runs%2C+%3E12%3A1+selectivity+was+observed.+Presence+of+pyridine+in+the+Bz-pyrimidine+starting+material+significantly+degraded+the+regioselectivity.+A+batch+with+1+wt%25+pyridine+gave+%E2%88%BC3%3A1+selectivity.+Removal+of+pyridine+after+the+benzoylation+step+by+extracting+with+dilute+HCl+is+recommended."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm0704705b00042_1"><span><span class="NLM_string-ref">Brown, G. R.; Foubister, A. J.; Wright, B. Chiral synthesis of 3-substituted morpholines via serine enantiomers and reductions of 5-oxomorpholine-3-carboxylate. <i>  J. Chem. Soc., Perkin Trans. I</i><b>1985</b>, 2577−2580.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2577&publication_year=1985&pages=2580&author=G.+R.+Brown&author=A.+J.+Foubister&author=B+Wright&title=Chiral+synthesis+of+3-substituted+morpholines+via+serine+enantiomers+and+reductions+of+5-oxomorpholine-3-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BR.%26atitle%3DChiral%2520synthesis%2520of%25203-substituted%2520morpholines%2520via%2520serine%2520enantiomers%2520and%2520reductions%2520of%25205-oxomorpholine-3-carboxylate%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%2520I%26date%3D1985%26volume%3D2577%26spage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00043"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00043'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="jm0704705b00043_1"><span><span class="NLM_string-ref">De Kimpe, N.; Stevens, C. A convenient synthesis of 6-acetyl-1,2,3,4-tetrahydropyridine, the principle bread flavor component. <i>  J. Org. Chem.</i><b>1993</b>, <i>58</i>, 2904−2906.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=2906&author=N.+De+Kimpe&author=C+Stevens&title=A+convenient+synthesis+of+6-acetyl-1%2C2%2C3%2C4-tetrahydropyridine%2C+the+principle+bread+flavor+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DN.%26atitle%3DA%2520convenient%2520synthesis%2520of%25206-acetyl-1%252C2%252C3%252C4-tetrahydropyridine%252C%2520the%2520principle%2520bread%2520flavor%2520component%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D2906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00044"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00044'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="jm0704705b00044_1"><span><span class="NLM_string-ref">Belleau, B. The synthesis of (+/−), (+), and (−) α-(3-thiamorpholinyl)-benzhydrol, a new selective stimulant of the central nervous system. <i>  J. Med. Pharm. Chem.</i><b>1960</b>, <i>2</i>, 553−562.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1960&pages=562&author=B+Belleau&title=The+synthesis+of+%28%2B%2F%E2%88%92%29%2C+%28%2B%29%2C+and+%28%E2%88%92%29+%CE%B1-%283-thiamorpholinyl%29-benzhydrol%2C+a+new+selective+stimulant+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB%26atitle%3DThe%2520synthesis%2520of%2520%2528%252B%252F%25E2%2588%2592%2529%252C%2520%2528%252B%2529%252C%2520and%2520%2528%25E2%2588%2592%2529%2520%25CE%25B1-%25283-thiamorpholinyl%2529-benzhydrol%252C%2520a%2520new%2520selective%2520stimulant%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1960%26volume%3D2%26spage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00045"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00045'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="jm0704705b00045_1"><span><span class="NLM_string-ref">Bousquet, Y.; Anderson, P. C.; Bogri, T.; Duceppe, J.-S.; Grenier, L.; Guse, I. Preparation of enantiopure 4-oxygenated pipecolic acid derivatives. <i>  Tetrahedron</i><b>1997</b>, <i>53</i>, 15671−15680.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=15680&author=Y.+Bousquet&author=P.+C.+Anderson&author=T.+Bogri&author=J.-S.+Duceppe&author=L.+Grenier&author=I+Guse&title=Preparation+of+enantiopure+4-oxygenated+pipecolic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBousquet%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520enantiopure%25204-oxygenated%2520pipecolic%2520acid%2520derivatives%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D15680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00046"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00046'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="jm0704705b00046_1"><span><span class="NLM_string-ref">Pozdnev, V. F. Activation of carboxylic acids by pyrocarbonates. Application of di-<i>tert</i>-butyl pyrocarbonate as condensing reagent in the synthesis of amides of protected aminoacids and peptides. <i>  Tetrahedron </i><i>Lett.</i><b>1995</b>, <i>36</i>, 7115−7118.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7118&author=V.+F+Pozdnev&title=Activation+of+carboxylic+acids+by+pyrocarbonates.+Application+of+di-tert-butyl+pyrocarbonate+as+condensing+reagent+in+the+synthesis+of+amides+of+protected+aminoacids+and+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnev%26aufirst%3DV.%2BF%26atitle%3DActivation%2520of%2520carboxylic%2520acids%2520by%2520pyrocarbonates.%2520Application%2520of%2520di-tert-butyl%2520pyrocarbonate%2520as%2520condensing%2520reagent%2520in%2520the%2520synthesis%2520of%2520amides%2520of%2520protected%2520aminoacids%2520and%2520peptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D7118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00047"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00047'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="jm0704705b00047_1"><span><span class="NLM_string-ref">The e.e. were determined by chiral HPLC using a column Chiralpak AD 250 × 4.6 mm. Eluent <i>n</i>-hexane/ethanol = 85:15 for compound <b>85a</b> and <i>n</i>-hexane/isopropanol = 50:50 for compound <b>86a</b>; flow rate = 1 mL/min, λ = 300 nm.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+e.e.+were+determined+by+chiral+HPLC+using+a+column+Chiralpak+AD+250+%C3%97+4.6+mm.+Eluent+n-hexane%2Fethanol+%3D+85%3A15+for+compound+85a+and+n-hexane%2Fisopropanol+%3D+50%3A50+for+compound+86a%3B+flow+rate+%3D+1+mL%2Fmin%2C+%CE%BB+%3D+300+nm.+The+e.e.+were+determined+by+chiral+HPLC+using+a+column+Chiralpak+AD+250+%C3%97+4.6+mm.+Eluent+n-hexane%2Fethanol+%3D+85%3A15+for+compound+85a+and+n-hexane%2Fisopropanol+%3D+50%3A50+for+compound+86a%3B+flow+rate+%3D+1+mL%2Fmin%2C+%CE%BB+%3D+300+nm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00048"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00048'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="jm0704705b00048_1"><span><span class="NLM_string-ref">Manfrè, F.; Kern, J.-M.; Biellmann, J.-F. Synthesis of proline analogues as potential mechanism-based inhibitors of proline dehydrogenase:  4-Methylene-<span class="smallcaps smallerCapital">l</span>-, (<i>E</i>)- and (<i>Z</i>)-4-fluoromethylene)-<span class="smallcaps smallerCapital">l</span>-, <i>cis</i>- and <i>trans</i>-5-ethynyl-(+/−)-, and <i>cis</i>- and <i>trans</i>-5-vinyl-<span class="smallcaps smallerCapital">l</span>-proline. <i>  J. Org. Chem.</i><b>1992</b>, <i>57</i>, 2060−2065.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=2065&author=F.+Manfr%C3%A8&author=J.-M.+Kern&author=J.-F+Biellmann&title=Synthesis+of+proline+analogues+as+potential+mechanism-based+inhibitors+of+proline+dehydrogenase%3A%E2%80%89+4-Methylene-l-%2C+%28E%29-+and+%28Z%29-4-fluoromethylene%29-l-%2C+cis-+and+trans-5-ethynyl-%28%2B%2F%E2%88%92%29-%2C+and+cis-+and+trans-5-vinyl-l-proline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfr%25C3%25A8%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520proline%2520analogues%2520as%2520potential%2520mechanism-based%2520inhibitors%2520of%2520proline%2520dehydrogenase%253A%25E2%2580%2589%25204-Methylene-l-%252C%2520%2528E%2529-%2520and%2520%2528Z%2529-4-fluoromethylene%2529-l-%252C%2520cis-%2520and%2520trans-5-ethynyl-%2528%252B%252F%25E2%2588%2592%2529-%252C%2520and%2520cis-%2520and%2520trans-5-vinyl-l-proline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D2065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00049"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0704705b00049'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="jm0704705b00049_1"><span><span class="NLM_string-ref">Smith, E. M.; Swiss, G. F.; Neustadt, B. R.; Gold, E. H.; Sommer, J. A.; Brown, A. D.; Chiu, P. J. S.; Moran, R.; Sybertz, E. J.; Baum, T. Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors:  <i>N</i>-(Mercaptoacyl)-4-substituted- (<i>S</i>)-prolines. <i>  J. Med. Chem.</i><b>1988</b>, <i>31</i>, 875−885.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=885&author=E.+M.+Smith&author=G.+F.+Swiss&author=B.+R.+Neustadt&author=E.+H.+Gold&author=J.+A.+Sommer&author=A.+D.+Brown&author=P.+J.+S.+Chiu&author=R.+Moran&author=E.+J.+Sybertz&author=T+Baum&title=Synthesis+and+pharmacological+activity+of+angiotensin+converting+enzyme+inhibitors%3A%E2%80%89+N-%28Mercaptoacyl%29-4-substituted-+%28S%29-prolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%2BM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520activity%2520of%2520angiotensin%2520converting%2520enzyme%2520inhibitors%253A%25E2%2580%2589%2520N-%2528Mercaptoacyl%2529-4-substituted-%2520%2528S%2529-prolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0704705b00050"><div class="reference"><div class="NLM_citation" id="jm0704705b00050_1"><span><span class="NLM_string-ref">Demange, L.; Menez, A.; Dugave, C. Practical synthesis of Boc- and Fmoc-protected 4-fluoro and 4-difluoroprolines from <i>trans</i>-4-hydroxyproline. <i>  Tetrahedron Lett.</i><b>1998</b>, <i>39</i>, 1169−1172.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1172&author=L.+Demange&author=A.+Menez&author=C+Dugave&title=Practical+synthesis+of+Boc-+and+Fmoc-protected+4-fluoro+and+4-difluoroprolines+from+trans-4-hydroxyproline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemange%26aufirst%3DL.%26atitle%3DPractical%2520synthesis%2520of%2520Boc-%2520and%2520Fmoc-protected%25204-fluoro%2520and%25204-difluoroprolines%2520from%2520trans-4-hydroxyproline%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm0704705b00001':['jm0704705b00001_1'],'jm0704705b00002':['jm0704705b00002_1'],'jm0704705b00003':['jm0704705b00003_1'],'jm0704705b00004':['jm0704705b00004_1'],'jm0704705b00005':['jm0704705b00005_1'],'jm0704705b00006':['jm0704705b00006_1'],'jm0704705b00007':['jm0704705b00007_1'],'jm0704705b00008':['jm0704705b00008_1'],'jm0704705b00009':['jm0704705b00009_1'],'jm0704705b00010':['jm0704705b00010_1'],'jm0704705b00011':['jm0704705b00011_1'],'jm0704705b00012':['jm0704705b00012_1'],'jm0704705b00013':['jm0704705b00013_1'],'jm0704705b00014':['jm0704705b00014_1'],'jm0704705b00015':['jm0704705b00015_1'],'jm0704705b00016':['jm0704705b00016_1'],'jm0704705b00017':['jm0704705b00017_1'],'jm0704705b00018':['jm0704705b00018_1'],'jm0704705b00019':['jm0704705b00019_1'],'jm0704705b00020':['jm0704705b00020_1'],'jm0704705b00021':['jm0704705b00021_1'],'jm0704705b00022':['jm0704705b00022_1'],'jm0704705b00023':['jm0704705b00023_1'],'jm0704705b00024':['jm0704705b00024_1'],'jm0704705b00025':['jm0704705b00025_1'],'jm0704705b00026':['jm0704705b00026_1'],'jm0704705b00027':['jm0704705b00027_1'],'jm0704705b00028':['jm0704705b00028_1'],'jm0704705b00029':['jm0704705b00029_1'],'jm0704705b00030':['jm0704705b00030_1'],'jm0704705b00031':['jm0704705b00031_1'],'jm0704705b00032':['jm0704705b00032_1'],'jm0704705b00033':['jm0704705b00033_1'],'jm0704705b00034':['jm0704705b00034_1'],'jm0704705b00035':['jm0704705b00035_1'],'jm0704705b00036':['jm0704705b00036_1'],'jm0704705b00037':['jm0704705b00037_1'],'jm0704705b00038':['jm0704705b00038_1'],'jm0704705b00039':['jm0704705b00039_1'],'jm0704705b00040':['jm0704705b00040_1'],'jm0704705b00041':['jm0704705b00041_1'],'jm0704705b00042':['jm0704705b00042_1'],'jm0704705b00043':['jm0704705b00043_1'],'jm0704705b00044':['jm0704705b00044_1'],'jm0704705b00045':['jm0704705b00045_1'],'jm0704705b00046':['jm0704705b00046_1'],'jm0704705b00047':['jm0704705b00047_1'],'jm0704705b00048':['jm0704705b00048_1'],'jm0704705b00049':['jm0704705b00049_1'],'jm0704705b00050':['jm0704705b00050_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nicolino Pala, Francesca Esposito, Enzo Tramontano, Pankaj Kumar Singh, Vanna Sanna, Mauro Carcelli, Lisa D. Haigh, Sandro Satta, <span class="NLM_string-name hlFld-ContribAuthor">Mario Sechi</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Raltegravir-based Photoaffinity-Labeled Probe for Human Immunodeficiency Virus-1 Integrase Capture. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1986-1992. <a href="https://doi.org/10.1021/acsmedchemlett.0c00009" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00009%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Ba%252BRaltegravir-based%252BPhotoaffinity-Labeled%252BProbe%252Bfor%252BHuman%252BImmunodeficiency%252BVirus-1%252BIntegrase%252BCapture%26aulast%3DPala%26aufirst%3DNicolino%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06012020%26date%3D28042020%26date%3D05052020%26date%3D28042020%26volume%3D11%26issue%3D10%26spage%3D1986%26epage%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Savina Malancona, Mattia Mori, Paola Fezzardi, Marisabella Santoriello, Andreina Basta, Martina Nibbio, Lesia Kovalenko, Roberto Speziale, Maria Rosaria Battista, Antonella Cellucci, Nadia Gennari, Edith Monteagudo, Annalise Di Marco, Alessia Giannini, Rajhans Sharma, Manuel Pires, Eleonore Real, Maurizio Zazzi, Maria Chiara Dasso Lang, Davide De Forni, Francesco Saladini, Yves Mely, Vincenzo Summa, Steven Harper, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Botta</span>. </span><span class="cited-content_cbyCitation_article-title">5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 766-772. <a href="https://doi.org/10.1021/acsmedchemlett.9b00608" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00608%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5%25252C6-Dihydroxypyrimidine%252BScaffold%252Bto%252BTarget%252BHIV-1%252BNucleocapsid%252BProtein%26aulast%3DMalancona%26aufirst%3DSavina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D19032020%26date%3D23032020%26date%3D19032020%26volume%3D11%26issue%3D5%26spage%3D766%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Allie
Y. Chen, Rebecca N. Adamek, Benjamin L. Dick, Cy V. Credille, Christine N. Morrison, <span class="NLM_string-name hlFld-ContribAuthor">Seth M. Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metalloenzymes for Therapeutic Intervention. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1323-1455. <a href="https://doi.org/10.1021/acs.chemrev.8b00201" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00201%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252BMetalloenzymes%252Bfor%252BTherapeutic%252BIntervention%26aulast%3DChen%26aufirst%3DAllie%2BY.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D07092018%26volume%3D119%26issue%3D2%26spage%3D1323%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ozgur Yilmaz, Martins S. Oderinde, <span class="NLM_string-name hlFld-ContribAuthor">Marion H. Emmert</span>. </span><span class="cited-content_cbyCitation_article-title">Photoredox-Catalyzed Cα–H Cyanation of Unactivated Secondary and Tertiary Aliphatic Amines: Late-Stage Functionalization and Mechanistic Studies. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (18)
                                     , 11089-11100. <a href="https://doi.org/10.1021/acs.joc.8b01700" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01700%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhotoredox-Catalyzed%252BC%2525CE%2525B1%2525E2%252580%252593H%252BCyanation%252Bof%252BUnactivated%252BSecondary%252Band%252BTertiary%252BAliphatic%252BAmines%25253A%252BLate-Stage%252BFunctionalization%252Band%252BMechanistic%252BStudies%26aulast%3DYilmaz%26aufirst%3DOzgur%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05072018%26date%3D30082018%26volume%3D83%26issue%3D18%26spage%3D11089%26epage%3D11100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petra  Králová</span>, <span class="hlFld-ContribAuthor ">Veronika  Fülöpová</span>, <span class="hlFld-ContribAuthor ">Michal  Maloň</span>, <span class="hlFld-ContribAuthor ">Tereza  Volná</span>, <span class="hlFld-ContribAuthor ">Igor  Popa</span>, and <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Polymer-Supported Synthesis of Morpholine- and Thiomorpholine-3-carboxylic Acid Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2017,</strong> <em>19 </em>
                                    (3)
                                     , 173-180. <a href="https://doi.org/10.1021/acscombsci.6b00178" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00178%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DStereoselective%252BPolymer-Supported%252BSynthesis%252Bof%252BMorpholine-%252Band%252BThiomorpholine-3-carboxylic%252BAcid%252BDerivatives%26aulast%3DKr%25C3%25A1lov%25C3%25A1%26aufirst%3DPetra%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2017%26date%3D30112016%26date%3D10012017%26date%3D30012017%26date%3D13032017%26date%3D13012017%26volume%3D19%26issue%3D3%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">María  Sánchez-Roselló</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Carlos  del Pozo</span>, <span class="hlFld-ContribAuthor ">Alexander E.  Sorochinsky</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (4)
                                     , 2432-2506. <a href="https://doi.org/10.1021/cr4002879" title="DOI URL">https://doi.org/10.1021/cr4002879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr4002879%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DFluorine%252Bin%252BPharmaceutical%252BIndustry%25253A%252BFluorine-Containing%252BDrugs%252BIntroduced%252Bto%252Bthe%252BMarket%252Bin%252Bthe%252BLast%252BDecade%252B%2525282001%2525E2%252580%2525932011%252529%26aulast%3DWang%26aufirst%3DJiang%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D27052013%26date%3D03122013%26date%3D26022014%26volume%3D114%26issue%3D4%26spage%3D2432%26epage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Horrick  Sharma</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Cheng</span>, and <span class="hlFld-ContribAuthor ">John K.  Buolamwini</span>  . </span><span class="cited-content_cbyCitation_article-title">Homology Model-Guided 3D-QSAR Studies of HIV-1 Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (2)
                                     , 515-544. <a href="https://doi.org/10.1021/ci200485a" title="DOI URL">https://doi.org/10.1021/ci200485a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200485a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200485a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHomology%252BModel-Guided%252B3D-QSAR%252BStudies%252Bof%252BHIV-1%252BIntegrase%252BInhibitors%26aulast%3DSharma%26aufirst%3DHorrick%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D12102011%26date%3D07022012%26date%3D27022012%26date%3D18012012%26volume%3D52%26issue%3D2%26spage%3D515%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendra P.  Singh</span> and <span class="hlFld-ContribAuthor ">Teruo  Umemoto</span>  . </span><span class="cited-content_cbyCitation_article-title">4-Fluoropyrrolidine-2-carbonyl Fluorides: Useful Synthons and Their Facile Preparation with 4-tert-Butyl-2,6-dimethylphenylsulfur Trifluoride. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (9)
                                     , 3113-3121. <a href="https://doi.org/10.1021/jo1025783" title="DOI URL">https://doi.org/10.1021/jo1025783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo1025783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo1025783%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D4-Fluoropyrrolidine-2-carbonyl%252BFluorides%25253A%252BUseful%252BSynthons%252Band%252BTheir%252BFacile%252BPreparation%252Bwith%252B4-tert-Butyl-2%25252C6-dimethylphenylsulfur%252BTrifluoride%26aulast%3DSingh%26aufirst%3DRajendra%2BP.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D28122010%26date%3D29032011%26date%3D06052011%26volume%3D76%26issue%3D9%26spage%3D3113%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Shao</span>, <span class="hlFld-ContribAuthor ">Leihong  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Fan</span>, and <span class="hlFld-ContribAuthor ">Yiyu  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Consensus Ranking Approach to Understanding the Underlying Mechanism With QSAR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2010,</strong> <em>50 </em>
                                    (11)
                                     , 1941-1948. <a href="https://doi.org/10.1021/ci100305g" title="DOI URL">https://doi.org/10.1021/ci100305g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100305g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100305g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DConsensus%252BRanking%252BApproach%252Bto%252BUnderstanding%252Bthe%252BUnderlying%252BMechanism%252BWith%252BQSAR%26aulast%3DShao%26aufirst%3DLi%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D9%252008%25202010%26date%3D04112010%26date%3D22112010%26volume%3D50%26issue%3D11%26spage%3D1941%26epage%3D1948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuguang  Gao</span>, <span class="hlFld-ContribAuthor ">Yuqing  Liu</span>, <span class="hlFld-ContribAuthor ">Shuqin  Kwong</span>, <span class="hlFld-ContribAuthor ">Zhengshuang  Xu</span> and <span class="hlFld-ContribAuthor ">Tao  Ye</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis and Stereochemical Reassignment of Bisebromoamide. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2010,</strong> <em>12 </em>
                                    (13)
                                     , 3018-3021. <a href="https://doi.org/10.1021/ol101021v" title="DOI URL">https://doi.org/10.1021/ol101021v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol101021v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol101021v%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTotal%252BSynthesis%252Band%252BStereochemical%252BReassignment%252Bof%252BBisebromoamide%26aulast%3DGao%26aufirst%3DXuguang%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D04%252005%25202010%26date%3D08062010%26date%3D02072010%26volume%3D12%26issue%3D13%26spage%3D3018%26epage%3D3021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roland E.  Dolle</span>, <span class="hlFld-ContribAuthor ">Bertrand Le  Bourdonnec</span>, <span class="hlFld-ContribAuthor ">Allan J.  Goodman</span>, <span class="hlFld-ContribAuthor ">Guillermo A.  Morales</span>, <span class="hlFld-ContribAuthor ">Craig J.  Thomas</span> and <span class="hlFld-ContribAuthor ">Wei  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2007. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2008,</strong> <em>10 </em>
                                    (6)
                                     , 753-802. <a href="https://doi.org/10.1021/cc800119z" title="DOI URL">https://doi.org/10.1021/cc800119z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc800119z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc800119z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DComprehensive%252BSurvey%252Bof%252BChemical%252BLibraries%252Bfor%252BDrug%252BDiscovery%252Band%252BChemical%252BBiology%25253A%252B2007%26aulast%3DDolle%26aufirst%3DRoland%2BE.%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D10%252011%25202008%26date%3D10%252011%25202008%26date%3D11%252007%25202008%26volume%3D10%26issue%3D6%26spage%3D753%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Alessia  Petrocchi</span>, <span class="hlFld-ContribAuthor ">Fabio  Bonelli</span>, <span class="hlFld-ContribAuthor ">Benedetta  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>, <span class="hlFld-ContribAuthor ">Odalys  Gonzalez Paz</span>, <span class="hlFld-ContribAuthor ">Daria J.  Hazuda</span>, <span class="hlFld-ContribAuthor ">Philip  Jones</span>, <span class="hlFld-ContribAuthor ">Olaf  Kinzel</span>, <span class="hlFld-ContribAuthor ">Ralph  Laufer</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Ester  Muraglia</span>, <span class="hlFld-ContribAuthor ">Emanuela  Nizi</span>, <span class="hlFld-ContribAuthor ">Federica  Orvieto</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Giovanna  Pescatore</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Kara  Stillmock</span>, <span class="hlFld-ContribAuthor ">Marc V.  Witmer</span> and <span class="hlFld-ContribAuthor ">Michael  Rowley</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (18)
                                     , 5843-5855. <a href="https://doi.org/10.1021/jm800245z" title="DOI URL">https://doi.org/10.1021/jm800245z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800245z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BRaltegravir%25252C%252Ba%252BPotent%25252C%252BSelective%252BOrally%252BBioavailable%252BHIV-Integrase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHIV-AIDS%252BInfection%26aulast%3DSumma%26aufirst%3DVincenzo%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D25%252009%25202008%26date%3D03%252009%25202008%26date%3D6%252003%25202008%26volume%3D51%26issue%3D18%26spage%3D5843%26epage%3D5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ester  Muraglia</span>, <span class="hlFld-ContribAuthor ">Olaf  Kinzel</span>, <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>, <span class="hlFld-ContribAuthor ">Benedetta  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Emanuela  Nizi</span>, <span class="hlFld-ContribAuthor ">Federica  Orvieto</span>, <span class="hlFld-ContribAuthor ">Giovanna  Pescatore</span>, <span class="hlFld-ContribAuthor ">Ralph  Laufer</span>, <span class="hlFld-ContribAuthor ">Odalys  Gonzalez-Paz</span>, <span class="hlFld-ContribAuthor ">Annalise  Di Marco</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Fonsi</span>, <span class="hlFld-ContribAuthor ">Peter J.  Felock</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span> and <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (4)
                                     , 861-874. <a href="https://doi.org/10.1021/jm701164t" title="DOI URL">https://doi.org/10.1021/jm701164t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm701164t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm701164t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBicyclic%252BPyrimidinones%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BHIV-1%252BIntegrase%252BInhibitors%26aulast%3DMuraglia%26aufirst%3DEster%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D28%252002%25202008%26date%3D25%252001%25202008%26date%3D18%252009%25202007%26volume%3D51%26issue%3D4%26spage%3D861%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey V.  Smolobochkin</span>, <span class="hlFld-ContribAuthor ">Almir S.  Gazizov</span>, <span class="hlFld-ContribAuthor ">Alexander R.  Burilov</span>, <span class="hlFld-ContribAuthor ">Mikhael A.  Pudovik</span>, <span class="hlFld-ContribAuthor ">Oleg G.  Sinyashin</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the synthesis of heterocycles bearing an endocyclic urea moiety. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (3)
                                     , 395-417. <a href="https://doi.org/10.1070/RCR4988" title="DOI URL">https://doi.org/10.1070/RCR4988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4988%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DAdvances%252Bin%252Bthe%252Bsynthesis%252Bof%252Bheterocycles%252Bbearing%252Ban%252Bendocyclic%252Burea%252Bmoiety%26aulast%3DSmolobochkin%26aufirst%3DAndrey%2BV.%26date%3D2021%26volume%3D90%26issue%3D3%26spage%3D395%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Dario Oliveira  Passos</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lyumkis</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 205. <a href="https://doi.org/10.3390/v13020205" title="DOI URL">https://doi.org/10.3390/v13020205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13020205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13020205%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DIntegrase%252BStrand%252BTransfer%252BInhibitors%252BAre%252BEffective%252BAnti-HIV%252BDrugs%26aulast%3DSmith%26aufirst%3DSteven%2BJ.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blanca  López</span>, <span class="hlFld-ContribAuthor ">Martí  Bartra</span>, <span class="hlFld-ContribAuthor ">Ramon  Berenguer</span>, <span class="hlFld-ContribAuthor ">Xavier  Ariza</span>, <span class="hlFld-ContribAuthor ">Jordi  Garcia</span>, <span class="hlFld-ContribAuthor ">Roberto  Gómez</span>, <span class="hlFld-ContribAuthor ">Hèctor  Torralvo</span>. </span><span class="cited-content_cbyCitation_article-title">An Enantioselective Approach to 4-Substituted Proline Scaffolds: Synthesis of (S)-5-(tert-Butoxy carbonyl)-5-azaspiro[2.4]heptane-6-carboxylic Acid. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5644. <a href="https://doi.org/10.3390/molecules25235644" title="DOI URL">https://doi.org/10.3390/molecules25235644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235644%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BEnantioselective%252BApproach%252Bto%252B4-Substituted%252BProline%252BScaffolds%25253A%252BSynthesis%252Bof%252B%252528S%252529-5-%252528tert-Butoxy%252Bcarbonyl%252529-5-azaspiro%25255B2.4%25255Dheptane-6-carboxylic%252BAcid%26aulast%3DL%25C3%25B3pez%26aufirst%3DBlanca%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew K.  Kwegyir-Afful</span>, <span class="hlFld-ContribAuthor ">Senthilmurugan  Ramalingam</span>, <span class="hlFld-ContribAuthor ">Vidya P.  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Puranik  Purushottamachar</span>, <span class="hlFld-ContribAuthor ">Francis N.  Murigi</span>, <span class="hlFld-ContribAuthor ">Tadas S.  Vasaitis</span>, <span class="hlFld-ContribAuthor ">Weiliang  Huang</span>, <span class="hlFld-ContribAuthor ">Maureen A.  Kane</span>, <span class="hlFld-ContribAuthor ">Yuji  Zhang</span>, <span class="hlFld-ContribAuthor ">Nicholas  Ambulos</span>, <span class="hlFld-ContribAuthor ">Sudhir  Tiwari</span>, <span class="hlFld-ContribAuthor ">Pratima  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ivo P.  Nnane</span>, <span class="hlFld-ContribAuthor ">Arif  Hussain</span>, <span class="hlFld-ContribAuthor ">Yun  Qiu</span>, <span class="hlFld-ContribAuthor ">David J.  Weber</span>, <span class="hlFld-ContribAuthor ">Vincent C. O.  Njar</span>. </span><span class="cited-content_cbyCitation_article-title">Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 1637. <a href="https://doi.org/10.3390/cancers11111637" title="DOI URL">https://doi.org/10.3390/cancers11111637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11111637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11111637%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DGaleterone%252Band%252BThe%252BNext%252BGeneration%252BGaleterone%252BAnalogs%25252C%252BVNPP414%252Band%252BVNPP433-3%2525CE%2525B2%252BExert%252BPotent%252BTherapeutic%252BEffects%252Bin%252BCastration-%25252FDrug-Resistant%252BProstate%252BCancer%252BPreclinical%252BModels%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DKwegyir-Afful%26aufirst%3DAndrew%2BK.%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y.  Wang</span>, <span class="hlFld-ContribAuthor ">F.  Yan</span>, <span class="hlFld-ContribAuthor ">Q.  Jia</span>, <span class="hlFld-ContribAuthor ">Y.  Dai</span>, <span class="hlFld-ContribAuthor ">Q.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative structure-activity relationship of anti-HIV integrase and reverse transcriptase inhibitors using norm indexes. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (12)
                                     , 1025-1044. <a href="https://doi.org/10.1080/1062936X.2017.1397055" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1397055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1397055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1397055%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DQuantitative%252Bstructure-activity%252Brelationship%252Bof%252Banti-HIV%252Bintegrase%252Band%252Breverse%252Btranscriptase%252Binhibitors%252Busing%252Bnorm%252Bindexes%26aulast%3DWang%26aufirst%3DY.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D12%26spage%3D1025%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diane  Beylkin</span>, <span class="hlFld-ContribAuthor ">Gyanendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Jaehyeon  Park</span>, <span class="hlFld-ContribAuthor ">Trushar  Jeevan</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Lagisetti</span>, <span class="hlFld-ContribAuthor ">Rhodri  Harfoot</span>, <span class="hlFld-ContribAuthor ">Richard J.  Webby</span>, <span class="hlFld-ContribAuthor ">Stephen W.  White</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-17419-6" title="DOI URL">https://doi.org/10.1038/s41598-017-17419-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-17419-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-17419-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DProtein-Structure%252BAssisted%252BOptimization%252Bof%252B4%25252C5-Dihydroxypyrimidine-6-Carboxamide%252BInhibitors%252Bof%252BInfluenza%252BVirus%252BEndonuclease%26aulast%3DBeylkin%26aufirst%3DDiane%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luana Janaína  de Campos</span>, <span class="hlFld-ContribAuthor ">Eduardo Borges  de Melo</span>. </span><span class="cited-content_cbyCitation_article-title">A QSAR study of integrase strand transfer inhibitors based on a large set of pyrimidine, pyrimidone, and pyridopyrazine carboxamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1141 </em>, 252-260. <a href="https://doi.org/10.1016/j.molstruc.2017.03.103" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.03.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.03.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.03.103%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252BQSAR%252Bstudy%252Bof%252Bintegrase%252Bstrand%252Btransfer%252Binhibitors%252Bbased%252Bon%252Ba%252Blarge%252Bset%252Bof%252Bpyrimidine%25252C%252Bpyrimidone%25252C%252Band%252Bpyridopyrazine%252Bcarboxamide%252Bderivatives%26aulast%3Dde%2BCampos%26aufirst%3DLuana%2BJana%25C3%25ADna%26date%3D2017%26volume%3D1141%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander D.  Tereshchenko</span>, <span class="hlFld-ContribAuthor ">Julia S.  Myronchuk</span>, <span class="hlFld-ContribAuthor ">Lena D.  Leitchenko</span>, <span class="hlFld-ContribAuthor ">Irina V.  Knysh</span>, <span class="hlFld-ContribAuthor ">Ganna O.  Tokmakova</span>, <span class="hlFld-ContribAuthor ">Olena O.  Litsis</span>, <span class="hlFld-ContribAuthor ">Andrey  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Konstantin  Liubchak</span>, <span class="hlFld-ContribAuthor ">Pavel  Mykhailiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-oxadiazolyl/triazolyl morpholines: Novel scaffolds for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (6)
                                     , 750-757. <a href="https://doi.org/10.1016/j.tet.2016.12.052" title="DOI URL">https://doi.org/10.1016/j.tet.2016.12.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.12.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252B3-oxadiazolyl%25252Ftriazolyl%252Bmorpholines%25253A%252BNovel%252Bscaffolds%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DTereshchenko%26aufirst%3DAlexander%2BD.%26date%3D2017%26volume%3D73%26issue%3D6%26spage%3D750%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christelle  Doebelin</span>, <span class="hlFld-ContribAuthor ">Yuanjun  He</span>, <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>. </span><span class="cited-content_cbyCitation_article-title">Multigram-scale synthesis of enantiopure 3,3-difluoroproline. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (50)
                                     , 5658-5660. <a href="https://doi.org/10.1016/j.tetlet.2016.11.012" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMultigram-scale%252Bsynthesis%252Bof%252Benantiopure%252B3%25252C3-difluoroproline%26aulast%3DDoebelin%26aufirst%3DChristelle%26date%3D2016%26volume%3D57%26issue%3D50%26spage%3D5658%26epage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leen  Heirbaut</span>, <span class="hlFld-ContribAuthor ">Sebastiaan  van Goethem</span>, <span class="hlFld-ContribAuthor ">Koen  Jansen</span>, <span class="hlFld-ContribAuthor ">Hans  de Winter</span>, <span class="hlFld-ContribAuthor ">Nicole  Lamoen</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Ingrid  de Meester</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 433-438. <a href="https://doi.org/10.1039/C5MD00454C" title="DOI URL">https://doi.org/10.1039/C5MD00454C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00454C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00454C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DProbing%252Bfor%252Bimproved%252Bselectivity%252Bwith%252Bdipeptide-derived%252Binhibitors%252Bof%252Bdipeptidyl%252Bpeptidases%252B8%252Band%252B9%25253A%252Bthe%252Bimpact%252Bof%252BP1-variation%26aulast%3DHeirbaut%26aufirst%3DLeen%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D433%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael U.  Luescher</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Bode</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Synthesis of N-Unprotected Piperazines, Morpholines, and Thiomorpholines from Aldehydes and SnAP Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (37)
                                     , 11034-11038. <a href="https://doi.org/10.1002/ange.201505167" title="DOI URL">https://doi.org/10.1002/ange.201505167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201505167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201505167%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCatalytic%252BSynthesis%252Bof%252BN-Unprotected%252BPiperazines%25252C%252BMorpholines%25252C%252Band%252BThiomorpholines%252Bfrom%252BAldehydes%252Band%252BSnAP%252BReagents%26aulast%3DLuescher%26aufirst%3DMichael%2BU.%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D37%26spage%3D11034%26epage%3D11038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael U.  Luescher</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Bode</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Synthesis of N-Unprotected Piperazines, Morpholines, and Thiomorpholines from Aldehydes and SnAP Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (37)
                                     , 10884-10888. <a href="https://doi.org/10.1002/anie.201505167" title="DOI URL">https://doi.org/10.1002/anie.201505167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201505167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201505167%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCatalytic%252BSynthesis%252Bof%252BN-Unprotected%252BPiperazines%25252C%252BMorpholines%25252C%252Band%252BThiomorpholines%252Bfrom%252BAldehydes%252Band%252BSnAP%252BReagents%26aulast%3DLuescher%26aufirst%3DMichael%2BU.%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D37%26spage%3D10884%26epage%3D10888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul V.  Patel</span>, <span class="hlFld-ContribAuthor ">Young-Soo  Keum</span>, <span class="hlFld-ContribAuthor ">Se Won  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Sketching the historical development of pyrimidones as the inhibitors of the HIV integrase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 649-663. <a href="https://doi.org/10.1016/j.ejmech.2014.07.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSketching%252Bthe%252Bhistorical%252Bdevelopment%252Bof%252Bpyrimidones%252Bas%252Bthe%252Binhibitors%252Bof%252Bthe%252BHIV%252Bintegrase%26aulast%3DPatel%26aufirst%3DRahul%2BV.%26date%3D2015%26volume%3D97%26spage%3D649%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Shouyi  Xuan</span>, <span class="hlFld-ContribAuthor ">Yue  Feng</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting HIV-1 integrase with strand transfer inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (4)
                                     , 435-449. <a href="https://doi.org/10.1016/j.drudis.2014.12.001" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTargeting%252BHIV-1%252Bintegrase%252Bwith%252Bstrand%252Btransfer%252Binhibitors%26aulast%3DLi%26aufirst%3DYang%26date%3D2015%26volume%3D20%26issue%3D4%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhijit M.  Godbole</span>, <span class="hlFld-ContribAuthor ">Senthilmurugan  Ramalingam</span>, <span class="hlFld-ContribAuthor ">Vidya P.  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Aakanksha  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Robert D.  Bruno</span>, <span class="hlFld-ContribAuthor ">Vijay V.  Upreti</span>, <span class="hlFld-ContribAuthor ">Lalji K.  Gediya</span>, <span class="hlFld-ContribAuthor ">Puranik  Purushottamachar</span>, <span class="hlFld-ContribAuthor ">Hannah W.  Mbatia</span>, <span class="hlFld-ContribAuthor ">Sankar  Addya</span>, <span class="hlFld-ContribAuthor ">Nicholas  Ambulos</span>, <span class="hlFld-ContribAuthor ">Vincent C.O.  Njar</span>. </span><span class="cited-content_cbyCitation_article-title">VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2014,</strong> <em>734 </em>, 98-104. <a href="https://doi.org/10.1016/j.ejphar.2014.04.004" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DVN%25252F14-1%252Binduces%252BER%252Bstress%252Band%252Bautophagy%252Bin%252BHP-LTLC%252Bhuman%252Bbreast%252Bcancer%252Bcells%252Band%252Bhas%252Bexcellent%252Boral%252Bpharmacokinetic%252Bprofile%252Bin%252Bfemale%252BSprague%252BDawley%252Brats%26aulast%3DGodbole%26aufirst%3DAbhijit%2BM.%26date%3D2014%26volume%3D734%26spage%3D98%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario A.  Quevedo</span>, <span class="hlFld-ContribAuthor ">Sergio R.  Ribone</span>, <span class="hlFld-ContribAuthor ">Margarita C.  Briñón</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2014,</strong> <em>52 </em>, 82-90. <a href="https://doi.org/10.1016/j.jmgm.2014.06.007" title="DOI URL">https://doi.org/10.1016/j.jmgm.2014.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2014.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2014.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDevelopment%252Bof%252Ba%252Breceptor%252Bmodel%252Bfor%252Befficient%252Bin%252Bsilico%252Bscreening%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DQuevedo%26aufirst%3DMario%2BA.%26date%3D2014%26volume%3D52%26spage%3D82%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luciana L.  de Carvalho</span>, <span class="hlFld-ContribAuthor ">Vinícius G.  Maltarollo</span>, <span class="hlFld-ContribAuthor ">Emmanuela Ferreira  de Lima</span>, <span class="hlFld-ContribAuthor ">Karen C.  Weber</span>, <span class="hlFld-ContribAuthor ">Kathia M.  Honorio</span>, <span class="hlFld-ContribAuthor ">Albérico B. F.  da Silva</span>, . </span><span class="cited-content_cbyCitation_article-title">Molecular Features Related to HIV Integrase Inhibition Obtained from Structure- and Ligand-Based Approaches. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , e81301. <a href="https://doi.org/10.1371/journal.pone.0081301" title="DOI URL">https://doi.org/10.1371/journal.pone.0081301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0081301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0081301%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DMolecular%252BFeatures%252BRelated%252Bto%252BHIV%252BIntegrase%252BInhibition%252BObtained%252Bfrom%252BStructure-%252Band%252BLigand-Based%252BApproaches%26aulast%3Dde%2BCarvalho%26aufirst%3DLuciana%2BL.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D1%26spage%3De81301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallikarjun Reddy  Sura</span>, <span class="hlFld-ContribAuthor ">Vasu Govardhana Reddy  Peddiahgari</span>, <span class="hlFld-ContribAuthor ">Rajendra Prasad Reddy  Bhoomireddy</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Vadde</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New 2,4-Diaryl-6-methyl-5-nitropyrimidines as Antibacterial and Antioxidant Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2013,</strong> <em>50 </em>
                                    (6)
                                     , 1395-1399. <a href="https://doi.org/10.1002/jhet.1645" title="DOI URL">https://doi.org/10.1002/jhet.1645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.1645%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNew%252B2%25252C4-Diaryl-6-methyl-5-nitropyrimidines%252Bas%252BAntibacterial%252Band%252BAntioxidant%252BAgents%26aulast%3DSura%26aufirst%3DMallikarjun%2BReddy%26date%3D2013%26date%3D2013%26volume%3D50%26issue%3D6%26spage%3D1395%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shenghui  Yu</span>, <span class="hlFld-ContribAuthor ">Tino Wilson  Sanchez</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Yanzhen  Yin</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (22)
                                     , 6134-6137. <a href="https://doi.org/10.1016/j.bmcl.2013.09.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bpyrimidone%252Banalogues%252Bas%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DYu%26aufirst%3DShenghui%26date%3D2013%26volume%3D23%26issue%3D22%26spage%3D6134%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karnati Konda  Reddy</span>, <span class="hlFld-ContribAuthor ">Sanjeev Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Nigus  Dessalew</span>, <span class="hlFld-ContribAuthor ">Sunil Kumar  Tripathi</span>, <span class="hlFld-ContribAuthor ">Chandrabose  Selvaraj</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modelling and atom-based 3D-QSAR studies on
              N
              -methyl pyrimidones as HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2012,</strong> <em>27 </em>
                                    (3)
                                     , 339-347. <a href="https://doi.org/10.3109/14756366.2011.590803" title="DOI URL">https://doi.org/10.3109/14756366.2011.590803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2011.590803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2011.590803%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore%252Bmodelling%252Band%252Batom-based%252B3D-QSAR%252Bstudies%252Bon%252BN%252B-methyl%252Bpyrimidones%252Bas%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DReddy%26aufirst%3DKarnati%2BKonda%26date%3D2012%26date%3D2011%26volume%3D27%26issue%3D3%26spage%3D339%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Najeh  Tka</span>, <span class="hlFld-ContribAuthor ">Béchir  Ben Hassine</span>. </span><span class="cited-content_cbyCitation_article-title">New Chiral Aminoamidoximes: Syntheses and Investigation of Heterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2012,</strong> <em>42 </em>
                                    (6)
                                     , 828-835. <a href="https://doi.org/10.1080/00397911.2010.531441" title="DOI URL">https://doi.org/10.1080/00397911.2010.531441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2010.531441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2010.531441%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DNew%252BChiral%252BAminoamidoximes%25253A%252BSyntheses%252Band%252BInvestigation%252Bof%252BHeterocyclic%252BCompounds%26aulast%3DTka%26aufirst%3DNajeh%26date%3D2012%26date%3D2011%26volume%3D42%26issue%3D6%26spage%3D828%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrej  Kolarovič</span>. </span><span class="cited-content_cbyCitation_article-title">Lithiations and Grignard Reactions on Pyrimidine and Quinazoline. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 21-64. <a href="https://doi.org/10.1007/7081_2012_94" title="DOI URL">https://doi.org/10.1007/7081_2012_94</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2012_94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2012_94%26sid%3Dliteratum%253Aachs%26atitle%3DLithiations%252Band%252BGrignard%252BReactions%252Bon%252BPyrimidine%252Band%252BQuinazoline%26aulast%3DKolarovi%25C4%258D%26aufirst%3DAndrej%26date%3D2012%26date%3D2012%26spage%3D21%26epage%3D64%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DMetalation%252Bof%252BAzines%252Band%252BDiazines%26aulast%3DSchn%25C3%25BCrch%26aufirst%3DMichael%26date%3D2013%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kerti  Ausmees</span>, <span class="hlFld-ContribAuthor ">Anastasia  Selyutina</span>, <span class="hlFld-ContribAuthor ">Kristel  Kütt</span>, <span class="hlFld-ContribAuthor ">Kristin  Lippur</span>, <span class="hlFld-ContribAuthor ">Tõnis  Pehk</span>, <span class="hlFld-ContribAuthor ">Margus  Lopp</span>, <span class="hlFld-ContribAuthor ">Eva  Žusinaite</span>, <span class="hlFld-ContribAuthor ">Andres  Merits</span>, <span class="hlFld-ContribAuthor ">Tõnis  Kanger</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activity of Bimorpholine and its Carbanucleoside. </span><span class="cited-content_cbyCitation_journal-name">Nucleosides, Nucleotides and Nucleic Acids</span><span> <strong>2011,</strong> <em>30 </em>
                                    (11)
                                     , 897-907. <a href="https://doi.org/10.1080/15257770.2011.621919" title="DOI URL">https://doi.org/10.1080/15257770.2011.621919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15257770.2011.621919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15257770.2011.621919%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleosides%252C%2520Nucleotides%2520and%2520Nucleic%2520Acids%26atitle%3DSynthesis%252Band%252BBiological%252BActivity%252Bof%252BBimorpholine%252Band%252Bits%252BCarbanucleoside%26aulast%3DAusmees%26aufirst%3DKerti%26date%3D2011%26volume%3D30%26issue%3D11%26spage%3D897%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa S.  Egbertson</span>, <span class="hlFld-ContribAuthor ">Neville J.  Anthony</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">HIV Integrase Inhibitors: From Diketo Acids to Heterocyclic Templates: History of HIV Integrase Medicinal Chemistry at Merck West Point and Merck Rome (IRBM) Leading to Discovery of Raltegravir. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 197-229. <a href="https://doi.org/10.1002/9781118015377.ch14" title="DOI URL">https://doi.org/10.1002/9781118015377.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118015377.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118015377.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DHIV%252BIntegrase%252BInhibitors%25253A%252BFrom%252BDiketo%252BAcids%252Bto%252BHeterocyclic%252BTemplates%25253A%252BHistory%252Bof%252BHIV%252BIntegrase%252BMedicinal%252BChemistry%252Bat%252BMerck%252BWest%252BPoint%252Band%252BMerck%252BRome%252B%252528IRBM%252529%252BLeading%252Bto%252BDiscovery%252Bof%252BRaltegravir%26aulast%3DEgbertson%26aufirst%3DMelissa%2BS.%26date%3D2011%26date%3D2011%26spage%3D197%26epage%3D229%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DHIV-1%252BIntegrase%26aulast%3DNeamati%26aufirst%3DNouri%26date%3D2011%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheo B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Natural Product Inhibitors of HIV-1 Integrase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 309-323. <a href="https://doi.org/10.1002/9781118015377.ch21" title="DOI URL">https://doi.org/10.1002/9781118015377.ch21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118015377.ch21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118015377.ch21%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BNatural%252BProduct%252BInhibitors%252Bof%252BHIV-1%252BIntegrase%26aulast%3DSingh%26aufirst%3DSheo%2BB.%26date%3D2011%26date%3D2011%26spage%3D309%26epage%3D323%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DHIV-1%252BIntegrase%26aulast%3DNeamati%26aufirst%3DNouri%26date%3D2011%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas N.  Telvekar</span>, <span class="hlFld-ContribAuthor ">Kavitkumar N.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Development and Docking Studies of the HIV-1 Integrase Inhibitors Derived from N-methylpyrimidones, Dihydroxypyrimidines, and Bicyclic Pyrimidinones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2011,</strong> <em>78 </em>
                                    (1)
                                     , 150-160. <a href="https://doi.org/10.1111/j.1747-0285.2011.01130.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01130.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01130.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DPharmacophore%252BDevelopment%252Band%252BDocking%252BStudies%252Bof%252Bthe%252BHIV-1%252BIntegrase%252BInhibitors%252BDerived%252Bfrom%252BN-methylpyrimidones%25252C%252BDihydroxypyrimidines%25252C%252Band%252BBicyclic%252BPyrimidinones%26aulast%3DTelvekar%26aufirst%3DVikas%2BN.%26date%3D2011%26date%3D2011%26volume%3D78%26issue%3D1%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of HIV Integrase Inhibitor Raltegravir. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 181-195. <a href="https://doi.org/10.1002/9780470929353.ch13" title="DOI URL">https://doi.org/10.1002/9780470929353.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470929353.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470929353.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BHIV%252BIntegrase%252BInhibitor%252BRaltegravir%26aulast%3DSumma%26aufirst%3DVincenzo%26date%3D2011%26date%3D2011%26spage%3D181%26epage%3D195%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DAntiviral%252BDrugs%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2011%26volume%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasthuraiah  Maddali</span>, <span class="hlFld-ContribAuthor ">Vineet  Kumar</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Sanjay V.  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2011,</strong> <em>2 </em>
                                    (2)
                                     , 143-150. <a href="https://doi.org/10.1039/C0MD00201A" title="DOI URL">https://doi.org/10.1039/C0MD00201A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0MD00201A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0MD00201A%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DBiological%252Bevaluation%252Bof%252Bimidazolium-%252Band%252Bammonium-based%252Bsalts%252Bas%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DMaddali%26aufirst%3DKasthuraiah%26date%3D2011%26date%3D2011%26volume%3D2%26issue%3D2%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Abele</span>, <span class="hlFld-ContribAuthor ">R.  Abele</span>, <span class="hlFld-ContribAuthor ">L.  Golomba</span>, <span class="hlFld-ContribAuthor ">J.  Višņevska</span>, <span class="hlFld-ContribAuthor ">T.  Beresneva</span>, <span class="hlFld-ContribAuthor ">K.  Rubina</span>, <span class="hlFld-ContribAuthor ">E.  Lukevics</span>. </span><span class="cited-content_cbyCitation_article-title">Oximes of six-membered heterocyclic compounds with two and three heteroatoms. II.* Reactions and biological activity (review). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2010,</strong> <em>46 </em>
                                    (8)
                                     , 905-930. <a href="https://doi.org/10.1007/s10593-010-0602-2" title="DOI URL">https://doi.org/10.1007/s10593-010-0602-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-010-0602-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-010-0602-2%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DOximes%252Bof%252Bsix-membered%252Bheterocyclic%252Bcompounds%252Bwith%252Btwo%252Band%252Bthree%252Bheteroatoms.%252BII.%252A%252BReactions%252Band%252Bbiological%252Bactivity%252B%252528review%252529%26aulast%3DAbele%26aufirst%3DE.%26date%3D2010%26date%3D2010%26volume%3D46%26issue%3D8%26spage%3D905%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kavya  Ramkumar</span>, <span class="hlFld-ContribAuthor ">Erik  Serrao</span>, <span class="hlFld-ContribAuthor ">Srinivas  Odde</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 integrase inhibitors: 2007-2008 update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2010,</strong> <em>30 </em>
                                    (6)
                                     , 890-954. <a href="https://doi.org/10.1002/med.20194" title="DOI URL">https://doi.org/10.1002/med.20194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20194%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHIV-1%252Bintegrase%252Binhibitors%25253A%252B2007-2008%252Bupdate%26aulast%3DRamkumar%26aufirst%3DKavya%26date%3D2010%26date%3D2010%26volume%3D30%26issue%3D6%26spage%3D890%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian A.  Johns</span>. </span><span class="cited-content_cbyCitation_article-title">HIV
              Integrase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 75-106. <a href="https://doi.org/10.1002/0471266949.bmc225" title="DOI URL">https://doi.org/10.1002/0471266949.bmc225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc225%26sid%3Dliteratum%253Aachs%26atitle%3DHIV%252BIntegrase%26aulast%3DJohns%26aufirst%3DBrian%2BA.%26date%3D2010%26date%3D2010%26spage%3D75%26epage%3D106%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (17)
                                     , 5031-5034. <a href="https://doi.org/10.1016/j.bmcl.2010.07.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.07.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.07.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-pyrrolidinyl-N-methyl%252Bpyrimidones%252Bas%252Bpotent%252Band%252Borally%252Bbioavailable%252BHIV%252Bintegrase%252Binhibitors%26aulast%3DFerrara%26aufirst%3DMarco%26date%3D2010%26volume%3D20%26issue%3D17%26spage%3D5031%26epage%3D5034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuleika  Michelini</span>, <span class="hlFld-ContribAuthor ">Clementina Maria  Galluzzo</span>, <span class="hlFld-ContribAuthor ">Donatella R.M.  Negri</span>, <span class="hlFld-ContribAuthor ">Pasqualina  Leone</span>, <span class="hlFld-ContribAuthor ">Roberta  Amici</span>, <span class="hlFld-ContribAuthor ">Roberta  Bona</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Roberto  Di Santo</span>, <span class="hlFld-ContribAuthor ">Roberta  Costi</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Lucia  Palmisano</span>, <span class="hlFld-ContribAuthor ">Stefano  Vella</span>, <span class="hlFld-ContribAuthor ">Andrea  Cara</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virological Methods</span><span> <strong>2010,</strong> <em>168 </em>
                                    (1-2)
                                     , 272-276. <a href="https://doi.org/10.1016/j.jviromet.2010.06.004" title="DOI URL">https://doi.org/10.1016/j.jviromet.2010.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jviromet.2010.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jviromet.2010.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virological%2520Methods%26atitle%3DEvaluation%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%252Bon%252Bhuman%252Bprimary%252Bmacrophages%252Busing%252Ba%252Bluciferase-based%252Bsingle-cycle%252Bphenotypic%252Bassay%26aulast%3DMichelini%26aufirst%3DZuleika%26date%3D2010%26volume%3D168%26issue%3D1-2%26spage%3D272%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julianne A.  Hunt</span>. </span><span class="cited-content_cbyCitation_article-title">Raltegravir (Isentress): The First-in-Class HIV-1 Integrase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 1-15. <a href="https://doi.org/10.1002/9780470768594.ch1" title="DOI URL">https://doi.org/10.1002/9780470768594.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470768594.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470768594.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DRaltegravir%252B%252528Isentress%252529%25253A%252BThe%252BFirst-in-Class%252BHIV-1%252BIntegrase%252BInhibitor%26aulast%3DHunt%26aufirst%3DJulianne%2BA.%26date%3D2010%26date%3D2010%26spage%3D1%26epage%3D15%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DModern%252BDrug%252BSynthesis%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2010%26date%3D2010%26volume%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Abele</span>, <span class="hlFld-ContribAuthor ">R.  Abele</span>, <span class="hlFld-ContribAuthor ">E.  Lukevics</span>. </span><span class="cited-content_cbyCitation_article-title">Oximes of six-membered heterocyclic compounds with two or three hetero-atoms: I. Synthesis and structure (review). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2009,</strong> <em>45 </em>
                                    (12)
                                     , 1420-1440. <a href="https://doi.org/10.1007/s10593-010-0446-9" title="DOI URL">https://doi.org/10.1007/s10593-010-0446-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-010-0446-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-010-0446-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DOximes%252Bof%252Bsix-membered%252Bheterocyclic%252Bcompounds%252Bwith%252Btwo%252Bor%252Bthree%252Bhetero-atoms%25253A%252BI.%252BSynthesis%252Band%252Bstructure%252B%252528review%252529%26aulast%3DAbele%26aufirst%3DE.%26date%3D2009%26date%3D2010%26volume%3D45%26issue%3D12%26spage%3D1420%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Nizi</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Orsale</span>, <span class="hlFld-ContribAuthor ">Benedetta  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Giovanna  Pescatore</span>, <span class="hlFld-ContribAuthor ">Ester  Muraglia</span>, <span class="hlFld-ContribAuthor ">Anna  Alfieri</span>, <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>, <span class="hlFld-ContribAuthor ">Stéphane A.H.  Spieser</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: Improving cell based activity by the quaternarization of a chiral center. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (16)
                                     , 4617-4621. <a href="https://doi.org/10.1016/j.bmcl.2009.06.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.06.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.06.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.06.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydroxy-pyrimidine%252Band%252BN-methylpyrimidone%252BHIV-integrase%252Binhibitors%25253A%252BImproving%252Bcell%252Bbased%252Bactivity%252Bby%252Bthe%252Bquaternarization%252Bof%252Ba%252Bchiral%252Bcenter%26aulast%3DNizi%26aufirst%3DEmanuela%26date%3D2009%26volume%3D19%26issue%3D16%26spage%3D4617%26epage%3D4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kasthuraiah  Maddali</span>, <span class="hlFld-ContribAuthor ">B.  Christie Vu</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (10)
                                     , 2714-2717. <a href="https://doi.org/10.1016/j.bmcl.2009.03.122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.03.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.03.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.03.122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExamination%252Bof%252Bhalogen%252Bsubstituent%252Beffects%252Bon%252BHIV-1%252Bintegrase%252Binhibitors%252Bderived%252Bfrom%252B2%25252C3-dihydro-6%25252C7-dihydroxy-1H-isoindol-1-ones%252Band%252B4%25252C5-dihydroxy-1H-isoindole-1%25252C3%2525282H%252529-diones%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D2714%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Olaf D.  Kinzel</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—A new class of HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (7)
                                     , 1930-1934. <a href="https://doi.org/10.1016/j.bmcl.2009.02.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-Hydroxy-4-oxo-4H-pyrido%25255B1%25252C2-a%25255Dpyrimidine-2-carboxylates%2525E2%252580%252594A%252Bnew%252Bclass%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DDonghi%26aufirst%3DMonica%26date%3D2009%26volume%3D19%26issue%3D7%26spage%3D1930%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralph  Laufer</span>, <span class="hlFld-ContribAuthor ">Odalys Gonzalez  Paz</span>, <span class="hlFld-ContribAuthor ">Annalise  Di Marco</span>, <span class="hlFld-ContribAuthor ">Fabio  Bonelli</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2009,</strong> <em>37 </em>
                                    (4)
                                     , 873-883. <a href="https://doi.org/10.1124/dmd.108.023804" title="DOI URL">https://doi.org/10.1124/dmd.108.023804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.108.023804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.108.023804%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DQuantitative%252BPrediction%252Bof%252BHuman%252BClearance%252BGuiding%252Bthe%252BDevelopment%252Bof%252BRaltegravir%252B%252528MK-0518%25252C%252BIsentress%252529%252Band%252BRelated%252BHIV%252BIntegrase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DRalph%26date%3D2009%26date%3D2009%26volume%3D37%26issue%3D4%26spage%3D873%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria del Rosario Rico  Ferreira</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Cecere</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Routes to HIV-integrase inhibitors: efficient synthesis of bicyclic pyrimidones by ring expansion or amination at a benzylic position. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2009,</strong> <em>50 </em>
                                    (2)
                                     , 148-151. <a href="https://doi.org/10.1016/j.tetlet.2008.10.119" title="DOI URL">https://doi.org/10.1016/j.tetlet.2008.10.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2008.10.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2008.10.119%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRoutes%252Bto%252BHIV-integrase%252Binhibitors%25253A%252Befficient%252Bsynthesis%252Bof%252Bbicyclic%252Bpyrimidones%252Bby%252Bring%252Bexpansion%252Bor%252Bamination%252Bat%252Ba%252Bbenzylic%252Bposition%26aulast%3DFerreira%26aufirst%3DMaria%2Bdel%2BRosario%2BRico%26date%3D2009%26volume%3D50%26issue%3D2%26spage%3D148%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Stéphane A.H.  Spieser</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (14)
                                     , 3865-3869. <a href="https://doi.org/10.1016/j.bmcl.2008.06.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.06.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.06.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Hydroxy-5-pyrrolinone-3-carboxamide%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DPace%26aufirst%3DPaola%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D3865%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Emilia  Di Francesco</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Francesca  Naimo</span>, <span class="hlFld-ContribAuthor ">Fabio  Bonelli</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-tbutyl-N-methyl pyrimidones as potent inhibitors of HIV integrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (8)
                                     , 2709-2713. <a href="https://doi.org/10.1016/j.bmcl.2008.03.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-tbutyl-N-methyl%252Bpyrimidones%252Bas%252Bpotent%252Binhibitors%252Bof%252BHIV%252Bintegrase%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BEmilia%26date%3D2008%26volume%3D18%26issue%3D8%26spage%3D2709%26epage%3D2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 From diketoacid inhibitors <b>1</b> to naphthyridine <b>2</b> and dihydroxypyrimidine carboxamide <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705f00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00002.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 From aromatic derivatives to aliphatic heterocyclic compounds.<sup>29</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705f00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00003.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 From dihydroxypyrimidines <b>8</b> and <b>9</b> to N−Me pyrimidones <b>10</b> and <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705f00004" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00004.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Glucuronide formation rate of compound <b>27a</b> in rat, dog, rhesus, and human liver microsomes in the presence of UDPGA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705f00005" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705f00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00005.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Pharmacokinetic profile for compound <b>27a</b> in dogs dosed intravenously (4 mg/kg) and orally (10 mg/kg) as a solution in 35%DMSO/65% (0.9% NaCl) and in 1% methylcellulose, respectively. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705f00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705f00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00001" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00001.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  Synthesis of Final Compounds <b>11</b>,<b> 25</b>−<b>30</b>, and <b>46</b>-<b>49</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions (yields are reported for compound <b>27</b>):  (a) NH<sub>2</sub>OH·HCl, Et<sub>3</sub>N, EtOH, reflux, 5 h, 89%; (b) DMAD, CHCl<sub>3</sub>, reflux, 1 h, 78%; (c) <i>o</i>-xylenes, reflux, 12 h, 54%; (d) Bz<sub>2</sub>O, Py, 3 h, 71%; (e) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub>, 64%; (f) 4F-BnNH<sub>2</sub>, MeOH, reflux in a sealed tube, 2 h, 68%; (g) TFA-DCM, rt, quant.; (h) H<sub>2</sub>, Pd/C, MeOH, rt, 5 h; (i) HCOH or CH<sub>3</sub>COH, NaCNBH<sub>3</sub>, MeOH; (l) Ac<sub>2</sub>O, Py; (m) NaIO<sub>4</sub>, H<sub>2</sub>O, EtOH; (n) <i>m</i>-CPBA, DCM; (o) NEt<sub>3</sub>, MeI, THF. <i><sup>b</sup></i><sup></sup><i>cis</i>-Configuration. <i><sup>c</sup></i><sup></sup>Reference 29.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00002" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00002.jpeg" id="rightTab-_i26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Novel Synthesis of Boc-Protected Morpholine-3-nitrile <b>62a</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) <i>t</i>-BuOCl, MTBE; (b) NaOMe, MeOH; (c) HCN, H<sub>2</sub>O; (d) Boc<sub>2</sub>O, DMAP, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00003" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00003.jpeg" id="rightTab-_i28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Synthesis of Boc-Protected Nitriles <b>62b</b> and <b>62c</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, H<sub>2</sub>O, CHCl<sub>3</sub>; (b) NaOH, MeOH; (c) Boc<sub>2</sub>O, NH<sub>4</sub>HCO<sub>3</sub>, Py, dioxane, rt;<sup>46</sup> (d) TFAA, Et<sub>3</sub>N, DCM, rt; (e) <span class="smallcaps smallerCapital">l</span>-selectride, THF, 0 °C, 2.5 h, 95%; (f) NaH, THF, BnBr.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00004" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00004.jpeg" id="rightTab-_i30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4.  Synthesis of Compound <b>32</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub>; (b) 4F-BnNH<sub>2</sub>, MeOH, reflux, 2 d; (c) H<sub>2</sub>, Pd/C, MeOH, 1 N HCl; (d) Et<sub>3</sub>N, DCM, MsCl, rt, 2 h; (e) BnMeNH, CH<sub>3</sub>CN, reflux, 3 h; (f) TFA-DCM, rt, 3 h; (g) EtOCOCOH, NaCNBH<sub>3</sub>, MeOH, Et<sub>3</sub>N; (h) Et<sub>3</sub>N, MeOH, reflux, 5 h; (i) HCOH, NaCNBH<sub>3</sub>, MeOH, Et<sub>3</sub>N.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00005" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00005.jpeg" id="rightTab-_i32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5.  Synthesis of Final Compounds <b>10a</b>, and <b>12</b>−<b>24</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NH<sub>2</sub>OH·HCl, Et<sub>3</sub>N, EtOH, reflux, 5 h; (b) DMAD, CHCl<sub>3</sub>, reflux, 1 h; (c) <i>o</i>-xylenes, reflux, 12 h; (d) Bz<sub>2</sub>O, Py, 3 h; (e) LiH, dioxane, Me<sub>2</sub>SO<sub>4</sub> or Cs<sub>2</sub>CO<sub>3</sub>, THF, Me<sub>2</sub>SO<sub>4</sub>; (f) 4F-BnNH<sub>2</sub>, MeOH, reflux in a sealed tube, 2 h; (g) H<sub>2</sub>, Pd/C, MeOH; (h) TFA-DCM, rt; (i) MsCl, Et<sub>3</sub>N, DCM, rt, 1 h; (l) Ac<sub>2</sub>O, Py, rt, 1 h; (m) HCOH, NaCNBH<sub>3</sub>, MeOH. <i><sup>b</sup></i><sup></sup>Mixture of diastereoisomers, undetermined stereochemistry.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00006" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00006.jpeg" id="rightTab-_i34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6.  Protected Methylpyrrolidine Nitriles <b>81b</b>−<b>e</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, CbzCl, DMF; (b) LiBEt<sub>3</sub>H, THF; (c) TMSCN, ZnI<sub>2</sub>; (d) H<sub>2</sub>, PtO<sub>2</sub>, MeOH; (e) NH<sub>3</sub> 32%, THF; (f) TFAA, Et<sub>3</sub>N, DCM. <i><sup>b</sup></i><sup></sup>Reference 48.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00007" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00007.jpeg" id="rightTab-_i36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7.  Synthesis of Cbz 4-Substituted Pyrrolidine Nitriles <b>81f</b>−<b>n</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, THF, R<sub>1</sub>X; (b) Boc<sub>2</sub>O, NH<sub>4</sub>HCO<sub>3</sub>, Py, dioxane, rt, 72%;<sup>46</sup> (c) TFAA, Et<sub>3</sub>N, DCM, rt; (d) TsCl, Py; (e) NaN<sub>3</sub>, DMF; (f) PPh<sub>3</sub>; H<sub>2</sub>O, THF; (g) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM; (h) NaOH, MeOH; (i) DAST, dry DCM, −78 °C; (l) DMSO, (COCl)<sub>2</sub>, Et<sub>3</sub>N, DCM. <i><sup>b</sup></i><sup></sup> Reference 49.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00008" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00008.jpeg" id="rightTab-_i38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8.  Synthesis of Piperazines <b>31</b> and <b>33</b>−<b>44</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) SOCl<sub>2</sub>, Py, DMF, THF, 4 h, 40 °C; (b) NH<sub>3</sub> 0.5 M in dioxane, DCM, 2 h, 40 °C; (c) CbzCl, Et<sub>3</sub>N, DCM, rt, o/n; (d) TFAA, Et<sub>3</sub>N, DCM, 0 °C; (e) NH<sub>2</sub>OH, Et<sub>3</sub>N, MeOH, rt, o/n; (f) DMAD, CHCl<sub>3</sub>, reflux, 12 h; (g) <i>o</i>-xylenes, 160 °C for 8 h and then 120 °C for 48 h; (h) Bz<sub>2</sub>O, Py, rt, 3 h; (i) Cs<sub>2</sub>CO<sub>3</sub>, THF, Me<sub>2</sub>SO<sub>4</sub>, 40 °C, 1 h; (l) H<sub>2</sub>, Pd/C, MeOH; (m) HCOH or CH<sub>3</sub>COH or acetone, NaCNBH<sub>3</sub>, MeOH; (n) 4F-BnNH<sub>2</sub>, MeOH, reflux in sealed tube, 12 h; (o) TFA−DCM, rt; (p) Ac<sub>2</sub>O or Bz<sub>2</sub>O in pyridine or <i>N</i>,<i>N</i>-dimethylglycine hydrochloride, WSCDI, HOBt, DIPEA, DCM; (q) EtNCO, Py, rt, 0.5 h; (r) PhSO<sub>2</sub>Cl or Me<sub>2</sub>NSO<sub>2</sub>Cl, NaOH (1 M), DCM; (s) MsCl, NEt<sub>3</sub>, DCM.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0704705h00009" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/medium/jm0704705h00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00009.jpeg" id="rightTab-_i40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9.  Synthesis of Carboxamides <b>50</b>−<b>61</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) TFA−DCM, rt; (b) HCOH, NaCNBH<sub>3</sub>, MeOH; (c) R<sub>3</sub>R‘NH, MeOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-20/jm0704705/production/images/large/jm0704705h00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0704705&amp;id=jm0704705h00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm005002004975" id="jm005002004975"></a></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm0704705b00001"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00001_1"><span><span class="NLM_string-ref">Castro, H. C.; Loureiro, N. I. V.; Pujol-Luz, M.; Souza, A. M. T.; Albuquerque, M. G.; Santos, D. O.; Cabral, L. M.; Frugulhetti, I. C.; Rodrigues, C. R. HIV-1 reverse transcriptase:  A therapeutic target in the spotlight. <i>  Curr. Med. Chem.</i><b>2006</b>, <i>13</i>, 313−324.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=324&author=H.+C.+Castro&author=N.+I.+V.+Loureiro&author=M.+Pujol-Luz&author=A.+M.+T.+Souza&author=M.+G.+Albuquerque&author=D.+O.+Santos&author=L.+M.+Cabral&author=I.+C.+Frugulhetti&author=C.+R.+Rodrigues&title=therapeutic+target+in+the+spotlight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DH.%2BC.%26atitle%3Dtherapeutic%2520target%2520in%2520the%2520spotlight%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00002"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00002_1"><span><span class="NLM_string-ref">Locatelli, G. A.; Cancio, R.; Spadari, S.; Maga, G. HIV-1 reverse transcriptase inhibitors:  Current issues and future perspectives. <i>  Curr. Drug </i><i>Metab.</i><b>2004</b>, <i>5</i>, 283−290.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=290&author=G.+A.+Locatelli&author=R.+Cancio&author=S.+Spadari&author=G.+Maga&title=reverse+transcriptase+inhibitors%3A%E2%80%89+Current+issues+and+future+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DG.%2BA.%26atitle%3Dreverse%2520transcriptase%2520inhibitors%253A%25E2%2580%2589%2520Current%2520issues%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2004%26volume%3D5%26spage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00003"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00003_1"><span><span class="NLM_string-ref">Silvestri, R.; Maga, G. Current state-of-the-art in preclinical and clinical development of novel non-nucleoside HIV-1 reverse transcriptase inhibitors. <i>  Expert Opin. Ther. Pat.</i><b>2006</b>, <i>16</i>, 939−962.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=962&author=R.+Silvestri&author=G+Maga&title=Current+state-of-the-art+in+preclinical+and+clinical+development+of+novel+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DCurrent%2520state-of-the-art%2520in%2520preclinical%2520and%2520clinical%2520development%2520of%2520novel%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00004"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00004_1"><span><span class="NLM_string-ref">Vivet-Boudou, V.; Didierjean, J.; Isel, C.; Marquet, R. Nucleoside and nucleotide inhibitors of HIV-1 replication. <i>  Cell. Mol. Life Sci.</i><b>2006</b>, <i>63</i>, 163−186.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=186&author=V.+Vivet-Boudou&author=J.+Didierjean&author=C.+Isel&author=R+Marquet&title=Nucleoside+and+nucleotide+inhibitors+of+HIV-1+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVivet-Boudou%26aufirst%3DV.%26atitle%3DNucleoside%2520and%2520nucleotide%2520inhibitors%2520of%2520HIV-1%2520replication%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26spage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00005"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00005_1"><span><span class="NLM_string-ref">Lebon, F.; Ledecq, M. Approaches to the design of effective HIV-1 protease inhibitors. <i>  Curr. Med. Chem.</i><b>2000</b>, <i>7</i>, 455−477.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=477&author=F.+Lebon&author=M+Ledecq&title=Approaches+to+the+design+of+effective+HIV-1+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DF.%26atitle%3DApproaches%2520to%2520the%2520design%2520of%2520effective%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2000%26volume%3D7%26spage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00006"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00006_1"><span><span class="NLM_string-ref">Mastrolorenzo, A.; Rusconi, S.; Scozzafava, A.; Supuran, C. Inhibitors of HIV-1 protease. 10 years after. <i>  Expert Opin. Ther. Pat.</i><b>2006</b>, <i>16</i>, 1067−1091.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1091&author=A.+Mastrolorenzo&author=S.+Rusconi&author=A.+Scozzafava&author=C+Supuran&title=Inhibitors+of+HIV-1+protease.+10+years+after"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMastrolorenzo%26aufirst%3DA.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease.%252010%2520years%2520after%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00007"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00007_1"><span><span class="NLM_string-ref">Vacca, J. P.; Condra, J. H. Clinically effective HIV-1 Protease inhibitors. <i>  Drug Discovery Today</i><b>1997</b>, <i>2</i>, 261−272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=272&author=J.+P.+Vacca&author=J.+H+Condra&title=Clinically+effective+HIV-1+Protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DClinically%2520effective%2520HIV-1%2520Protease%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00008"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00008_1"><span><span class="NLM_string-ref">Anthony, N. J. HIV-1 integrase:  A target for new AIDS chemotherapeutics. <i>  Curr. Top. Med. Chem.</i><b>2004</b>, <i>4</i>, 979−990.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=990&author=N.+J.+Anthony&title=target+for+new+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3Dtarget%2520for%2520new%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00009"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00009_1"><span><span class="NLM_string-ref">Pommier, Y.; Johnson, A. A.; Marchand, C. Integrase inhibitors to treat HIV/AIDS. <i>  Nat. Rev. Drug Discovery</i><b>2005</b>, <i>4</i>, 236−248.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=248&author=Y.+Pommier&author=A.+A.+Johnson&author=C+Marchand&title=Integrase+inhibitors+to+treat+HIV%2FAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DIntegrase%2520inhibitors%2520to%2520treat%2520HIV%252FAIDS%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm0704705b00010_1"><span><span class="NLM_string-ref">Young, S. D. Inhibition of HIV-1 integrase by small molecules:  The potential for a new class of AIDS chemotherapeutics. <i>  Curr. Opin. Drug </i><i>Discovery Dev.</i><b>2001</b>, <i>4</i>, 402−410.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=410&author=S.+D+Young&title=Inhibition+of+HIV-1+integrase+by+small+molecules%3A%E2%80%89+The+potential+for+a+new+class+of+AIDS+chemotherapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BD%26atitle%3DInhibition%2520of%2520HIV-1%2520integrase%2520by%2520small%2520molecules%253A%25E2%2580%2589%2520The%2520potential%2520for%2520a%2520new%2520class%2520of%2520AIDS%2520chemotherapeutics%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00011"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00011_1"><span><span class="NLM_string-ref">Egbertson, M. S. HIV integrase inhibitors:  From diketoacids to heterocyclic templates:  A history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM). <i>  Curr. Top. Med. Chem.</i><b>2007</b>, <i>7</i>, 1251−1272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1272&author=M.+S+Egbertson&title=HIV+integrase+inhibitors%3A%E2%80%89+From+diketoacids+to+heterocyclic+templates%3A%E2%80%89+A+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS%26atitle%3DHIV%2520integrase%2520inhibitors%253A%25E2%2580%2589%2520From%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%25E2%2580%2589%2520A%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00012"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00012_1"><span><span class="NLM_string-ref">Chiu, T. K.; Davies, D. R. Structure and function of HIV-1 integrase. <i>  Curr. Top. Med. Chem.</i><b>2004</b>, <i>4</i>, 965−977.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=977&author=T.+K.+Chiu&author=D.+R+Davies&title=Structure+and+function+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DT.%2BK.%26atitle%3DStructure%2520and%2520function%2520of%2520HIV-1%2520integrase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00013"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00013_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Pramanik, B.; Wolfe, A. L. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. <i>  J. </i><i>Virol.</i><b>1997</b>, <i>71</i>, 7005−7011.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7011&author=D.+J.+Hazuda&author=P.+J.+Felock&author=J.+C.+Hastings&author=B.+Pramanik&author=A.+L+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00014"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00014_1"><span><span class="NLM_string-ref">Grobler, J. A.; Stillmock, K. A.; Binghua, H.; Witmer, M. V.; Felock, P. J.; Espeseth, A. S.; Wolfe, A. L.; Egbertson, M. S.; Bourgeois, M.; Melamed, J.; Wai, J. S.; Young, S. D.; Vacca, J. P.; Hazuda, D. J. Diketoacid inhibitor mechanism and HIV-1 integrase:  Implications for metal binding in the active site of phosphotransferase enzymes. <i>  Proc. Natl. </i><i>Acad. Sci. </i><i>U.S.A.</i><b>2002</b>, <i>99</i>, 6661−6666.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=6666&author=J.+A.+Grobler&author=K.+A.+Stillmock&author=H.+Binghua&author=M.+V.+Witmer&author=P.+J.+Felock&author=A.+S.+Espeseth&author=A.+L.+Wolfe&author=M.+S.+Egbertson&author=M.+Bourgeois&author=J.+Melamed&author=J.+S.+Wai&author=S.+D.+Young&author=J.+P.+Vacca&author=D.+J+Hazuda&title=Diketoacid+inhibitor+mechanism+and+HIV-1+integrase%3A%E2%80%89+Implications+for+metal+binding+in+the+active+site+of+phosphotransferase+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DDiketoacid%2520inhibitor%2520mechanism%2520and%2520HIV-1%2520integrase%253A%25E2%2580%2589%2520Implications%2520for%2520metal%2520binding%2520in%2520the%2520active%2520site%2520of%2520phosphotransferase%2520enzymes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D6666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00015"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00015_1"><span><span class="NLM_string-ref">Barreca, M. L.; Ferro, S.; Rao, A.; Luca, L. D.; Zappala, M.; Monforte, A. M.; Debyser, Z.; Witvrouw, M.; Chimirri, A. Pharmacophore-based design of HIV-1 strand transfer inhibitors. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 7084−7088.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7088&author=M.+L.+Barreca&author=S.+Ferro&author=A.+Rao&author=L.+D.+Luca&author=M.+Zappala&author=A.+M.+Monforte&author=Z.+Debyser&author=M.+Witvrouw&author=A+Chimirri&title=Pharmacophore-based+design+of+HIV-1+strand+transfer+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26atitle%3DPharmacophore-based%2520design%2520of%2520HIV-1%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00016"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00016_1"><span><span class="NLM_string-ref">Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinage, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor:  A platform for antiviral drug design. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1999</b>, <i>96</i>, 13040−13043.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13043&author=Y.+Goldgur&author=R.+Craigie&author=G.+H.+Cohen&author=T.+Fujiwara&author=T.+Yoshinage&author=T.+Fujishita&author=H.+Sugimoto&author=T.+Endo&author=H.+Murai&author=D.+R+Davies&title=Structure+of+the+HIV-1+integrase+catalytic+domain+complexed+with+an+inhibitor%3A%E2%80%89+A+platform+for+antiviral+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldgur%26aufirst%3DY.%26atitle%3DStructure%2520of%2520the%2520HIV-1%2520integrase%2520catalytic%2520domain%2520complexed%2520with%2520an%2520inhibitor%253A%25E2%2580%2589%2520A%2520platform%2520for%2520antiviral%2520drug%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00017"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00017_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Anthony, N. J.; Gomez, R. P.; Jolly, S. M.; Wai, J. S.; Zhuang, L.; Fisher, T. E.; Embrey, M.; Guare, J. P.; Egbertson, M. S.; Vacca, J. P.; Huff, J. R.; Felock, P. J.; Witmer, M. V.; Stillmock, K. A.; Danovich, R.; Grobler, J.; Miller, M. D.; Espeseth, A. S.; Jin, L.; Chen, I. W.; Lin, J. H.; Kassahun, K.; Ellis, J. D.; Wong, B. K.; Xu, W.; Pearson, P. G.; Schleif, W. A.; Cortese, R.; Emini, E.; Summa, V.; Holloway, M. K.; Young, S. D. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>2004</b>, <i>101</i>, 11233−11238.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=11238&author=D.+J.+Hazuda&author=N.+J.+Anthony&author=R.+P.+Gomez&author=S.+M.+Jolly&author=J.+S.+Wai&author=L.+Zhuang&author=T.+E.+Fisher&author=M.+Embrey&author=J.+P.+Guare&author=M.+S.+Egbertson&author=J.+P.+Vacca&author=J.+R.+Huff&author=P.+J.+Felock&author=M.+V.+Witmer&author=K.+A.+Stillmock&author=R.+Danovich&author=J.+Grobler&author=M.+D.+Miller&author=A.+S.+Espeseth&author=L.+Jin&author=I.+W.+Chen&author=J.+H.+Lin&author=K.+Kassahun&author=J.+D.+Ellis&author=B.+K.+Wong&author=W.+Xu&author=P.+G.+Pearson&author=W.+A.+Schleif&author=R.+Cortese&author=E.+Emini&author=V.+Summa&author=M.+K.+Holloway&author=S.+D+Young&title=A+naphthyridine+carboxamide+provides+evidence+for+discordant+resistance+between+mechanistically+identical+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DA%2520naphthyridine%2520carboxamide%2520provides%2520evidence%2520for%2520discordant%2520resistance%2520between%2520mechanistically%2520identical%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D11238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00018"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00018_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Young, S. D.; Guare, J. P.; Anthony, N. J.; Gomez, R. P.; Wai, J. S.; Vacca, J. P.; Handt, L.; Motzel, S. L.; Klein, H. J.; Dornadula, G.; Danovich, R. M.; Witmer, M. V.; Wilson, K. A. A.; Tussey, L.; Schleif, W. A.; Gabryelski, L. S.; Jin, L.; Miller, M. D.; Casimiro, D. R.; Emini, E. A.; Shiver, J. W. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. <i>  Science</i><b>2004</b>, <i>305</i>, 528−532.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=532&author=D.+J.+Hazuda&author=S.+D.+Young&author=J.+P.+Guare&author=N.+J.+Anthony&author=R.+P.+Gomez&author=J.+S.+Wai&author=J.+P.+Vacca&author=L.+Handt&author=S.+L.+Motzel&author=H.+J.+Klein&author=G.+Dornadula&author=R.+M.+Danovich&author=M.+V.+Witmer&author=K.+A.+A.+Wilson&author=L.+Tussey&author=W.+A.+Schleif&author=L.+S.+Gabryelski&author=L.+Jin&author=M.+D.+Miller&author=D.+R.+Casimiro&author=E.+A.+Emini&author=J.+W+Shiver&title=Integrase+inhibitors+and+cellular+immunity+suppress+retroviral+replication+in+rhesus+macaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DIntegrase%2520inhibitors%2520and%2520cellular%2520immunity%2520suppress%2520retroviral%2520replication%2520in%2520rhesus%2520macaques%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00019"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00019_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Pace, P.; Matassa, V. G.; De Francesco, R.; Altamura, S.; Tomei, L.; Koch, U.; Neuner, P. Discovery of alpha, gamma-diketoacids as potent selective and reversible inhibitors of hepatitis C virus NS5B RNA-dependent RNA Polymerase. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 14−17.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=17&author=V.+Summa&author=A.+Petrocchi&author=P.+Pace&author=V.+G.+Matassa&author=R.+De+Francesco&author=S.+Altamura&author=L.+Tomei&author=U.+Koch&author=P+Neuner&title=Discovery+of+alpha%2C+gamma-diketoacids+as+potent+selective+and+reversible+inhibitors+of+hepatitis+C+virus+NS5B+RNA-dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520alpha%252C%2520gamma-diketoacids%2520as%2520potent%2520selective%2520and%2520reversible%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520Polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm0704705b00020_1"><span><span class="NLM_string-ref">Pace, P.; Nizi, E.; Pacini, B.; Pesci, S.; Matassa, V.; De Francesco, R.; Altamura, S.; Summa, V. The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase. <i>  Bioorg. </i><i>Med. Chem.</i><i>Letters</i><b>2004</b>, <i>14</i>, 3257−3261.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3261&author=P.+Pace&author=E.+Nizi&author=B.+Pacini&author=S.+Pesci&author=V.+Matassa&author=R.+De+Francesco&author=S.+Altamura&author=V+Summa&title=The+monoethyl+ester+of+meconic+acid+is+an+active+site+inhibitor+of+HCV+NS5B+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26atitle%3DThe%2520monoethyl%2520ester%2520of%2520meconic%2520acid%2520is%2520an%2520active%2520site%2520inhibitor%2520of%2520HCV%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Letters%26date%3D2004%26volume%3D14%26spage%3D3261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00021"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00021_1"><span><span class="NLM_string-ref">Crescenzi, B.; Poma, M.; Ontoria, J. M.; Marchetti, A.; Nizi, E.; Matassa, V. G.; Gardelli, C. Phenyldihydroxypyrimidines as HCV NS5B RNA dependent RNA polymerase inhibitors. Part I:  Amides and ureas. <i>  Lett. Drug Des. Discovery</i><b>2005</b>, <i>2</i>, 451−455.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=455&author=B.+Crescenzi&author=M.+Poma&author=J.+M.+Ontoria&author=A.+Marchetti&author=E.+Nizi&author=V.+G.+Matassa&author=C+Gardelli&title=Phenyldihydroxypyrimidines+as+HCV+NS5B+RNA+dependent+RNA+polymerase+inhibitors.+Part+I%3A%E2%80%89+Amides+and+ureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrescenzi%26aufirst%3DB.%26atitle%3DPhenyldihydroxypyrimidines%2520as%2520HCV%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%2520inhibitors.%2520Part%2520I%253A%25E2%2580%2589%2520Amides%2520and%2520ureas%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00022"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00022_1"><span><span class="NLM_string-ref">Koch, U.; Attenni, B.; Malancona, S.; Colarusso, S.; Conte, I.; Di, Filippo, M.; Harper, S.; Pacini, B.; Giomini, C.; Thomas, S.; Incitti, I.; Tomei, L.; De Francesco, R.; Altamura, S.; Matassa, V. G.; Narjes, F. 2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase:  Discovery, SAR, modeling, and mutagenesis. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 1693−1705.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1705&author=U.+Koch&author=B.+Attenni&author=S.+Malancona&author=S.+Colarusso&author=I.+Conte&author=+Di&author=S.+Harper&author=B.+Pacini&author=C.+Giomini&author=S.+Thomas&author=I.+Incitti&author=L.+Tomei&author=R.+De+Francesco&author=S.+Altamura&author=V.+G.+Matassa&author=F.+Narjes&author=+Thienyl&title=as+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase%3A%E2%80%89+Discovery%2C+SAR%2C+modeling%2C+and+mutagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26atitle%3Das%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%25E2%2580%2589%2520Discovery%252C%2520SAR%252C%2520modeling%252C%2520and%2520mutagenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00023"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00023_1"><span><span class="NLM_string-ref">Ponzi, S.; Giuliano, C.; Donghi, M.; Poma, M.; Matassa, V. G.; Stansfield, I. Phenyldihydroxypyrimidines as HCV NS5B RNA dependent RNA polymerase inhibitors. Part II:  Sulfonamides. <i>  Lett. Drug Des. </i><i>Discovery</i><b>2005</b>, <i>2</i>, 456−461.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=461&author=S.+Ponzi&author=C.+Giuliano&author=M.+Donghi&author=M.+Poma&author=V.+G.+Matassa&author=I+Stansfield&title=Phenyldihydroxypyrimidines+as+HCV+NS5B+RNA+dependent+RNA+polymerase+inhibitors.+Part+II%3A%E2%80%89+Sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzi%26aufirst%3DS.%26atitle%3DPhenyldihydroxypyrimidines%2520as%2520HCV%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%2520inhibitors.%2520Part%2520II%253A%25E2%2580%2589%2520Sulfonamides%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2005%26volume%3D2%26spage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00024"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00024_1"><span><span class="NLM_string-ref">Stansfield, I.; Avolio, S.; Colarusso, S.; Gennari, N.; Narjes, F.; Pacini, B.; Ponzi, S.; Harper, S. Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid. <i>  Bioorg. Med. Chem.</i><i>Lett.</i><b>2004</b>, <i>14</i>, 5085−5088.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5088&author=I.+Stansfield&author=S.+Avolio&author=S.+Colarusso&author=N.+Gennari&author=F.+Narjes&author=B.+Pacini&author=S.+Ponzi&author=S+Harper&title=Active+site+inhibitors+of+HCV+NS5B+polymerase.+The+development+and+pharmacophore+of+2-thienyl-5%2C6-dihydroxypyrimidine-4-carboxylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfield%26aufirst%3DI.%26atitle%3DActive%2520site%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase.%2520The%2520development%2520and%2520pharmacophore%2520of%25202-thienyl-5%252C6-dihydroxypyrimidine-4-carboxylic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00025"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00025_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Matassa, V. G.; Taliani, M.; Laufer, R.; De Francesco, R.; Altamura, S.; Pace, P. HCV NS5B RNA-dependent RNA polymerase inhibitors:  From α,γ-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis. <i>  J. Med. Chem.</i><b>2004</b>, <i>47</i>, 5336−5339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5339&author=V.+Summa&author=A.+Petrocchi&author=V.+G.+Matassa&author=M.+Taliani&author=R.+Laufer&author=R.+De+Francesco&author=S.+Altamura&author=P.+Pace&title=RNA+polymerase+inhibitors%3A%E2%80%89+From+%CE%B1%2C%CE%B3-diketoacids+to+4%2C5-dihydroxypyrimidine-+or+3-methyl-5-hydroxypyrimidinonecarboxylic+acids.+Design+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DRNA%2520polymerase%2520inhibitors%253A%25E2%2580%2589%2520From%2520%25CE%25B1%252C%25CE%25B3-diketoacids%2520to%25204%252C5-dihydroxypyrimidine-%2520or%25203-methyl-5-hydroxypyrimidinonecarboxylic%2520acids.%2520Design%2520and%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00026"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00026_1"><span><span class="NLM_string-ref">Summa, V.; Petrocchi, A.; Matassa, V. G.; Gardelli, C.; Muraglia, E.; Rowley, M.; Gonzalez, Paz, O.; Laufer, R.; Monteagudo, E.; Pace, P. 4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profile in preclinical species. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 6646−6649.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6649&author=V.+Summa&author=A.+Petrocchi&author=V.+G.+Matassa&author=C.+Gardelli&author=E.+Muraglia&author=M.+Rowley&author=+Gonzalez&author=R.+Laufer&author=E.+Monteagudo&author=P.+Pace&author=+Dihydroxypyrimidine&title=carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+profile+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26atitle%3Dcarboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520profile%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00027"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00027_1"><span><span class="NLM_string-ref">Petrocchi, A.; Koch, U.; Matassa, V. G.; Pacini, B.; Stillmock, K. A.; Summa, V. From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors; SAR around the amide moiety. <i>  Bioorg. Med. </i><i>Chem.</i><i>Lett.</i><b>2007</b>, <i>17</i>, 350−353.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=353&author=A.+Petrocchi&author=U.+Koch&author=V.+G.+Matassa&author=B.+Pacini&author=K.+A.+Stillmock&author=V+Summa&title=From+dihydroxypyrimidine+carboxylic+acids+to+carboxamide+HIV-1+integrase+inhibitors%3B+SAR+around+the+amide+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26atitle%3DFrom%2520dihydroxypyrimidine%2520carboxylic%2520acids%2520to%2520carboxamide%2520HIV-1%2520integrase%2520inhibitors%253B%2520SAR%2520around%2520the%2520amide%2520moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00028"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00028_1"><span><span class="NLM_string-ref">Boffito, M.; Back, D. J.; Blaschke, T. F.; Rowland, M.; Bertz, R. J.; Gerber, J. G.; Miller, V. Protein binding in antiretroviral therapies. <i>  AIDS </i><i>Res. Hum. Retroviruses</i><b>2003</b>, <i>19</i>, 825−835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=835&author=M.+Boffito&author=D.+J.+Back&author=T.+F.+Blaschke&author=M.+Rowland&author=R.+J.+Bertz&author=J.+G.+Gerber&author=V+Miller&title=Protein+binding+in+antiretroviral+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoffito%26aufirst%3DM.%26atitle%3DProtein%2520binding%2520in%2520antiretroviral%2520therapies%26jtitle%3DAIDS%2520Res.%2520Hum.%2520Retroviruses%26date%3D2003%26volume%3D19%26spage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00029"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00029_1"><span><span class="NLM_string-ref">Pace, P.; Di Francesco, M. E.; Gardelli, C.; Muraglia, E.; Nizi, E.; Orvieto, F.; Petrocchi, A.; Rowley, M.; Harper, S.; Scarpelli, R.; Laufer, R.; Gonzalez Paz, O.; Monteagudo, E.; Bonelli, F.; Hazuda, D.; Stillmock, K. A.; Summa, V. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors. <i>  J. Med. Chem.</i><b>2007</b>, <i>50</i>, 2225−2239.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2239&author=P.+Pace&author=M.+E.+Di+Francesco&author=C.+Gardelli&author=E.+Muraglia&author=E.+Nizi&author=F.+Orvieto&author=A.+Petrocchi&author=M.+Rowley&author=S.+Harper&author=R.+Scarpelli&author=R.+Laufer&author=O.+Gonzalez+Paz&author=E.+Monteagudo&author=F.+Bonelli&author=D.+Hazuda&author=K.+A.+Stillmock&author=V.+Summa&author=+Dihydroxypyrimidine&title=as+novel+potent+and+selective+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26atitle%3Das%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm0704705b00030_1"><span><span class="NLM_string-ref">Hazuda, D. J.; Hastings, J. C.; Wolfe, A. L.; Emini, E. A. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. <i>  Nucleic Acids Res.</i><b>1994</b>, <i>22</i>, 1121−1122.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=1122&author=D.+J.+Hazuda&author=J.+C.+Hastings&author=A.+L.+Wolfe&author=E.+A+Emini&title=A+novel+assay+for+the+DNA+strand-transfer+reaction+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DA%2520novel%2520assay%2520for%2520the%2520DNA%2520strand-transfer%2520reaction%2520of%2520HIV-1%2520integrase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00031"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00031_1"><span><span class="NLM_string-ref">Wolfe, A. L.; Felock, P. J.; Hastings, J. C.; Blau, C. U.; Hazuda, D. J. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates. <i>  J. Virol.</i><b>1996</b>, <i>70</i>, 1424−1432.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1996&pages=1432&author=A.+L.+Wolfe&author=P.+J.+Felock&author=J.+C.+Hastings&author=C.+U.+Blau&author=D.+J+Hazuda&title=The+role+of+manganese+in+promoting+multimerization+and+assembly+of+human+immunodeficiency+virus+type+1+integrase+as+a+catalytically+active+complex+on+immobilized+long+terminal+repeat+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DThe%2520role%2520of%2520manganese%2520in%2520promoting%2520multimerization%2520and%2520assembly%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520as%2520a%2520catalytically%2520active%2520complex%2520on%2520immobilized%2520long%2520terminal%2520repeat%2520substrates%26jtitle%3DJ.%2520Virol.%26date%3D1996%26volume%3D70%26spage%3D1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00032"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00032_1"><span><span class="NLM_string-ref">Vacca, J. P.; Dorsey, B. D.; Schleif, W. A.; Levin, R. B.; McDaniel, S. L.; Darke, P. L.; Zugay, J.; Quintero, J. C.; Blahy, O. M.; Roth, E. L-735,524:  an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>1994</b>, <i>91</i>, 4096−4100.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4100&author=J.+P.+Vacca&author=B.+D.+Dorsey&author=W.+A.+Schleif&author=R.+B.+Levin&author=S.+L.+McDaniel&author=P.+L.+Darke&author=J.+Zugay&author=J.+C.+Quintero&author=O.+M.+Blahy&author=E.+Roth&title=an+orally+bioavailable+human+immunodeficiency+virus+type+1+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3Dan%2520orally%2520bioavailable%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D4100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00033"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00033_1"><span><span class="NLM_string-ref">Analytical HPLC/UV detection-based assay that measures the ability of a compound to bind with plasma proteins (primarily albumin) in pH 7.4 at room temperature.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Analytical+HPLC%2FUV+detection-based+assay+that+measures+the+ability+of+a+compound+to+bind+with+plasma+proteins+%28primarily+albumin%29+in+pH+7.4+at+room+temperature.+Analytical+HPLC%2FUV+detection-based+assay+that+measures+the+ability+of+a+compound+to+bind+with+plasma+proteins+%28primarily+albumin%29+in+pH+7.4+at+room+temperature."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00034"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00034_1"><span><span class="NLM_string-ref">The concentration of compound <b>27a</b> was 1 μM and microsomes 1 mg/mL. The degradation of the substrate was measured by LC/MS/MS during a 1 h incubation.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+concentration+of+compound+27a+was+1+%CE%BCM+and+microsomes+1+mg%2FmL.+The+degradation+of+the+substrate+was+measured+by+LC%2FMS%2FMS+during+a+1+h+incubation.+The+concentration+of+compound+27a+was+1+%CE%BCM+and+microsomes+1+mg%2FmL.+The+degradation+of+the+substrate+was+measured+by+LC%2FMS%2FMS+during+a+1+h+incubation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00035"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00035_1"><span><span class="NLM_string-ref">Butcher, J. W., Claremon, D. A., Connolly, T. M., Dean, D. C., Karczewski, J., Koblan, K. S., Kostura M.J., Liverton, N. J., Melillo D.G. Radioligand and binding assay. PCT Int. Appl. WO 2002 0205860 A1.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0205860&publication_year=2002&pages=A1&author=J.+W.+Butcher&author=D.+A.+Claremon&author=T.+M.+Connolly&author=D.+C.+Dean&author=J.+Karczewski&author=K.+S.+Koblan&author=M.J.+Kostura&author=N.+J.+Liverton&author=D.G+Melillo&title=Radioligand+and+binding+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26atitle%3DRadioligand%2520and%2520binding%2520assay%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2002%26volume%3D0205860%26spage%3DA1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00036"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00036_1"><span><span class="NLM_string-ref">Monteagudo, E.; Pesci, S.; Taliani, M.; Fiore, F.; Petrocchi, A.; Nizi, E.; Rowley, M.; Laufer, R.; Summa, V. Studies of metabolism and disposition of potent HIV integrase inhibitors using 19F-NMR spectroscopy. <i>  Xenobiotica</i>, <b>2007</b>, in press.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&conference=Xenobiotica&author=E.+Monteagudo&author=S.+Pesci&author=M.+Taliani&author=F.+Fiore&author=A.+Petrocchi&author=E.+Nizi&author=M.+Rowley&author=R.+Laufer&author=V.+Summa&title=Studies+of+metabolism+and+disposition+of+potent+HIV+integrase+inhibitors+using+19F-NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DMonteagudo%26aufirst%3DE.%26atitle%3DStudies%2520of%2520metabolism%2520and%2520disposition%2520of%2520potent%2520HIV%2520integrase%2520inhibitors%2520using%252019F-NMR%2520spectroscopy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00037"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00037_1"><span><span class="NLM_string-ref">Zhuang, L.; Wai, J. S.; Embrey, M. W.; Fisher, T. E.; Egbertson, M. S.; Payne, L. S.; Guare, J. P., Jr.; Vacca, J. P.; Hazuda, D. J.; Felock, P. J.; Wolfe, A. L.; Stillmock, K. A.; Witmer, M. V.; Moyer, G.; Schleif, W. A.; Gabryelski, L. J.; Leonard, Y. M.; Lynch, J. J., Jr.; Michelson, S. R.; Young, S. D. Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 453−456.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=456&author=L.+Zhuang&author=J.+S.+Wai&author=M.+W.+Embrey&author=T.+E.+Fisher&author=M.+S.+Egbertson&author=L.+S.+Payne&author=J.+P.+Guare&author=+Jr&author=D.+J.+Hazuda&author=P.+J.+Felock&author=A.+L.+Wolfe&author=K.+A.+Stillmock&author=M.+V.+Witmer&author=G.+Moyer&author=W.+A.+Schleif&author=L.+J.+Gabryelski&author=Y.+M.+Leonard&author=J.+J.+Lynch&author=+Jr&author=S.+D+Young&title=Design+and+synthesis+of+8-hydroxy-%5B1%2C6%5Dnaphthyridines+as+novel+inhibitors+of+HIV-1+integrase+in+vitro+and+in+infected+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520synthesis%2520of%25208-hydroxy-%255B1%252C6%255Dnaphthyridines%2520as%2520novel%2520inhibitors%2520of%2520HIV-1%2520integrase%2520in%2520vitro%2520and%2520in%2520infected%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00038"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00038_1"><span><span class="NLM_string-ref">Culbertson, T. P. Synthesis of 5,6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic acid, methyl ester, a correct structure. <i>  J. Heterocycl. Chem.</i><b>1979</b>, <i>16</i>, 1423−1424.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1424&author=T.+P+Culbertson&title=Synthesis+of+5%2C6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic+acid%2C+methyl+ester%2C+a+correct+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCulbertson%26aufirst%3DT.%2BP%26atitle%3DSynthesis%2520of%25205%252C6-dihydroxy-2-phenyl-4-pyrimidine-carboxylic%2520acid%252C%2520methyl%2520ester%252C%2520a%2520correct%2520structure%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00039"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00039_1"><span><span class="NLM_string-ref">Dreher, S. D.; Ikemoto, N.; Gresham, V.; Liu, J.; Dormer, P. G.; Balsells, J.; Mathre, D.; Novak, T. J.; Armstrong, J. D. I. Highly selective synthesis of 2-substituted-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid derivatives using a novel protected dihydroxyfumarate. <i>  Tetrahedron </i><i>Lett.</i><b>2004</b>, <i>45</i>, 6023−6025.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=6025&author=S.+D.+Dreher&author=N.+Ikemoto&author=V.+Gresham&author=J.+Liu&author=P.+G.+Dormer&author=J.+Balsells&author=D.+Mathre&author=T.+J.+Novak&author=J.+D.+I+Armstrong&title=Highly+selective+synthesis+of+2-substituted-5-hydroxy-6-oxo-1%2C6-dihydropyrimidine-4-carboxylic+acid+derivatives+using+a+novel+protected+dihydroxyfumarate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDreher%26aufirst%3DS.%2BD.%26atitle%3DHighly%2520selective%2520synthesis%2520of%25202-substituted-5-hydroxy-6-oxo-1%252C6-dihydropyrimidine-4-carboxylic%2520acid%2520derivatives%2520using%2520a%2520novel%2520protected%2520dihydroxyfumarate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D6025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm0704705b00040_1"><span><span class="NLM_string-ref">Zhong, Y.-L.; Zhou, H.; Gauthier, D. R.; Askin, D. Efficient synthesis of functionalized pyrimidones via microwave-accelerated reaction. <i>  Tetrahedron Lett.</i><b>2006</b>, <i>47</i>, 1315−1317.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1317&author=Y.-L.+Zhong&author=H.+Zhou&author=D.+R.+Gauthier&author=D+Askin&title=Efficient+synthesis+of+functionalized+pyrimidones+via+microwave-accelerated+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DY.-L.%26atitle%3DEfficient%2520synthesis%2520of%2520functionalized%2520pyrimidones%2520via%2520microwave-accelerated%2520reaction%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00041"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00041_1"><span><span class="NLM_string-ref">In some runs, >12:1 selectivity was observed. Presence of pyridine in the Bz-pyrimidine starting material significantly degraded the regioselectivity. A batch with 1 wt% pyridine gave ∼3:1 selectivity. Removal of pyridine after the benzoylation step by extracting with dilute HCl is recommended.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+In+some+runs%2C+%3E12%3A1+selectivity+was+observed.+Presence+of+pyridine+in+the+Bz-pyrimidine+starting+material+significantly+degraded+the+regioselectivity.+A+batch+with+1+wt%25+pyridine+gave+%E2%88%BC3%3A1+selectivity.+Removal+of+pyridine+after+the+benzoylation+step+by+extracting+with+dilute+HCl+is+recommended.+In+some+runs%2C+%3E12%3A1+selectivity+was+observed.+Presence+of+pyridine+in+the+Bz-pyrimidine+starting+material+significantly+degraded+the+regioselectivity.+A+batch+with+1+wt%25+pyridine+gave+%E2%88%BC3%3A1+selectivity.+Removal+of+pyridine+after+the+benzoylation+step+by+extracting+with+dilute+HCl+is+recommended."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00042"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00042_1"><span><span class="NLM_string-ref">Brown, G. R.; Foubister, A. J.; Wright, B. Chiral synthesis of 3-substituted morpholines via serine enantiomers and reductions of 5-oxomorpholine-3-carboxylate. <i>  J. Chem. Soc., Perkin Trans. I</i><b>1985</b>, 2577−2580.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2577&publication_year=1985&pages=2580&author=G.+R.+Brown&author=A.+J.+Foubister&author=B+Wright&title=Chiral+synthesis+of+3-substituted+morpholines+via+serine+enantiomers+and+reductions+of+5-oxomorpholine-3-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BR.%26atitle%3DChiral%2520synthesis%2520of%25203-substituted%2520morpholines%2520via%2520serine%2520enantiomers%2520and%2520reductions%2520of%25205-oxomorpholine-3-carboxylate%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%2520I%26date%3D1985%26volume%3D2577%26spage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00043"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00043" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00043_1"><span><span class="NLM_string-ref">De Kimpe, N.; Stevens, C. A convenient synthesis of 6-acetyl-1,2,3,4-tetrahydropyridine, the principle bread flavor component. <i>  J. Org. Chem.</i><b>1993</b>, <i>58</i>, 2904−2906.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=2906&author=N.+De+Kimpe&author=C+Stevens&title=A+convenient+synthesis+of+6-acetyl-1%2C2%2C3%2C4-tetrahydropyridine%2C+the+principle+bread+flavor+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DN.%26atitle%3DA%2520convenient%2520synthesis%2520of%25206-acetyl-1%252C2%252C3%252C4-tetrahydropyridine%252C%2520the%2520principle%2520bread%2520flavor%2520component%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D2906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00044"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00044" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00044_1"><span><span class="NLM_string-ref">Belleau, B. The synthesis of (+/−), (+), and (−) α-(3-thiamorpholinyl)-benzhydrol, a new selective stimulant of the central nervous system. <i>  J. Med. Pharm. Chem.</i><b>1960</b>, <i>2</i>, 553−562.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1960&pages=562&author=B+Belleau&title=The+synthesis+of+%28%2B%2F%E2%88%92%29%2C+%28%2B%29%2C+and+%28%E2%88%92%29+%CE%B1-%283-thiamorpholinyl%29-benzhydrol%2C+a+new+selective+stimulant+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB%26atitle%3DThe%2520synthesis%2520of%2520%2528%252B%252F%25E2%2588%2592%2529%252C%2520%2528%252B%2529%252C%2520and%2520%2528%25E2%2588%2592%2529%2520%25CE%25B1-%25283-thiamorpholinyl%2529-benzhydrol%252C%2520a%2520new%2520selective%2520stimulant%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1960%26volume%3D2%26spage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00045"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00045" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00045_1"><span><span class="NLM_string-ref">Bousquet, Y.; Anderson, P. C.; Bogri, T.; Duceppe, J.-S.; Grenier, L.; Guse, I. Preparation of enantiopure 4-oxygenated pipecolic acid derivatives. <i>  Tetrahedron</i><b>1997</b>, <i>53</i>, 15671−15680.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=15680&author=Y.+Bousquet&author=P.+C.+Anderson&author=T.+Bogri&author=J.-S.+Duceppe&author=L.+Grenier&author=I+Guse&title=Preparation+of+enantiopure+4-oxygenated+pipecolic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBousquet%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520enantiopure%25204-oxygenated%2520pipecolic%2520acid%2520derivatives%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D15680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00046"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00046" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00046_1"><span><span class="NLM_string-ref">Pozdnev, V. F. Activation of carboxylic acids by pyrocarbonates. Application of di-<i>tert</i>-butyl pyrocarbonate as condensing reagent in the synthesis of amides of protected aminoacids and peptides. <i>  Tetrahedron </i><i>Lett.</i><b>1995</b>, <i>36</i>, 7115−7118.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=7118&author=V.+F+Pozdnev&title=Activation+of+carboxylic+acids+by+pyrocarbonates.+Application+of+di-tert-butyl+pyrocarbonate+as+condensing+reagent+in+the+synthesis+of+amides+of+protected+aminoacids+and+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozdnev%26aufirst%3DV.%2BF%26atitle%3DActivation%2520of%2520carboxylic%2520acids%2520by%2520pyrocarbonates.%2520Application%2520of%2520di-tert-butyl%2520pyrocarbonate%2520as%2520condensing%2520reagent%2520in%2520the%2520synthesis%2520of%2520amides%2520of%2520protected%2520aminoacids%2520and%2520peptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D7118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00047"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00047" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00047_1"><span><span class="NLM_string-ref">The e.e. were determined by chiral HPLC using a column Chiralpak AD 250 × 4.6 mm. Eluent <i>n</i>-hexane/ethanol = 85:15 for compound <b>85a</b> and <i>n</i>-hexane/isopropanol = 50:50 for compound <b>86a</b>; flow rate = 1 mL/min, λ = 300 nm.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+e.e.+were+determined+by+chiral+HPLC+using+a+column+Chiralpak+AD+250+%C3%97+4.6+mm.+Eluent+n-hexane%2Fethanol+%3D+85%3A15+for+compound+85a+and+n-hexane%2Fisopropanol+%3D+50%3A50+for+compound+86a%3B+flow+rate+%3D+1+mL%2Fmin%2C+%CE%BB+%3D+300+nm.+The+e.e.+were+determined+by+chiral+HPLC+using+a+column+Chiralpak+AD+250+%C3%97+4.6+mm.+Eluent+n-hexane%2Fethanol+%3D+85%3A15+for+compound+85a+and+n-hexane%2Fisopropanol+%3D+50%3A50+for+compound+86a%3B+flow+rate+%3D+1+mL%2Fmin%2C+%CE%BB+%3D+300+nm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00048"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00048" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00048_1"><span><span class="NLM_string-ref">Manfrè, F.; Kern, J.-M.; Biellmann, J.-F. Synthesis of proline analogues as potential mechanism-based inhibitors of proline dehydrogenase:  4-Methylene-<span class="smallcaps smallerCapital">l</span>-, (<i>E</i>)- and (<i>Z</i>)-4-fluoromethylene)-<span class="smallcaps smallerCapital">l</span>-, <i>cis</i>- and <i>trans</i>-5-ethynyl-(+/−)-, and <i>cis</i>- and <i>trans</i>-5-vinyl-<span class="smallcaps smallerCapital">l</span>-proline. <i>  J. Org. Chem.</i><b>1992</b>, <i>57</i>, 2060−2065.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=2065&author=F.+Manfr%C3%A8&author=J.-M.+Kern&author=J.-F+Biellmann&title=Synthesis+of+proline+analogues+as+potential+mechanism-based+inhibitors+of+proline+dehydrogenase%3A%E2%80%89+4-Methylene-l-%2C+%28E%29-+and+%28Z%29-4-fluoromethylene%29-l-%2C+cis-+and+trans-5-ethynyl-%28%2B%2F%E2%88%92%29-%2C+and+cis-+and+trans-5-vinyl-l-proline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfr%25C3%25A8%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520proline%2520analogues%2520as%2520potential%2520mechanism-based%2520inhibitors%2520of%2520proline%2520dehydrogenase%253A%25E2%2580%2589%25204-Methylene-l-%252C%2520%2528E%2529-%2520and%2520%2528Z%2529-4-fluoromethylene%2529-l-%252C%2520cis-%2520and%2520trans-5-ethynyl-%2528%252B%252F%25E2%2588%2592%2529-%252C%2520and%2520cis-%2520and%2520trans-5-vinyl-l-proline%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D2065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00049"><div class="reference"><strong class="refLabel"><a href="#jm0704705b00049" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-jm0704705b00049_1"><span><span class="NLM_string-ref">Smith, E. M.; Swiss, G. F.; Neustadt, B. R.; Gold, E. H.; Sommer, J. A.; Brown, A. D.; Chiu, P. J. S.; Moran, R.; Sybertz, E. J.; Baum, T. Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors:  <i>N</i>-(Mercaptoacyl)-4-substituted- (<i>S</i>)-prolines. <i>  J. Med. Chem.</i><b>1988</b>, <i>31</i>, 875−885.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=885&author=E.+M.+Smith&author=G.+F.+Swiss&author=B.+R.+Neustadt&author=E.+H.+Gold&author=J.+A.+Sommer&author=A.+D.+Brown&author=P.+J.+S.+Chiu&author=R.+Moran&author=E.+J.+Sybertz&author=T+Baum&title=Synthesis+and+pharmacological+activity+of+angiotensin+converting+enzyme+inhibitors%3A%E2%80%89+N-%28Mercaptoacyl%29-4-substituted-+%28S%29-prolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%2BM.%26atitle%3DSynthesis%2520and%2520pharmacological%2520activity%2520of%2520angiotensin%2520converting%2520enzyme%2520inhibitors%253A%25E2%2580%2589%2520N-%2528Mercaptoacyl%2529-4-substituted-%2520%2528S%2529-prolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0704705b00050"><div class="reference"><div class="NLM_citation" id="rightTab-jm0704705b00050_1"><span><span class="NLM_string-ref">Demange, L.; Menez, A.; Dugave, C. Practical synthesis of Boc- and Fmoc-protected 4-fluoro and 4-difluoroprolines from <i>trans</i>-4-hydroxyproline. <i>  Tetrahedron Lett.</i><b>1998</b>, <i>39</i>, 1169−1172.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=1172&author=L.+Demange&author=A.+Menez&author=C+Dugave&title=Practical+synthesis+of+Boc-+and+Fmoc-protected+4-fluoro+and+4-difluoroprolines+from+trans-4-hydroxyproline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0704705b00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDemange%26aufirst%3DL.%26atitle%3DPractical%2520synthesis%2520of%2520Boc-%2520and%2520Fmoc-protected%25204-fluoro%2520and%25204-difluoroprolines%2520from%2520trans-4-hydroxyproline%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><b>Note Added after ASAP Publication.</b> This paper was published on September 8, 2007 with incorrect data reported in Scheme 6. The correct version was published ASAP on September 10, 2007.</div></div></div><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021%2Fjm0704705">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Experimental section relative to the synthesis of compounds <b>66d</b>, <b>78</b>, <b>89g</b>, <b>89h</b>, <b>85i</b>, <b>90n</b>, <b>86m</b>, <b>85b</b>, and <b>85e</b>, analytical data such as chromatographic and high-resolution mass data used as criterion of purity, and PK procedures are reported in details. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0704705/suppl_file/jm0704705si20070420_035126.pdf">jm0704705si20070420_035126.pdf (237.78 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm0704705&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-20%3Barticle%3Aarticle%3A10.1021%2Fjm0704705%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm0704705" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                398KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679950b58c203ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
